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I'm Just a Farmer, Plain and Simple 
I'm just a farmer, plain and simple. 
Not of royal birth, but rather a worker of the earth.  
I know not of riches, but rather of patches on my britches 
 
I'm just a farmer, plain and simple.  
I know of drought and rain, of pleasure and pain.  
I know the good, the bad, the happy and the sad.  
 
I'm a man of emotions.  
A man who loves this land and the beauty of its sand.  
I'm just a farmer, plain and simple.  
 
I know the spring's fresh flow and autumn's golden glow.  
Of a new born calf's hesitation and an eagle's destination.  
I'm just a farmer, plain and simple.  
 
I know of tall pines and long waiting lines.  
I know the warmth of campfires and the agony of flat tires.  
I'm just a farmer, plain and simple.  
 
I'm a man who loves his job  
And the life that I live.  
I'm just a farmer, plain and simple  
 
I'm a reaper of harvest.  
I'm the sower of seeds and I'm the tender of stock.  
I'm just a farmer, plain and simple.  
 
I know of planting wheat and baling hay and animals going astray.  
I live in a complex world, but my faith guides me.  
I'm just a farmer, plain and simple.  
 
I am a man who works with God. I cannot succeed without his help.  
For you see, I'm just a farmer, plain and simple. 
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In 2007, over 33.7 million head of cattle were harvested in the United States with 
steers and heifers accounting for 51.2% and 30.2% of that number, respectively (USDA, 
2007).  According to the 2005 National Beef Quality Audit (Garcia et al., 2008), the 
number one contributor to lost economic opportunities per slaughter steer/heifer to the 
industry was quality grade which accounted for almost one-half, or $26.81 of the total 
loss of $55.68 per head.  The remainder of the loss was attributed to yield grade and 
carcass weight.  This calculated to nearly a two billion dollar loss to the beef industry for 
2007.  This figure does not include losses incurred from the remaining 18.6% of animals 
harvested consisting mainly of dairy/beef cows and bulls.  One also needs to consider the 
waste of resources and resulting inefficiencies in production incurred by over-fattening 
cattle to improve the palatability and acceptability of meat for the consumer (S ith et al., 
2000).  Producing quality beef is at the forefront of concerns facing the U.S. fed-beef 
industry as evidenced by the top ten challenges put forth by participants in the 2005 
National Beef Quality Audit (Garcia et al., 2008).  Six of the top ten challenges can be 
related to either “inadequate” or “excessive” adipose tissue deposition.  Over the past 
several years, the beef industry has moved from a live- or carcass-weight pricing 
structure towards a “grid” based pricing structure in the marketing of fed cattle  
.
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(Schroeder et al., 2003), with the main components of most grid pricing frameworks 
consisting of quality grade and yield grade.  The majority of the “waste” nd “taste” 
inefficiencies in the beef industry are due to either excess or insufficient fat deposition 
(Dolezal, 2000); thus, it is important to characterize the differences between “ aste” fat 
and “taste” fat deposition sites relative to the value of the carcass.   
Numerous factors have been shown to affect the rate of intramuscular adipose 
tissue deposition (marbling) in beef cattle including regulation of lipogenesis, gnetics, 
age, nutrition, vitamins, management, and environment (Smith, 1995; Pyatt and Berger, 
2005; Ross et al., 2005).  The genetic relationships between body composition and 
adipose tissue (fat) accretion are of particular interest as they are directly related to final 
carcass composition and consequently the ultimate value of the carcass.  A moderate t  
strong genetic antagonism exists between carcass fatness traits and carcass yield 
percentage, across and within breeds of cattle (Gwartney et al., 1996; Vieselmeyer et al., 
1996; Burrow et al., 2001), which creates difficulty in resolving the problem of “waste” 
vs. “taste” adipose tissue deposition. 
The ability to utilize exogenous compounds to manipulate different aspects of 
muscle and adipose tissue to increase feedlot efficiency has had a great economic impact 
on the beef industry in recent years.  One such class of exogenous compounds is 
phenethanolamines or β-adrenergic agonists.  β-adrenergic agonists seem to act by 
increasing the efficiency of growth by preferentially stimulating skeletal muscle growth 
as compared to adipose tissue (Baxa, 2008).  Zilpaterol hydrochloride, commercially 
available as Zilmax® (Intervet/Schering-Plough Animal Health, Millsboro, DE), is a 
synthetic β2-adrenergic agonist used for increased rate of weight gain, improved feed 
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efficiency and increased carcass leanness in cattle fed in confinement for slaughter 
(Dikeman, 2007; Kern et al., 2009).  In 2006, Zilmax was approved by the U.S. Food and 
Drug Administration (FDA) as a feed ingredient for cattle during the last phase of the 
feeding period.  Zilpaterol hydrochloride (Zilmax®) has been shown to have an affect on 
growth performance, dressing percent, hot carcass weight, and carcass muscling in 
several studies. 
As adipose tissue accretion in the bovine is controlled by a balance of adipocyte 
proliferation and differentiation.  It is essential to evaluate how diet or the administration 
of exogenous compounds affects and/or regulates adipocyte proliferation in order to 
improve the quality of beef produced.  Knowledge and understanding of the relationships 
between mechanisms regulating metabolic and signaling pathways and other contributing 
factors which orchestrate adipose tissue deposition within and between adipose tissue 
depots could possibly be integrated into management practices in a value-based 
marketing system to produce a consistent and desirable product that would ultimately 
enhance consumer beef consumption, increase efficiency of production, and increase 











1. Determine the gene expression profiles of bovine intramuscular and subcutaneous 
adipose tissue depots at the end of the growing and finishing production phases 
using microarray and RT-PCR analysis.  The array used consisted of a 1,089 
cDNA non-redundant clone library constructed from subcutaneous and visceral 
adipose tissue. 
2. Determine the gene expression profiles of bovine intramuscular, subcutaneous, 
and visceral adipose tissue depots and Longissimus muscle tissue in cattle fed 
Zilpaterol hydrochloride the last 20 days of the feeding phase plus a 3-day 
withdrawal period using microarray and RT-PCR analysis.  A bovine array 
containing a total of 24,000 oligonucleotide probes was used in this research 
which includes 16,846 probes designed from ESTs that were aligned to 
homologous vertebrate proteins and to the 6X bovine genome assembly (BGA).  
The probe set was supplemented with oligos designed from 703 predicted RefSeq 
genes, 5,943 reproductive tissue ESTs with a BGA but no protein alignment, and 






REVIEW OF LITERATURE 
Introduction 
 
Value based marketing seems to be steadily driving the beef industry.  An 
increasingly larger percentage of cattle seem to be moving from a live- or carcass-weight 
pricing structure through a grid pricing structure and/or a production alliance program 
(Schroeder et al., 2003; Johnson and Ward, 2005).  Grid pricing allows for adjustment 
with premiums, as well as discounts, to a base price according to the merits of the 
individual beef carcass (Feuz et al., 1993).  Grid premiums and discounts send a signal to 
the producer regarding those traits processors are looking for based on consumer 
preference (Johnson, 2006a).  In comparing different marketing methods of slaughter 
cattle including sales on a live-weight basis, sales on a dressed carcass weight, sales on a 
dressed weight/grade and yield basis, and following a value based marketing approach, it 
was determined that feedlot production variables best explained the profit/loss differences 
under live-weight marketing better than did the carcass characteristi s.  However, carcass 
characteristics appeared to become as important, or more important, to profit/loss 
differences as the feedlot production variables when cattle were marketed on a grade and 
yield basis or through a value-based marketing program (Feuz et al., 1993).  Feuz et al. 
(1993) also pointed out in his analysis of marketing strategies that the amount of  
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subcutaneous (s.c.) fat, unwanted by the consumer, was negatively related to profit, 
regardless of the marketing method.  The components involved in most grid pricing or 
value based pricing structures are quality grade and yield grade.  Quality grade is an 
indication of eating satisfaction or palatability while yield grade is an estimate of the 
percentage of closely trimmed retail cuts to be derived from the carcass.  Mrbling, or 
intramuscular (i.m.) fat, is a component of quality grade and is evaluated in a cross 
section of the Longissimus muscle (LM).  Yield grade is determined by the amount of 
external fat on the carcass at the 12th rib (s.c.) and is factored by the percentage of kidney, 
pelvic and heart (KPH) fat determined in the carcass (USDA, 2001).  The single most 
important factor for determining carcass quality in the United States and abroad continues 
to be marbling score; however, during the last three decades, there has been a noticeable 
decrease in USDA beef carcass quality grades with no change in the average USDA yield 
grade (Chung and Johnson, 2008).  Marbling is considered to be a moderately to highly 
heritable trait, with approximately 37% of the observed differences attributed to heredity 
(Utrera and Van Vleck, 2004).  This means that approximately 63% of marbling in an 
animal depends on environment, management and nutrition.  
What affects the industry as a whole actually begins at the cow/calf sector, as hat 
sector’s end product is dealt with downstream in the industry.  The route a calf takes to 
get to the feedyard can track in many different directions.  In 2007, over 33.7 million 
head of cattle were harvested in the United States with steers and heifers accounting for 
51.2% and 30.2% of that number, respectively (USDA, 2007).  According to the 2005 
National Beef Quality Audit (Garcia et al., 2008), the number one contributor to lost 
economic opportunities per slaughter steer/heifer to the industry was quality gr de, which 
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accounted for almost one-half, or $26.81 of the total loss of $55.68 per head.  The 
remainder of the loss was attributed to yield grade and carcass weight.  As divergent as 
the beef industry may seem at times, there are still shared concerns between the different 
production sectors.  The “Top Ten Quality Challenges” put forth in the 2005 National 
Beef Quality Audit by those engaged in the four production sectors; consisting of he 
seed stock, cow/calf, stocker/backgrounding and feedlot/finishing sectors included: 1) 
insufficient marbling and low quality grades, 2) lack of uniformity in cattle, 3) inadequate 
tenderness of beef, 4) yield grades too high, 5-tie) low cutability, 5-tie) carcass weights to 
heavy, 7) injection site lesions, 8) inadequate flavor, 9) inadequate muscling, and 10) 
excess fat cover (Smith et al., 2006a).  Six of these ten “quality challenges” or concerns 
can be tied to and/or trace back to “inadequate” or “excess” adipose tissue deposition.  
The majority of the “waste” and “taste” inefficiencies in the beef industry are due to 
either excess or insufficient fat deposition (Dolezal, 2000) and calculates to an annual 
loss of nearly 2 billion dollars to the beef industry.  This does not include the 
inefficiencies of production that are incurred due to over-fattening cattle, trying to create 
that “higher quality carcass” that will fit the consumer’s wants and expectations (Smith et 
al., 2000).  Thus, it is important to characterize the differences between “waste” fat and 
“taste” fat deposition sites relative to the value of the carcass. 
Due to geographical regions in the United States, there is diversity in management 
skills and systems within and between the different sectors of the beef industry (Bennett 
and Williams, 1994).  The diversity in geographic regions also extends between the 
extremes as it pertains to feedstuff availability during the growing or stocker phase of 
production.  Backgrounding, a term used predominately in the northern regions of the 
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United States (Peel, 2000), has been described as the production phase between the tim a 
calf is weaned until it’s placement into a feedyard for finishing (Thomson and White, 
2006).  Stockers, a term used predominately in the southern regions of the United States 
(Peel, 2000), describes young lightweight calves which are raised primarily on available 
forage or pasture diets until they reach a desired weight and placed in the feedlot (Bock et 
al., 1991).  The importance of these backgrounding or stocker programs are evident as it 
is estimated that on January 1 of a given year, 76% of the previous year’s calf crop is still 
available for feedlot placement (Peel, 2000).  Animals in stocker/backgrounder programs 
may be raised to 1/2 to 2/3 harvest weight (Sainz and Vernazza Paganini, 2004) and can 
serve to combine smaller groups of cattle into larger groups and distribute cattle numbers 
from a seasonal production cycle to a year-round production cycle (Bennett and 
Williams, 1994). 
Due to geographical regions in the U. S., backgrounding/stocker programs 
involve a wide range of production environments and management skills, such that, not 
all programs and systems are feasible for producers in the various locations in the U.S. 
(Peel, 2006).  Though stocker cattle are most often grazed on forages; resources, 
environment and/or market conditions might warrant the confinement of the animal to a 
drylot system with those animals fed a grain-based ration (Thomson and White, 2006).  
Two alternatives to roughage or pasture based programs are: 1) program fed, defin  by 
Galyean, (1999) as the use of net energy equations to calculate the quantities of feed 
required to meet the needs of maintenance plus a specific average daily gain (ADG), and 
2) calf-fed programs, a system where cattle are placed on an ad libitum finishing diet 
immediately following weaning (Lardy, 1998).  Advantages of program fed cattle using a 
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high concentrate diet vs. grazing include; reduced feed costs when pasture costs are high 
or in short supply and easier adaptation of cattle to an ad libitum finishing diet (Galyean, 
1999).  Advantages of a calf-fed program may be realized when large framed cattl  are 
placed on a high concentrate diet offered ad libitum after weaning in order to insure an 
adequate level of body fat is achieved (Lardy, 1998).  Implementing a calf-fed program 
for smaller framed cattle may be detrimental to the quality of the carcass due to a shift in 
the animal’s physiological maturity to a point where those cattle do not have time to 
develop i.m. fat (Schoonmaker et al., 2004; McCurdy, 2006) 
Nutrition during the growing phase has been shown to affect the performance of 
cattle during their finishing phase as hot carcass weight, Longissimus muscle area, and 
marbling score were greater for steers grazing winter wheat compared to steers grazing 
native range prior to feedlot placement (Choat et al., 2003).  Cattle fed grain-based diets 
have been shown to have increased i.m. fat compared to those fed forage-based diets as 
marbling scores were significantly lower for steers grazed on summer pastu e nd then 
fed for either 45 or 75 d in the feedlot compared to steers taken to the feedlot 
immediately after weaning (Schaake et al., 1993).  Furthermore, steers fed a diet 
consisting of 68% high-moisture corn and 25% alfalfa silage had increased i.m. fat
compared to cattle fed a 95% alfalfa silage diet for the same number of days on feed 
(Mandell et al., 1998).  In addition, grazing-based growing programs prior to feedl t 
entry resulted in cattle with lower marbling scores compared to calves placed directly in a 
drylot and fed a silage-based diet followed by a corn diet (Hedrick et al., 1983).  More so, 
using suppressive subtractive hybridization, Ross et al., (2005) reported different 
nutritional background in beef steers (i.e., steers on supplemented native range or steers 
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on high-gain wheat pasture) altered gene expression in s.c. and i.m. adipose tissue depots 
during the feedlot phase.  Thus, it is important to determine the effects of background, 
previous nutrition and management systems throughout the production phases on 
marbling and subsequent quality of the carcass.  
 
Adipose Tissue 
 Adipose tissue can be described as a loose association of lipid filled adipocytes 
held in a framework of connective tissue containing not only adipocytes, but also 
preadipocytes, stromal vascular cells, multipotent mesenchymal stem cells, endothelial 
progenitor cells, fibroblastic connective tissue cells, leukocytes, and macrophages 
(Albright and Stern, 1998; Cinti, 2005; Tchkonia et al., 2007).  Most adipose tissues form 
at sites of loose connective tissue (Rosen and Spiegelman, 2000); more so, i.m. adipose 
tissue has been shown to develop within perimysium connective tissue alongside 
myofibers (Moody and Cassens, 1968).  Each individual adipocyte is supported by a 
basement membrane composed of collagens and other extracellular matrix (ECM) 
components (Pierleoni et al., 1998), with adipocyte size varying dramatically depending 
on varying physiological conditions (Farnier et al., 2003).  The onset of adipogenesis is 
usually defined by ECM remodeling with the ECM adhesion molecules and other 
signaling components changing with adipose differentiation (Liu et al., 2005).  Each
adipocyte is in contact with at least one capillary providing support for metabolism 
(Albright and Stern, 1998; Harper and Pethick, 2004; Vázquez-Vela et al., 2008) with 
each adipocyte being highly innervated (Fliers et al., 2003; Cinti, 2005).  Arteriolar 
development precedes adipose development in internal fat depots as the earliest event 
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associated with adipogenesis is the increase in the abundance of the capillary networks in 
regions of s.c. loose connective tissue (Hausman and Richardson, 2004).  A key 
characteristic of angiogenesis is the breakdown of connective tissue and basement 
membrane proteins (Yancopoulos et al., 2000), which include several angiogenic factors 
including vascular endothelial growth factor (VEGF), VEGF receptors, matrix 
metalloproteinases and the plasminogen enzymatic system (Hausman and Richar son, 
2004).  Hausman and Thomas (1984) reported that in pigs, capillary beds in dense 
connective tissue are immature and contain few adipocytes, whereas capillary beds in 
loose connective tissue are mature and contain more adipocytes.  Although angiogenesis 
is unmistakably linked to adipogenesis, it is not apparent whether adipogenesis can 
induce angiogenesis or vice-versa or both (Rosen, 2002). 
Bovine adipocytes have been shown to vary in size according to depot site 
(Moody and Cassens, 1968).  According to work by Smith and Crouse, (1984), i.m. 
adipose tissue had smaller mean cell diameter and smaller mean cell volume than s.c. 
adipose tissue with the i.m. adipose tissue tending to have a greater number of cells per 
gram of tissue than s.c. adipose tissue.  More so, i.m. adipose tissue cell diameter has 
been reported to differ within the same deposition site between different breeds of cattle 
(Hood and Allen, 1973; Miller et al., 1991); between different deposition sites between 
different breeds of cattle (Cianzio et al., 1985; May et al., 1994); and between different 
deposition sites within the same breed of cattle, with i.m. adipose cell diameter smaller 
than s.c. cell diameter (Lin et al., 1992).  Adipocyte diameter was reported to be larger in 
the intermuscular adipose tissue than in the s.c. and i.m. adipose tissues in Japanese Black 
x Holstein crossbred steers (Yang et al, 2003).  The contribution of hypertrophy 
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(increased cell size) and hyperplasia (increased cell number) to i.m. fat deposition is 
controversial; however, Yang et al. (2006) reported that hyperplasia plays a greater role 
in i.m. fat deposition than hypertrophy.  It is unclear whether cell size reflects features of 
the muscle environment or a genetically determined potential for cell growth (Harper and 
Pethick, 2004), as marbling adipocytes from Wagyu steers exhibited twice the rate of 
DNA synthesis at the same physiological maturity as marbling adipocytes from Angus 
steers suggesting that the adipose tissues from Wagyu steers possessed a greater capacity 
for cell proliferation than adipose tissues from Angus steers (May et al., 1994).  Cianzio 
(1985) reported the adipose cell number/gram of intramuscular adipose tissue a better
indicator of marbling score than adipose cell diameter. 
Mature adipocytes function in lipid storage and energy flow but also can act as an 
endocrine organ in the production of hormones or regulatory compounds termed 
“adipokines” (Otto and Lane, 2005; Wang et al., 2008; Dodson and Fernyhough, 2008).  
The adipocyte is essentially a lipid storage container whose morphology is supported by 
components of the extracellular matrix (Pierleoni et al., 1998; Wang et al., 2008) and can 
be controlled by, not only the level of metabolites in the blood, but by paracrine, 
autocrine and/or endocrine factors as well as neural regulation (Fliers et al., 2003; Cinti, 
2005; Otto and Lane, 2005). 
A mature white adipocyte cell can range in size from 25 to 200 microns and 
usually contains only one large fat droplet, or is termed unilocular; however, multiocular 
cells can occur.  The adipocyte cell contains mitochondria and a nucleus, which are 
usually located, due to the size of lipid droplet, near the outer rim of the cytoplasm 
(Harper and Pethick, 2004; Cinti, 2005; Vázquez-Vela et al., 2008).  This unilocular lobe 
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contains no intracellular organelles and is composed mainly of triglycerides; however, 
some free fatty acids, diglycerides, cholesterol, and phospholipids, proteins, and water are 
present.  Over twenty different fatty acids have been profiled in bovine i.m. fat; however, 
over 92% of the total fatty acid content was composed of six main fatty acids; oleic 
(C18:1; 41%), palmitic (C16:0; 27%), stearic (C18:0;15%), linoleic (C18:2; 3.9%), 
palmitoleic (C16:1; 3.7%) and myristic (C14:0; 3.6%) (Albright and Stern, 1998; 
Duckett, 2001).  In ruminants, de novo fat synthesis, consisting mainly of C18:0 and 
C16:0 in an approximate 2:1 ratio (Jenkins, 1992), occurs in adipose tissue rather than the 
liver and has been shown to occur three to five times greater in adipocytes from s.c. 
deposition than from adipocytes from i.m. deposition (Hood and Allen, 1973).  
Precursors include acetate, glucose, propionate, valerate, isobutyrate, isovalrate, nd 2-
methyl butyrate.  Acetyl Co-A is at the center of synthesis and can be produced from 
fatty acids, glucose (through pyruvate), amino acids, and ketone bodies.  In addition, i.m. 
and s.c. adipose tissues exhibit characteristic patterns in the uptake of lipogenic 
precursors used for fatty acid synthesis as indicated by in vitro studies.   
In s.c. adipose tissue, acetate has been shown to provide 70 to 80% of the acetyl 
units used in lipogenesis compared to i.m. adipose tissue, where acetate has been shown 
to provide only 10 to 25% of the acetyl units for lipogenesis.  On the other hand, in s.c. 
adipose tissue, glucose provides only 1 to 10% of the acetyl units for lipogenesis while 
providing 50 to 75% of the acetyl units in i.m. adipose tissue (Smith and Crouse, 1984).   
Adipose tissue can be divided into four distinct depots (Rouse and Wilson, 2001); 
fat surrounding the internal organs or internal fat/mesenteric fat; fat between the muscles 
or seam/intermuscular fat, which is higher in the forequarter than hindquarter area in 
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bovine (Swatland, 2009); fat on the surface of the animal under the hide or s.c., which is 
similar in both the forequarter and hindquarter area in bovine (Swatland, 2009); and fat 
within the muscle or i.m./marbling.  The order of deposition occurs at different times in 
the animal’s life with the order of deposition in cattle being mesenteric, intermuscular, 
s.c. and finally, i.m. (Pethick et al., 2004).  Seam fat, s.c. fat, and internal fat can be 
regarded as “waste fat”, while i.m. fat can be considered “taste fat” (Rouse and Wilson, 
2001; Pethick et al., 2004).  As mentioned earlier, the majority of the “waste” and “taste” 
inefficiencies in the beef industry are due to either excess or insufficient fat deposition 
(Dolezal, 2000). 
The literature indicates that i.m. and s.c. adipocytes represent cell populations that 
differ from each other, both morphologically and metabolically, as fatty acid biosynthesis 
in marbling adipocytes is 5 to 10% of the rates seen in s.c. adipose tissue with rate of 
incorporation of palmitic acid in i.m. adipose tissue exceeding the rate of incorporation in 
s.c. adipose tissue (Hood and Allen, 1973; Lin et al., 1992; Smith et al., 2000).  Hood and 
Allen (1973) reported adipocyte growth in young beef cattle was due to both hyperplasia 
(proliferation of cell number) and hypertrophy (enlargement of cell size) up to a juncture 
in the animal’s growth phase (reported at 8 mo of age), after which s.c. adipose tissue 
hyperplasia ceased and growth was due exclusively to hypertrophy; however, i.m. 
adipose tissue hyperplasia continued throughout 14 mo of age.   
As previously mentioned, adipose tissue can be distinguished from other lipid 
depots by its location within the perimysium connective tissue alongside myofibers 
(Moody and Cassens, 1968).  However, in some cases subjective judgment is necessary 
to discriminate i.m. adipose tissue (marbling) from connective tissue.  Marbling, or i.m. 
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fat, does not include fat that connects with any s.c. or intermuscualr fat depot.  When 
connections do occur, this seam fat is considered an invasion and is not included in the 
marbling score.  From a developmental point of view, this exclusion may or may not be
appropriate as the fore mentioned depots can be described as adipose tissue p r e, in that 
it is made up of adipose cells imbedded in connective tissue in close proximity to a blood 
capillary network (Harper and Pethick, 2004).  More so, myocytes have the ability to 
store some fat as droplets termed intramyocellular lipid that are not visible with the naked 
eye and thus are not regarded as a major contributor to the total intramuscular (marbling) 
fat pool of the beef carcass (Harper and Pethick, 2004). 
 
Adipose Development 
Numerous genes are expressed exclusively in adipose tissue during adipogenesis, 
the process by which mature fat cells develop from preadipocytes (Rosen and 
Spiegelman, 2000; Rosen et al., 2002).  The fate of the adipocyte precursor cell depends 
on the orchestration of various factors including the adhesion of the cell to the 
surrounding ECM or to neighboring cells, the combination of growth factors, the 
endocrine environment, neural inputs and the availability of macro- and micronutrients 
(Hausman et al., 2009).  Preadipocytes are an intermediate cell type which develop prior 
to obtaining the expression characteristics of differentiated adipocytes (Harper and 
Pethick, 2004), but can be induced to terminally differentiate into mature adipocytes 
when treated with “adipogenic” factors.  The timing of adipose tissue development, 
which tends to occur in multiple locations in the body (Rosen and Spiegelman, 2000), 
depends not only on the species studied, but also on the specific adipose location, or 
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depot, being studied (Corino et al., 2005).  For a specific depot to acquire and maintain 
the adipocyte phenotype, the timing of expression of these genes is critical(Tan ka et al., 
1997).  The adipocyte cell lineage develops from multipotent stem cells of mesenchymal 
(mesodermal) origin that can also give rise to muscle, bone, and cartilage (Rosen, 2002; 
Otto and Lane, 2005; Singh et al., 2007).  Even though these multipotent cells can 
undergo commitment to several different and distinct lineages, all are within a particular 
physiological system.  Although several factors have been identified that lead to the 
transformation of the multipotent mesenchymal cell to the adipocyte cell lineage in vitro; 
the signal(s), factor(s), or gene(s) responsible for this molecular transfo mation in vivo is 
still yet to be identified (Boone et al., 2000; Otto and Lane, 2005).  The potential for 
cellular development of adipocytes is thought to be fixed relatively early in life after 
which, changes in either the size of the cells or in the numbers of cells occurs in 
proportion to the initial number of cells and the lipogenic enzymes expressed (Pethick et 
al., 2004; Cartwright et al., 2007; Wang et al., 2009).  
Our present-day understanding of adipocyte development has been acquired from 
the study of adipogenesis employing cell culture models. These models have mainly 
utilized two types of cell lines, each representing cells arrested at different stages of 
adipocyte development (MacDougald and Lane, 1995; Novakofski, 2004; Otto and Lane, 
2005). The pattern of adipose differentiation observed in vitro appears to follow that of in 
vivo differentiation in that the adipocyte cells express markers of terminal differentiation; 
that is, the ability to accumulate lipid, and express signaling and metabolic pathways 
associated with mature adipocytes with the cells becoming hormone, or insulin sensitive 
(Gaillard et al., 1991; MacDougald and Lane, 1995; Gregoire et al., 1998; Novakofski, 
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2004; Rosen, 2005).  The first example consists of a model system utilizing multipotent 
stem cells that have not yet undergone commitment to the adipose lineage, i.e. 
C3H10T1/2, NIH-3T3, or BALB/3T3cell lines (MacDougald and Lane, 1995; Otto and 
Lane, 2005).  Commitment, as defined by Otto and Lane (2005), is the process by which 
a stem cell from the vascular stroma responds to signal(s) and undergoes restriction to the 
adipocyte lineage, but does not express markers of terminal differentiation.  The second 
model system utilizes preadipocytes, or cell lines, which have already been committed to 
the adipocyte lineage, i.e. 3T3-L1, 3T3-F442A, or Ob17.  The in vivo adipogenic factors 
used to stimulate differentiation usually consists of a combination of 3-
isobutylmethylxanthine, insulin, and dexamethasone (Rubin et al., 1978; Gaillard et al., 
1991; MacDougald and Lane, 1995; Otto and Lane, 2005).  Individual exposure to any of 
the three differentiation factors stimulates only a low degree of differentiatio  (Tang et 
al., 2003a).  Committed preadipocytes maintain the propensity for growth but withdraw 
from the cell cycle before adipose conversion or differentiation (Gregoire et al., 1998).  
Prior to differentiation the morphological characteristics of the preadipocyte cell line is 
similar to that of a fibroblastic preadipose cell found in the stroma of adipose tissu .  
However, upon the initiation of differentiation, the fibroblastic appearance is abandoned 
and a rounded “unilocular” appearance is assumed and the cell acquires the 
morphological and biochemical characteristics of an adipocyte (Ailhaud et al., 1992; 
MacDougald and Lane, 1995; Otto and Lane, 2005). 
The differentiation process involves the interaction of both positive and negative 
factors, of both a cis-acting and trans-acting nature, regulating an intricate cascade of 
signaling pathways (MacDougald and Lane, 1995; Gregoire et al., 1998; Boone et al., 
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2000; Rosen, 2005).  Some pathways involve the suppression of negative effectors that 
act to maintain the undifferentiated state (Boone et al., 2000; Moldes et al., 2003), some 
pathways act to regulate transcription factors which orchestrate differentiatio  (Boone et 
al., 2000; Prusty et al., 2002), and yet other pathways regulate the adipocyte in response 
to certain physiological condition(s) of the individual.  The first stage of differentiation of 
the preadipocyte is growth arrest at the G0/G1 (G1/S1) checkpoint of the cell cycle 
(Gregoire et al., 1998).  Preadipocytes grown under cell culture conditions begin to 
differentiate shortly after confluency or cell to cell contact.  Preadipocyte differentiation 
requires this period of growth arrest, not cell confluency or cell to cell contact.  Although 
confluency leads to growth arrest, cell to cell contact is not a prerequisite (Ailhaud et al., 
1992; Gregoire et al., 1998).  Following growth arrest, an appropriate combination of 
mitogenic and adipogenic signals are needed for the preadipocytes to re-ener th  cell 
cycle, in what is termed a period of mitotic clonal expansion, a period where cells carry 
out at least one round of DNA replication and cell doubling (Gregoire et al., 1998; Tang 
et al., 2003a; Otto and Lane, 2005).  Numerous studies have established that mitotic 
clonal expansion inhibition clearly blocks adipogenesis and is a prerequisite for in vitro 
terminal differentiation (Gregoire et al., 1998; Tang et al., 2003a; Otto and Lane, 2005).  
Rosen et al. (2000) pointed out that even though mitotic clonal expansion is required for 
in vitro preadipocytes, a debate over the in vivo requirement still exists.  Upon 
completion of mitotic clonal expansion, the cells enter a distinct arrest stage of the cell 
cycle termed GD; cells must arrest and be maintained at this stage for differentiation to 
occur.  Cells arrested at this stage can either re-differentiate or reinstat  cell proliferation 
(cell mitosis) (Scott et al., 1982a; Otto and Lane, 2005).  However, once the cells exit the 
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GD stage, they become committed to terminal differentiation and growth is directe  
towards deposition of intracellular fat globules.  Mitotic clonal expansion comes to an 
end with the expression of the transcription factors, peroxisome proliferator-activated 
receptor-gamma (PPARγ) and CCAAT/enhancer binding protein alpha (C/EBP/α), that 
act synergistically to coordinate the regulation of gene expression and whose actions 
characterize the differentiated adipocyte (Tanaka et al., 1997). 
Three types of PPAR identified are α, δ, and γ; with four isoforms of 
PPARγ arising from differential promoter action and alternate gene splicing PPARγ(1-4) 
(Metzger et al., 2005; Fernyhough et al., 2007).  PPARγ1 and 2 differ by 30 amino acids 
with PPARγ2 expressed selectively in adipocytes, while PPARγ1 is expressed in several 
different tissues and PPARγ 3 has been shown to be expressed in macrophages, 
adipocytes, and the large intestine (Spiegelman, 1998; Tsai and Maeda, 2005; 
Fernyhough et al., 2007).  PPARγ3 and 4 produce translated proteins identical to 
PPARγ1; thus, only two receptors result in the biological system, PPARγ1and 2 
(Fernyhough et al., 2007).  PPARγ expression in adipocytes is 10 to 30 times higher than 
in other tissues (Spiegelman, 1998) with the roles of PPARγ1 and 2 still remaining an 
open question, as no clear consensus has been drawn from the literature thus far (Rosen 
and MacDougald, 2006).  However, several genes involved in adipocyte differentiation 
have been found to be regulated by PPARγ2, including CD36 and phosphoenolpyruvate 
carboxykinase (Fernyhough et al., 2007). 
PPARγ and C/EBP/α are elevated throughout the differentiation process as well 
as the rest of the life of the adipose tissue (Tontonoz et al., 1994, 1995; Rosen, 2002).  
The increase of PPARγ and C/EBP/α is preceded by the activation of two other members 
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of the C/EBP family expressed within two to four hours after induction of differentiation, 
C/EBPβ and C/EBPδ (Lane et al., 1999; Wu et al., 1999a; Tang et al., 2003b).  A slight 
reduction in adipose development has been observed in cells under in vitro conditions 
which lack either C/EBPβ or C/EBPδ; however, if both C/EBPβ and C/EBPδ are lacking 
the cells are severely restricted in their development (Rosen and Spiegelman, 2000).  
Despite C/EBPβ and C/EBPδ having been shown to be required for differentiation in 
vitro, Tanaka et al. (1997), in studies using C/EBPβ(-/-) and C/EBPδ(-/-) null mice, 
reported C/EBPβ and C/EBPδ were not required for differentiation i vivo, although it 
was shown that adipogenesis was drastically impaired.  Likewise, even though PPARγ 
and C/EBP/α can be induced in the absence of C/EBPβ and C/EBPδ, co-expression of 
PPARγ and C/EBP/α alone is not adequate for complete adipocyte differentiation in vivo 
(Tanaka et al., 1997).  As previously mentioned, PPARγ and C/EBP/α act synergistically 
to coordinate the regulation of gene expression and are required for adipogenesis both in 
vitro and in vivo; however, C/EBP/α is not capable of supporting adipogenesis in the 
absence of PPARγ.  Rosen et al. (2002) reported that ectopic C/EBP/α, using a retroviral 
delivery system, failed to induce lipid accumulation in PPARγ (-/-) cells; suggesting 
C/EBP/α is limited to the induction and maintenance of PPARγ levels and the 
establishment of insulin sensitivity in the cell, as adipocytes lacking C/EBP/α are not 
insulin sensitive (Wu et al., 1999a; Wu et al., 1999b).  On the other hand, Wu et al. 
(1999b), using C/EBPα (+/+) and C/EBPα (-/-) cell lines, demonstrated that PPARγ was 
capable of supporting adipogenesis in the absence of C/EBP/α, but only when PPARγ is 
ectopically expressed and observed the number of C/EBPα (-/-) cells were comparable to 
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the C/EBPα (+/+); however, the C/EBPα (-/-) cells accumulated less lipid in smaller 
droplets than the C/EBPα (+/+).  Also, ectopically delivered PPARγ, via a retroviral 
delivery system, was shown to rescue the adipogenic potential in PPARγ (-/-) cells 
demonstrating that PPARγ is required for adipogenesis (Rosen et al., 2002).  The 
preceding indicates both PPARγ and C/EBP/α contribute to a single pathway of adipose 
development, maintaining each other’s expression and acting to synergistically initiate 
adipogenesis gene expression.  
 
Adipose Related Genes  
Fatty Acid Binding Protein 4  
Fatty acid binding protein 4 (FABP4) is one of nine members in the superfamily 
of lipid-binding proteins.  Expression of fatty acid binding proteins (FABP) are tissue-
specific and are regulated at the transcriptional level with most exhibiting patterns of 
expression related to cellular development and differentiation (Glatz and van der Vusse, 
1996; Storch and Thumser, 2000; Zimmerman and Veerkamp, 2002; Chmurzynska, 
2006).  FABP’s have been shown to modulate intracellular lipid homeostasis, as they 
bind with high affinity to both long chain (C ≥ 14) saturated and unsaturated fatty acids 
and regulate the transport of fatty acids between cellular compartments, enzymes, and/or 
the metabolism of fatty acids in the cell (Zimmerman and Veerkamp, 2002; Jenkins-
Kruchten et al., 2003; Chmurzynska, 2006; Storch and McDermott, 2008).  Two different 
transfer mechanisms are utilized by FABP’s in the transfer of fatty acids to membranes; 
an aqueous phase diffusion transfer and a transfer involving a direct interaction with the 
membrane (Weisiger, 2002).  FABP4, shown to be expressed in both adipose tissue and 
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macrophages, is expressed in fully differentiated cells exhibiting high rates of fatty acid 
metabolism and constitutes approximately 1 to 6% of the cytosolic protein in a mature 
adipocyte (Smith and Storch, 1999; Storch and Thumser, 2000; Storch and McDermott, 
2008).  FABP4 is thought to transfer lipids to membranes through a direct, or collisional 
mechanism, involving ionic interactions with the lysine residues within the helix-turn-
helix domain (Smith and Storch, 1999).  FABP4 also has been shown to interact with 
hormone-sensitive lipase (HSL), the rate limiting enzyme of lipolysis or the break down 
(or hydrolysis) of stored fat in the cell.  Substrates for HSL include triglycerides, 
cholesterol esters and retinyl esters (Shen et al., 1999; Kraemer and Shen, 2002; Jenkins-
Kruchten et al., 2003).  FABP4 has been shown to enhance the transcriptional activities 
of PPARγ and PPARβ (Tan et al., 2002; Storch and McDermott, 2008), and the activity 
of keratinocyte fatty acid binding protein (KFBP), also found in adipocytes and 
macrophages (Storch and McDermott, 2008).  The association between FABP’s and 
PPAR’s seems to be highly selective for different FABP/PPAR pairings a d dependent 
on the presence of specific ligands.  For example, FABP4 specifically enhances 
PPARγ while KFBP activates PPARβ (Tan et al., 2002).  Work by Deng et al. (2006) 
demonstrated that PPARγ positively up-regulated HSL in the presence of the 
transcription factor, specificity-1 (SP1), as the use of mithramycin A, a specific inhibitor 
of SP1, abolished the up-regulation of HSL.  Previous work by Moore et al. (1991) 
showed the activity of FABP4 in the Longissimus muscle not to be a good index for the 
determination of i.m. fat accretion in bovine.  However, FABP4 polymorphisms from 
high- and low-marbling animals revealed two single nucleotide polymorphisms (SNPs): 
AAFC01136716.1:g.7516G>C and g.7713G>C and were shown to be associated with 
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both marbling (i.m.) and s.c. fat depth in cattle (Michal et al., 2006).  Also, FABP4 
polymorphisms were shown to be associated with fatness traits and i.m. fat accretion in 
pigs (Chmurzynska, 2006; Damon et al., 2006).  When adipose cells were compared at 
the same size and same age in porcine, the FABP4 transcript and protein content was 
lower in i.m. adipocytes compared to s.c. adipocytes (Gardan et al., 2007).   
More recently, Jurie et al. (2007) reported on the possibility of the FABP4 mRNA 
levels and protein content, indicators of i.m. adipocyte number and oxidative enzyme 
activities, as indicators of the ability of steers to deposit intramuscular fat ccording to 
muscle type and breed.  In looking at two different breeds of cattle, Japanese Black (J ) 
and Holstein (HOL), FABP4 expression level was higher in all stages of cells from 
preadipocytes to differentiation in JB than HOL suggesting a higher potential for the JB 
to accumulate lipids (Ohsaki et al., 2007).  In JB and HOL animals (approximately 11 
months of age) after a fattening period of 60 d, Wang et al. (2005b) reported FABP4 
mRNA levels to be elevated in JB cattle vs. HOL, indicating that JB animals had 
accumulated more mature adipocytes per unit of muscle than HOL.  More so, in a study 
conducted to identify marbling-related genes in high and low marbled Hanwoo steers, th  
gene expression of FABP4 was approximately two times higher in high marbled relative 
to low marbled steers (Lee et al., 2008b).  Similar results between animals with marbling 
potential were reported by Wang et al. (2009), where FABP4 mRNA levels were shown 
to be elevated at the time of weaning in Wagyu x Hereford crossbred animals vs. 
Piedmontese x Hereford crossbred animals suggesting evidence of early cellular
development of adipocytes in animals with marbling potential.  In animals of the fore-
mentioned crosses, fetal Longissimus muscle was sampled at four stages of myogenesis 
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and muscle maturation; primary myogenesis (d 60), secondary myogenesis (d 135), 
beginning (d 195) and final stages (birth).  FABP4 expression was greater in the 
Longissimus muscle of Wagyu-sired fetuses at d195 and birth than Piedmontese sired 
fetuses (Lehnert et al., 2007).  In a later study by Lee et al. (2007) looking at FABP4 gene 
expression in the Longissimus muscle between high and low marbling Hanwoo cattle, 
FABP4 gene expression was greater in the high marbling group of cattle relative to the 
low marbling group.  
 
Stearoyl-CoA Desaturase 
Two main transformations occur when dietary lipids enter the rumen.  The first is
the hydrolysis of the ester bond present in the triacylglylcerides, phospholipids and 
glycolipids by bacterial lipases with the glycerol that is released being readily utilized by 
the rumen microorganisms.  The second arises due to the fact that polyunsaturated fats 
are toxic to rumen microorganisms, so a process termed biohydrogenation transforms the 
unsaturated fatty acids to saturated fatty acids (Church, 1988; Bauman et al., 2003; Nam 
and Garnsworthy, 2007).  Biohydrogenation involves the isomerization of the fatty acid 
chain to a monoenoic acid and then ultimately to stearic acid (C18:0) (McDonald et al., 
2002; Bauman et al., 2003), which is one of the main fatty acids that dictates fat hardness 
(Smith et al., 1998).  Stearoyl-CoA desaturase (SCD) is an integral membrane protein of 
the endoplasmic reticulum that catalyzes the ∆9 desaturation of saturated fatty acids that 
are synthesized e novo or derived from the diet.  The main fatty acids involved in 
desaturation by SCD are myristate, palmitate, and stearate into the ∆9 monounsaturated 
fatty acids (MUFA), myristoleate, palmitoleate and oleate, respectively (Cameron et al., 
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1994; Miyazaki and Ntambi, 2003; Dobrzyn and Ntambi, 2005; Ohsaki et al., 2007).  
MUFA’s are key substrates used in the synthesis of complex lipids such as triglycerides, 
diacylglycerol, cholesterol esters and wax esters (Miyazaki and Ntambi, 2003; Dobrzyn 
et al., 2008).  However, long chain polyunsaturated fatty acids (PUFA’s) such as 
eicosapentanoic acid (20:5) and docosahexaenoic acid (20:6) are not incorporated into 
triglycerides to any extent in ruminants, but are mainly restricted to membrane 
phospholipids, and thus, are found primarily in muscle rather than fat tissue (Wood et al., 
1999).  Oleic acid (18:1) is the most abundant fatty acid in US beef and is the active 
precursor for acyl-CoA cholesterol acyltransferase (ACAT) in cholesterol ester synthesis 
and diacylglycerol acyltransferase (DGAT) in triacylglycerol synthesis; thus, SCD 
activity can affect both the fatty acid composition in the plasma membrane and lipid 
metabolism in adipose tissue (Chung and Johnson, 2007).   
SCD activity and gene expression has been shown to be higher in bovine adipose 
tissue than in muscle, liver, or intestinal mucosa (Smith et al., 2006b).  SCD activity 
appears to be essential for subsequent development of lipogenic activity of s.c. adipose 
tissue in growing steers (Smith et al., 2006b; Hausman et al., 2009) as s.c. adipose tissue 
was shown to have approximately twice the SCD catalytic activity as i.m. adipose tissue, 
and also a greater concentration of MUFA than i.m. adipose tissue (Archibeque et al., 
2005).  However, in many breed types of cattle, there has been shown to be an almost 
linear increase in i.m. adipose tissue deposition over time on a finishing diet with this 
increase in i.m. adipose tissue deposition being consistent with an increase in i.m. adipose 
tissue MUFA and SCD activity (Hausman et al., 2009).  Depot differences in SCD 
 26
mRNA expression have also been reported in sheep where SCD expression was higher in
s.c. adipose tissue compared to omental or perirenal adipose tissue (Daniel et al., 2004).  
Grain-based diets provide carbon for i.m. adipose tissue development and 
promote fat softness by stimulating the expression of SCD (Smith and Lunt, 2007).  More 
so, in cattle fed a grain based diet, the fatty acids in adipose tissue typically become less 
saturated between weaning and slaughter (Smith et al., 2006b).  In looking at SCD gene 
expression in the Longissimus muscle between high and low marbling Hanwoo cattle, 
Lee et al. (2007) observed SCD gene expression to be greater in the low marbling group 
of cattle relative to the high marbling group, and suggested the SCD gene may be related 
to fatty acid composition rather than the amount of fat accumulation.  In a recent study by 
Smith et al. (2009), where 8 mo old steers were adapted to a corn-based diet (calf-fd) or 
allowed to graze native pasture until 12 mo of age (yearling-fed), SCD gene expression 
was only barely detectable in s.c adipose tissue of the 8 mo old weaned calves.  The SCD 
gene expression was almost eight times greater in both the s.c. and i.m. adipose depots in
steers on the corn-based diet than those allowed to graze native pasture.  It was suggested 
the difference to be from the higher concentrate intake of the corn-fed steers relative to 
those on native pasture.  Additionally, SCD gene expression declined in the corn-fed diet 
steers between 12 and 16 mo of age in both the s.c. and i.m. adipose depots. 
However, in comparing s.c. adipose tissue from the mid-loin region of pasture-fed 
cattle or cattle placed in the feedlot fed a diet consisting of sorghum, roughage, and 5% 
whole cottonseed for 100, 200, or 300 d, SCD activity was observed to be 60 to 85% 
greater in cattle from the pasture-fed diet than cattle on the feedlot diet suggesting that 
feeding whole cottonseed reduced the activity of SCD (Yang et al., 1999).  Cattle from 
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the pasture-fed diet had lower total saturated fatty acids and higher total unsaturated fatty 
acids in adipose tissue than cattle in the feedlot.  However, no differences were obs ved 
in the fatty acid composition or in SCD activity in the s.c. adipose tissue between cattle 
fed in the feedlot for 100, 200 or 300 d (Yang et al., 1999).   
Multiple SCD isoforms have been identified in several animal species includ g 
rat, hamster, humans and most recently bovine, with the discovery of the SCD5 isoform 
(Lengi and Corl, 2007).  The isoforms seem to follow a pattern of tissue-specific 
expression with evidence of specific-substrate preferences, giving rise to th  concept that 
the isoforms play distinct physiological roles in the body (Lengi and Corl, 2007; Lengi 
and Corl, 2008).  For example in the mouse, SCD1, SCD2, and SCD4 desaturate both 
palmitoyl-CoA and stearoyl-CoA, while SCD3 desaturates palmitoyl-CoA but not 
stearoyl-CoA (Miyazaki et al., 2006).  SCD mRNA levels were shown to be affected by 
breed as SCD mRNA was higher in both Longissimus muscle and s.c. adipose tissue in 
JB cattle than in HOL cattle.  Subsequently, JB cattle had a higher MUFA percentage in 
the s.c. adipose tissue than HOL cattle (Taniguchi et al., 2004).   
More recently, three polymorphisms in SCD1 were found to be associated with 
six fat deposition and fatty acid composition traits in skeletal muscle in a Wagyu x 
Limousin reference population.  Positive correlations were shown for beef marbling 
score, amount of MUFA, and conjugated linoleic acid (CLA) content but a negative 
correlation was shown for saturated fatty acid content.  However, these three SNPs were 
observed not to be associated with s.c. fat depth or percent KPH fat in the same reference 




CD36, originally referred to as fatty acid translocase (Su and Abumrad, 2009), is 
a membrane bound glycoprotein, expressed at the cell surface and in lysosomes and 
belongs to the class B scavenger receptor family with the primary role varying with cell 
type (Hajri and Abumrad, 2002).  CD36 can facilitate the translocation of long chain fatty 
acids in adipocytes as well as in heart and muscle cells (Nicholson et al., 2000; Febbraio 
et al., 2001; Su and Abumrad, 2009).  CD36 can also function as a cell adhesion molecule 
and as a class B scavenger receptor (Hajri and Abumrad, 2002).  There are eight diff rent 
subclasses to the scavenger receptor family (A-H) (Murphy et al., 2005).  Class B 
receptors recognize a wide range of ligands including collagen, fatty acids, nionic 
phospholipids, thrombospondin, apoptotic cells, native LDL, Ox LDL, HDL and VLDL 
(Murphy et al., 2005).  CD36 has been shown to be expressed by macrophages, dendritic 
cells, platelets, endothelium, adipocytes, smooth muscle and certain epithelia such as the 
breast, retina, and intestine (Nicholson et al., 2000; Febbraio et al., 2001; Murphy et al., 
2005).  
CD36 within cellular membranes seem to be associated with lipid rafts which can 
be described as detergent-resistant membranes with a microdomain size of 50 nm 
containing high levels of sphingolipids and cholesterol (Ehehalt et al., 2006; Ehehalt et 
al., 2008; Su and Abumrad, 2009).  Long chain fatty acid (LCFA) uptake was shown to 
be dependent on the integrity of these lipid rafts.  Decreasing the level of cholester l 
decreased the level of long chain fatty acid uptake by as much as 50%.  Also, decreasing 
ceramide synthesis was shown to lower long chain fatty acid uptake (Ehehalt et al., 
2008).  Caveolae are formed from lipid rafts that contain the proteins caveolin-1, -2 and  
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-3, and can be described as small invaginations (50 to 100 nm) of the plasma membrane 
of many cell types, especially adipocytes, which have been shown to interact functionally 
with CD36 (Shu et al., 2008).  Caveolin-1 deficient mice have reduced levels of CD36 
(Ring et al., 2006; Frank et al., 2008) or the CD36 is mistargeted away from the 
membrane reducing fatty acid uptake (Shu et al., 2008) and exhibit phenotypic features 
similar to CD36 null mice (Razani et al., 2002). 
 In vitro studies using 3T3-L1 cells showed no CD36 protein detected in 
preadipocytes; however, CD36 was detected in cells 3 days post-differentiation (Qia  et 
al., 2008).  CD36 has been identified as an important marker of preadipocyte 
differentiation into adipocytes as CD36 mRNA expression was induced during the 
differentiation process and fatty acid uptake coincided with the up-regulated expression 
of CD36 (Abumrad et al., 1993; Sfeir et al., 1997).  CD36 gene expression in weaning 
piglets was shown to be higher in visceral adipose tissue as compared to s.c. and i.m.  
However, an in vitro preadipocyte culture showed CD36 mRNA expression to be greater 
in adipocytes from i.m. adipose tissue than from s.c. adipose tissue (Shu et al., 2008).  
CD36 has been shown to be regulated by all three peroxisome proliferator receptors 
(PPAR) α, γ, and δ  in a tissue specific manner (Hajri and Abumrad, 2002).  More so, 
CD36 contains a C/EBP response element and C/EBP α and β were shown to increase 
CD36 expression with C/EBPα being a more potent inducer of CD36 than 
C/EBPβ, indicating C/EBPα involvement in regulating CD36 expression at the 
transcriptional level (Qiao et al., 2008).  
The in vivo uptake and metabolism of two iodinated fatty acid analogs, beta-
methyl-iodo-phenyl pentadecanoic acid (BMIPP) and 15-(p-iodophenyl) pentadecanoic 
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acid (IPPA), was investigated in different tissues of CD36 null mice along with the in 
vitro lipid incorporation of palmitate by adipocytes.  Uptake of BMIPP and IPPA was 
reduced in tissue such as heart (50-80%), skeletal muscle (40-75%), and adipose tissue 
(60-70%) of CD36 null mice compared to that of the wild type.  These tissues normally 
have high expression levels of CD36.  However, in tissues where there is normally a low 
expression level or an undetectable level of CD36, no alteration of intakes was detecte  
(Coburn et al., 2000).  Triglyceride synthesis was inhibited at the level of diacylglycerol 
acyltransferase as a 50-68% decrease in labeled incorporation into triglyceride along with 
a 2 to3 fold increase in labeled incorporation into diglycerides was observed (Coburn et 
al., 2000).  Similarly, the rate of long chain fatty acid transport across the cell membrane 
was increased with increased CD36 expression at the membrane level with long c ain 
fatty acid transport decreased with decreased CD36 expression at the membrane level 
(Coburn et al., 2001).  The transport of fatty acids was shown to be increased in 
contracting muscle as a result of CD36 being translocated from an intracellul r depot to 
the plasma membrane (Bonen et al., 2004; Holloway, 2008). Also, fatty acid oxidatin 
has been shown to be regulated in part by both carnitine palmitoyltransferase I (CPT1) 
and CD36 in the mitochondria (Holloway, 2008).  More so, insulin has been shown to 
induce the translocation of FAT/CD36 from an intracellular depot to the plasma 
membrane via a phosphatidylinositol signaling step revealing a level of regulation that 
may further help our understanding of the relation between fatty acid metabolism and 




Fatty Acid Synthase  
Fatty acid synthase (FAS) is a multienzyme complex containing seven distinct 
domains which catalyzes the last step in the fatty acid biosynthetic pathway (Zhang et al., 
2008).  Changes in FAS mRNA content are tissue specific and are affected by altered 
rates of gene transcription, mRNA processing, and/or mRNA stability (Clarke, 1993).  
The thioesterase domain (discussed below) is responsible for termination of fatty acid 
synthesis and thus plays an essential role in the determination of the chain length of the 
FAS final product (Clarke, 1993).  Recently, single nucleotide polymorphisms have been 
reported in the bovine FAS gene (Roy et al., 2006; Morris et al., 2007; Zhang et al., 2007; 
Zhang et al., 2008).  FAS polymorphisms were reported to be associated with milk-fat 
percentage in HOL cows (Roy et al., 2006), and the five polymorphisms reported by 
(Morris et al., 2007) were associated with variations in the fatty acid composition in milk 
and s.c. adipose tissue, as increased percentages of C14:0 were shown in milk fat with an 
opposite effect occurring in s.c. adipose tissue.  Furthermore, two of the three 
polymorphisms identified in the thioesterase domain, g.17924A>G and g.18663 T>C 
were significantly associated with fatty acid composition of several fatty acids, 
phospholipids, triacylglycerides, and the overall total lipids in Angus cattle (Zhang et al., 
2007; Zhang et al., 2008).  Cattle with the g.17924GG genotype had a greater percentage 
of oleic acid (C18:1), docosapentaenoic acid (C22:5), and total monounsaturated fatty 
acids (MUFA) compared to the g.17924AA genotype.  In contrast, the eicosatrienoate 
(C20:3) content was greater and the polyunsaturated fatty acids tended to be greater in 
cattle with the g.17924AA genotype vs. the g.17924GG genotype, indicating that 
contributions in the variation of MUFA content in cattle is not only from variation in the 
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SCD genotype (mentioned earlier), but also from the FAS genotype (Zhang et al., 2007; 
Zhang et al., 2008). 
The FAS complex consists of seven subunits; β-ketoacyl synthase (KS), 
malonyl/acetyl transferase (MAT), β-hydroxyl dehydratase (HD), enoyl reductase (ER), 
β-ketoacyl reductase (KR), acyl carrier protein (ACP), and palmitoyl thioesterase (TE)  
(Asturias et al., 2005; Carlisle-Moore et al., 2005; Cronan, 2004; Maier et al., 2006; 
Witkowski et al., 2004).  The first committed step in the synthesis of palmitate is th  
formation of malonyl-CoA from HCO3 and acetyl-CoA catalyzed by acetyl-CoA 
carboxylase.  One “primer” molecule of acetyl-CoA and six molecules of mal nyl-CoA 
interact, one-after-the-other, with the FAS complex to yield palmitate.  Entry into fatty 
acid synthesis cycle, involves the transfer of a “primer” acetyl-CoA to the ACP involving 
MAT to produce a “transient” acetyl-ACP; as there is a subsequent transfer of th  acetyl 
group of acetyl-ACP to a cysteine residue of ß-KS.  Malonyl-ACP is formed from the 
transfer of malonyl-CoA to ACP again involving MAT.  For both the preceding 
reactions, the attacking group of MAT is the oxygen of a serine hydroxyl group.  The 
next reaction is a condensation reaction and involves the transfer of the acetyl group of 
the β-ΚS to the methyl group of malonyl-ACP to form aceto-acetyl-ACP.  This involves 
the decarboxylation of malonyl, followed by the attack of the resultant carbon ion on the 
carbonyl carbon of the acetyl group.  Aceto-acetyl-ACP is reduced to D-β-
hydroxybutyryl-ACP by β-KR which is converted, in a hydration reaction, to α−β-trans-
butenoyl-ACP by β-HD.  The α−β-trans-butenoyl-ACP is then hydrogenated to form 
butyryl-ACP by ER. NADPH is used in the two preceding reduction reactions.  The 
butyryl-ACP then cycles back through the FAS complex, entering in the place of tyl-
 
ACP; another malonyl-ACP is formed via MAT
to form palmitate, as each cycle elongates the fatty acid chain by two carbons.  At the end 
of the last cycle, TE terminates the chain elongation and releases palmitate from the ACP 
by hydrolyzing the acyl-S
Palmitoyl thioesterase is very crucial, as it is the monitor to ensure that palmitate is the 
major end product of the FAS complex (Chakravarty et al., 2004).  Only the last two 
carbons of the fatty acid chain of palmitate originate from acetyl
carbons are from malonyl
al., 2005; Maier et al., 2006)
illustrates the interaction of the subunits involved in FAS begi
transfer of the acyl group of acetyl Co
and the termination cycle involving the release of palmitate from the 
Figure 1. FAS catalytic cycle and domain organization
The following equation sums the 
CoA is originally derived from acetyl
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.  This elongation cycle repeats six times 
-phosphopantetheine thioester bond (Chakravarty et 
-CoA, the remaining 
-CoA (Murray et al., 2003; Voet and Voet, 2004b; Asturias et 
.  The following reaction (Figure 1, Maier et al., 2006) 
nning with the initial 
-A to the ACP (1); the six repeating cycles (2
ACP
 
Adapted from Maier et al. (2006). 
 
fatty acid synthesis reaction; keep in mind
-CoA (Murray et al., 2003; Voet and Voet, 2004b)
al., 2004).  
-6); 
 (7).  




8 acetyl-CoA + 14 NADPH + 7 ATP                                                         
                            
           Palmitate + 14 NADP+ + 8CoA + 6 H2O + 7 ADP + 7 Pi 
 
The ACP is bound to the growing fatty acid chain throughout fatty acid synthesis and is 
released at the end of the last cycle through FAS.  The intermediate products during fatty 
acid synthesis are attached as thioesters to the ACP (Majerus, 1967). The acyl binding 
site of both the ACP and CoA is 4’-phosphopantetheine which is linked to the ACP 
subunit via a serine residue and acts like a long flexible arm to orientate the intermediates 
to the active sites of the other subunits within the FAS complex (Majerus et al., 1965; 




The TE subunit of FAS is made of two subdomains made up of nine α-helices and 
eight β-strands.  Domain A, the larger of the two subdomains, consists of α−helices and 
β-strands while subdomain B consists of α-helices.  In human FAS, subdomain A 
contains the catalytic triad (Figure 2) consisting of serine-2308, aspartic acid-2338, and 
histdine-2481.  The palmitoyl chain-binding site consists of a long groove at the interface 
between subdomains A and B leading into a small “pocket”, in close proximity to the 
catalytic site.  The orientation and hydrophobic nature of the residues along the groov  
and the TE subunit’s orientation to the ACP, more or less, cause the groove to act as a 
“ruler” to ensure that palmitate (C16) is the correct end-product.  Approximately the last 
four carbons of the elongating fatty acid chain extend into the “pocket”, allowing room 
for two carbons to be added, before chain termination commences.  The TE subunit 
exhibits a high specificity for C16 compounds with a marked decline in enzyme activity 
 
for fatty acid chains shorter than C
chain-binding groove arise from the 
(Phe-2370 & 2371) helix of s




Conventional Dogma of FAS Organization
 
From the early 1980’s to as late as 2004, models in the literature depict the two 
monomers of FAS in a “head to tail” organization; that is, the monomers are laying side
by-side in an extended anti
synthesis (Jayakumar et al., 1997; Voet and Voet, 2004b)
microscopic and small-angle neutron
appearance of side-to-side chains with a dimension
various proteases, the s quenc
end was postulated (Figure 
organization is based on studies where 1,3,dibromo
between the active site of the 
phosphopantetheine group of the ACP subunit on the other monomer of FAS 
35
16 and chains longer than C18.  The residues lining the 
α8 (Phe-2418, Ala-2419, Ser-2422, Lys
ubdomain B, α1 (Leu-2223 & 2223, Val-2224) and the loop 
-2251) of subdomain A, (Chakravarty et al., 2004).
          
Structure and Molecular Organization of Mammalian Fatty 
Acid Synthase. Adapted from Chakravarty et al.
 
-parallel orientation allowing for two centers of fatty acid 
.  Biochemical, electron 
-scattering studies revealed FAS to take on the 
 f 160 x 146 x 73 Å. 
e of the FAS catalytic subunits from the amino to carboxyl 
3; Jayakumar et al., 1997).  The conventional dogma of FAS 
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ß-KS subunit on one monomer of FAS and to the 4’
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and Wakil, 2004; Cronan, 2004; Witkowski et al., 2004; Asturias et al., 2005).  Residues 
1-406 are assigned to ß-KS, 428-815 to MAT, 829-969 to ß-HD, 1630-1850 to ER, 1870-
2100 to ß-KR, 2114-2190 to the ACP, and 2200-2505 to TE.  There is a non-catalytic 
region extending from 970 to1630 (Joshi et al., 1997, 1998).  Keep in mind that in the 
hypothesized sequence of the subunits, the  ß-ketoacyl synthase subunit is the first 
subunit of the sequence and the ACP subunit is next to the last subunit of the sequence.  
During fatty acid synthesis, the interaction between the ß-KS subunit and the ACP 
subunit, due to the “loading” of the acetyl group from the ACP to the cysteine of the 
active site of ß-KS, is more critical than the interaction between the ACP and the active 
sites of the other subunits where the ACP orientates the substrate at the active site o 
facilitate enzymatic action (Cronan, 2004).  So, the postulated “head to tail” FAS model 
(Figure 3), which allows the –SH group of the 4’-phosphopantetheine group of the ACP 
of one monomer to be in close proximity to the –SH of the cysteine at the active site of 
the ß-KS on the other monomer, was deemed acceptable (Cronan, 2004; Voet and Voet, 
2004b; Witkowski et al., 2004). 
 
Figure 3. Postulated “head to tail” FAS model.                            





Alteration of Conventional Dogma Model 
 
Stuart Smith’s lab in 1997 (Joshi et al., 1997) and 1998 (Joshi et al., 1998) 
suggested the conventional model for FAS be revised to reflect the discovery that thewo
monomers of FAS are not simply positioned side-by-side in a fully extended 
conformation, but are coiled in a manner that allows the ACP to access the ß-HD domain
on the same monomer.  This was accomplished by using monomers where the active sites 
in the subunits were altered by mutations, but still produced fatty acids. Further work 
using monomers with altered mutations led to yet another proposed alternative model of 
FAS organization. 
 
Proposed Alternative Model of FAS Organization 
In 2004, Stuart Smith’s lab (Witkowski et al., 2004) noted several more 
discrepancies in this altered conventional model and proposed an alternative model; this 
time describing the FAS complex as an intertwined head to head dimer (Figure 4).  This 
model was proposed based on findings where altered FAS dimers, constructed from a 
wild type (functional) monomer and a nonfunctional monomer, due to altered subunit 
active sites by mutation, were still able to synthesize fatty acids. In this model, there is a 
still a separation of the ß-KS of the two monomers; however, it was observed that for 
FAS to form dimers the ß-KS subunits had to be present and the function of the ß-KS 
active site be maintained. 
The transition of the ß-KS subunits from a monomer to dimer paralleled the 
successful “loading” of the acetyl group from the ACP to the ß-KS cysteine rsidue at the 
active site.  The conditions that interrupted the monomer to dimer transition of the ß-KS 
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subunits also interrupted the monomer to dimer formation of the entire FAS complex 
(Cronan, 2004; Witkowski et al., 2004; Asturias et al., 2005).  FAS dimers constructed 
with subunits consisting of different mutations and studied under conditions that limit the 
conformation variability in the monomers using Cyro-Electron Microscopy and gold 
labeling of the N-terminal lended support to this proposed alternative model, as the ß-KS 
and MAT domains were shown to be able to access the ACP subunits of either monomer, 
which is not possible in the “head to tail” model (Asturias et al., 2005).  In addition, the 
symmetry shown within the FAS complexes constructed with different mutations implied 
that monomers in a functional FAS complex could exhibit different conformations 
suggesting the possibility of a different rate or stage of fatty acid synthesis occurring 
between the two monomers; possibly elongation occurring in one monomer and β-c rbon 
processing occurring in the other (Smith, 2006). 
 
Figure 4. Proposed Alternative Model of FAS Organization.      
Adapted from Witkowski et al. (2004). 
 
Alteration of the Proposed Alternative Model of FAS Organization 
Maier et al. (2006), using x-ray crystallography, revealed a 4.5 Å partial structure 
of porcine FAS.  For the most part, this structure agreed with the alternative model 
proposed by Smith, (2006) that is the FAS complex is indeed an intertwined head to head 
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dimer.  However, the subunit positioning is altered to some degree.  Maier’s group 
described FAS as an X-shaped unit consisting of a central body region with arms and legs 
(Figure 5-a).  The x-ray crystallography was able to offer the positioning of the catalytic 
subunits of the FAS dimer involved in elongation of the fatty acid chain.  The ACP and 
TE subunits could not be mapped with any degree of certainty due to their high degree of 
flexibility; the white stars in the figure below indicate possible regions of attachment.  
The ACP of each monomer is able to interact with the ß-KS and MAT subunits of its own 
monomer or the adjacent FAS monomer.  In Figure 5-b, the active sites of each subunit 
are depicted by the white and blue balls, while the hollow spheres around each of the 
active sites depicts the length of the 4’-phosphopantetheine arm, giving an estimat  of 
how close the ACP has to be for interaction with the active site of the subunit.  Maieret 
al. (2006) speculated that the 4’-phosphopantetheine arm may not serve as the lone 
“swinging arm” to facilitate substrate presentation per se, but may combine with the 
modest movement of the “arms”, “legs”, and “waist” regions of the monomer allowed by 
the interconnecting regions, with movement caused by the binding and releasing of 
substrate.  Although 65 to 80% of fatty acid chain elongation occurs from inter-monomer 
ACP/ ß-KS interaction and 20 to 35% occurs through intra-monomer interaction 
(Asturias, 2006), Maier et al. (2006) put forth that there may be difficulty in the ACP 
reaching the active centers of the opposite monomer based on this x-ray crystallography 
model and the predicted sites of the ACP location.  The intersubunit and interdomain 
connections are shown in figure 5-b.  The importance of the ß-KS dimerization for FAS 
activity was previously mentioned (Witkowski et al., 2004), however, there seems to be a
dimerization interface which extends through the body of FAS into the ER monomers. 
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The pseudo-dimer of ß-HD is not between the different monomers, but is within the chain 
of one monomer (Maier et al., 2006).  Therefore, there may be more significance to the 
FAS dimerization than the ß-KS subunit itself.  The evidence for the new structural 
model for FAS is evident; however, detailed understanding of the FAS complex is 
warranted. Cronan sums up these new findings very well;…“despite the wrong turn, it 
seems unlikely that the incorrect head to tail model seriously impeded progress with FAS.  
The difficulties have been technical, rather than conceptual, and working with such a 
large enzyme remains a formidable challenge” (Cronan, 2004). 
 
Figure 5. Alteration of the Proposed Alternative Model of FAS 
Organization.  Adapted fromMaier et al.( 2006).   
 
Zilpaterol Hydrochloride 
Zilmax® (Intervet/Schering-Plough Animal Health, Millsboro, DE) is a synthetic 
β2-adrenergic agonist used for increased rate of weight gain, improved feed efficiency 
and increased carcass leanness in cattle fed in confinement for slaughter (Dikeman, 2007; 
Kern et al., 2009), and contains the active ingredient zilpaterol hydrochloride (ZH), (±)-
trans-4,5,6,7-tetrahydro-7-hydroxy-6-(isopropylamino) imidazo [4,5,1-jk]-[1]benzazepin-
2(1H)-one, hydrochloride (Intervet, Inc. 2007).  Synthetic β-adrenergic agonists (β-AA) 
are similar pharmacologically and chemically to the naturally occurring catecholamines 
5-a 5-b 
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dopamine, norepinephrine, and epinephrine (Vasconcelos et al., 2008), with epinephrine 
being the methylation product of norepinephrine.  Norepinephrine and epinephrine are 
inactivated by the enzymes catechol-o-methyltransferase (COMT), which introduces a 
methyl group to the catecholamine 3-hydroxyl group of the aromatic ring, and 
monoamine oxidase, which uses oxygen to remove the amine group (Smith, 1998).  Some 
aromatic hydroxylations are not deactivated by COMT as some substitutions are 
deactivated in the liver and intestine by conjugative biotransformation enzymes, mainly
through glucuronidation and sulfation.  As β-agonists exist as racemates, they have been 
shown to be susceptible to stereospecific biotransformations, with those β-agonists 
containing halogen ion substitutions for hydroxyl groups on the aromatic ring bein 
resistant to rapid degradation by conjugative biotransformation enzymes (Smith, 1998).   
In 2006, ZH was approved by the U.S. Food and Drug Administration (FDA) as a 
feed ingredient for cattle during the last phase of the feeding period to imprve 
production efficiency, but has been used since the 1990’s in Mexico and South Africa 
(Avendano-Reyes et al., 2006).  Zilpaterol hydrochloride is administered through the feed 
the last 20 to 40 days of the feeding period at levels of 60 to 90 mg/animal/d and is 
required to be withdrawn three days prior to harvest.  In 2008, the FDA approved ZH for 
use in cattle feeds in five different combinations with MGA® (melengestrol acetate), 
Rumensin® (monensin, USP), and Tylan® (tylosin phosphate) [Zilpaterol, Rumensin, 
and Tylan; Zilmax and Rumensin; Zilmax and MGA; Zilmax, MGA, and Rumensin; 
Zilmax, MGA, Rumensin, and Tylan].   
Repartitioning agents developed in meat animals require safety and residue 
testing, and there is limited data on zilpaterol residues for Zilmax-treated food animals.  
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In humans, plasma levels of other β-AA generally occur within 1to3 hr after 
administration with excretion of radioactivity nearly completed by 48 to 72 hr following 
administration in most animals studied (Smith, 1998).  A rise in plasma levels of the β-
AA, clenbuterol, was detected within 20 min to 1 hr after administration in veal calves 
where peak plasma levels plateaued between 2 and 7 hr (Meyer and Rinke, 1991).  In 
lactating dairy cows, clenbuterol was present in plasma within 2 hr after initiation of 
treatment and shortly thereafter in the mammary gland with a plateau being reached in 
plasma by 3 to 4 d and in milk by 5 to 7 d (Stoffel and Meyer, 1993).  Similar findings 
were reported by Dave et al. (1998), where steady state clenbuterol concentrations were 
achieved at 5 d in 18 wk old calves.   
Zilpaterol hydrochloride residue levels in cattle have been below the threshold 
that poses any human health risk (Moody et al., 2000; Anderson et al., 2004) which are 
0.02, 0.05, 0.10, and 0.10 ppm for muscle, liver, kidney, and fat, respectively (Intervet, 
Inc. 2006).  The Freedom of Information Summary for Zilmax (Intervet, Inc. 2006) 
indicates that when cattle were fed 0.15 mg/kg BW (or 6.8 g/ton in the diet) of 14C-
zilpaterol, concentrations in edible tissues reached a steady state after 12 days of feeding 
(approximately 300 ng/g in liver and 25 ng/g in muscle) and levels of total residues 
(unchanged ZH and the major metabolite, deisopropyl-zilpaterol) in liver, kidney, muscle 
and fat after a 12-hr withdrawal to be 256±49.1, 161±27.0, 19±2.1, and 9.2 ppb, 
respectively.  Levels at the 24 hr withdrawal were 180±12.1, 88±4.3, 11±2.3 ppb, and 
non-detectable (ND), respectively.  Levels at the 48 hr withdrawal were 138±19.8, 
32±21.9 ppb, ND, and ND, respectively, while levels at the 96 hr withdrawal were 
99±14.9, 8±3.1 ppb, ND, and ND, respectively.  The data for total residue indicates the 
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residues deplete more slowly from the liver than the other tissues tested.  Zilpaterol 
hydrochloride concentrations in liver, kidney and muscle tissue in cattle fed 0.15 mg of 
ZH per kg body weight for 14 days after a one day withdrawal was 27.1, 44.3, and 6.93 
ug/kg (ppb), respectively, and after a ten day withdrawal were 0.03, 0.03, and 0.01 ug/kg 
(ppb), respectively (Stachel et al., 2003).  In sheep fed 0.15 mg of ZH per kg body weight 
for 10 days, liver ZH residues after a 0, 2, 5, and 9-d withdrawal were 29.3, 1.5, 0.13, and 
0.10 ng/g (ppb).  Kidney residues were 29.6, 1.10, 0.09, and ND ng/g (ppb), respectively, 
after a 0, 2, 5, and 9-d withdrawal and muscle residues were 13.3, 0.86, 0.12, and 0.08 
ng/g (ppb), respectively (Shelver and Smith, 2006).  Also, during the first three days of 
withdrawal, urinary ZH half-life in sheep was estimated to be approximately 15.3±1.87 h 
(Shelver and Smith, 2006).   
The current generation βAA’s possess structural configurations which have 
resulted in shorter half-lives and lower potencies allowing for their continued safe use in 
the livestock industry (Smith, 1998).  As the minimum concentration of Zilpaterol, or its 
metabolic products, in liver and muscle tissues to elicit a positive growth response is 
unclear, the continued action of Zilpaterol after withdrawal periods greater th n 3 d is 
doubtful.   
 
Adrenergic Receptors 
The concept of α- and β-adrenergic receptors in the late 1940’s came about 
through work by Ahlquist (Bylund, 2007) investigating the physiological functions 
stimulated or inhibited by norepinephrine and epinephrine and a few other compounds 
(Mersmann, 1998; Bylund, 2007).  Adrenergic receptors (AR) are categorized into two 
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main groups, α-adrenergic and β-adrenergic.  Original classification of the AR was based 
on their response in involuntary muscle to an adrenergic drug; α-AR causing contraction 
in involuntary muscle and β-AR causing relaxation of involuntary muscle (Peters, 1989).  
In general, alpha receptors mediate excitation or increased activity of the ef ector cells 
and beta receptors mediate relaxation or decreased activity of the effector cells.  The 
subtypes of the α-AR, α1 and α2, were further classified as either post-synaptic or pre-
synaptic, respectively, with classification οf the β-AR; β1, β2, and β3 based on the 
specific response of the tissue to the β-adrenergic drug (Peters, 1989).  Currently, the α1-
AR, α2-AR and β-AR are considered subfamilies with further subtype classification 
consisting of α1A-AR, α1B-AR, α1D-AR, for the α1-AR subfamily; α2A-AR, α2B-AR, α2C-
AR for the α2-AR subfamily; and β1, β2, and β3, with some speculation of a β4 in mouse, 
for the β-AR subfamily (Granneman, 2001; Mersmann, 2002; Badino et al., 2005).  
However, some have classified the β4 as a β3 isoform (β3a and β3b, respectively) (Evans et 
al., 1999).  Τhe subtypes of the β-AR subfamily, β1, β2, and β3, share an approximate 45 
to 60% homology within any given species (Mersmann, 2002), while an approximate 
70% homology is shared for any given subtype across species (Pietri-Rouxel and 
Strosberg, 1995; Mersmann, 2002).  The β1, β2, and β3-AR subtypes range in size from 
approximately 460 to 420 to 410 amino acids, respectively, with the species-specific 
amino acid sequence able to cause functional modification to any given β-AR subtype 
(Mersmann, 2002; Cherezov et al., 2007).  The distribution of the receptor subtypes 
depends on tissue type with the β1-AR subtype and β2-AR subtype co-expressed in most 
tissues with the ratio of these subtypes varying according to tissue type, while the β3-AR 
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subtype has a more limited pattern of expression and is found in both white and brown 
adipose tissue (Mills, 2002a).   
Phenothalamines developed for use in the livestock industry target the β1- and β2- 
subtype receptor (Moody et al., 2000).  The adrenergic receptors are anchored to the 
plasma membrane and consist of seven transmembrane helices connected by ex racellular 
and intracellular loops (Lefkowitz et al., 1988; Lefkowitz et al., 2008) and are present in 
essentially all mammalian tissues (Mersmann, 1995).  Ligand/receptor binding volves 
numerous amino acids from several of the domains and occurs at the center of the seven 
transmembrane domains (Mersmann, 1998), with the β-AR being deactivated by several 
different mechanisms.  Messenger RNA of all three β-AR subtypes has been shown to be 
expressed in bovine adipose tissue and have been shown to be involved in the 
multifaceted regulation of lipolysis in dairy cattle (Sumner and McNamara, 2007).  β2-
AR is the primary receptor (75%) found in bovine adipose tissue as compared to β1-AR 
(25%) (Van Liefde et al., 1994).  β2-AR was also reported as the primary receptor in 
perirenal adipose tissue and the Longissimus muscle (Sillence and Matthews, 1994).  β3-
AR mRNA expression was very low or undetectable in animals after three months of age 
(Casteilla et al., 1994; Van Liefde et al., 1994); however, adipocytes in rodents exhibit a 
strong response to β3–AR while human adipocytes are poorly responsive (Langin et al., 
1995).  More so, the most abundant β-AR mRNA in semimembranous muscle of 
finishing steers was for β2-AR as ractopamine supplementation for the last 28 d on feed 
had no effect on the abundance of ß1-AR or ß3-AR mRNA, but tended
 (P = 0.09) to 
increase ß2-AR mRNA (Winterholler et al., 2007).  Similar findings were reported by 
(Sissom et al., 2007) for heifers supplemented with ractopamine the last 28 d on feed as 
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there was no effect of ractopamine supplementation on ß1-AR mRNA expression; 
however, there was a tendency for ractopamine supplementation to increase expression of 
ß2-AR mRNA.  In Longissimus muscle of beef steers, Winterholler et al. (2008) reported 
ractopamine tended to increase the abundance of β1-AR mRNA, but did not affect β2-AR 
or β3-AR.  Contradictory results were reported by (Walker et al., 2007) as β1-AR, β2-AR, 
and β3-AR mRNA levels were present in LM of steers, but mRNA expression of  β1-AR 
and β2-AR mRNA was decreased by ractopamine supplementation for 28 d.  Transcript 
mRNA for β1-AR, β2-AR, and β3-AR were present in adipocytes of porcine (McNeel and 
Mersmann, 1995) and in the adipocytes in humans (Seydoux et al., 1996).  In swine,  β1 -
AR and β2 -AR were reported to comprise nearly 95% of the β-AR in adipocytes with β1 -
AR representing 80% of the total β-AR (McNeel and Mersmann, 1999), and the primary 
subtype mediating lipolysis (Mills et al., 2003).  However, β2-AR was reported to be the 
predominately expressed receptor in muscle while in the adipocyte β1-AR and β2-AR 
were reported to be expressed in almost an equal percentage (Spurlock et al., 1994; 
Sillence et al., 2005).   
The β2-adrenergic agonist zilpaterol has a greater affinity for the β2-AR subtype 
receptor compared to the β1-AR subtype but is capable of binding both the β1-AR 
subtype (Ki = 1.0 x 10-5) and β2-AR subtype (Ki = 1.1 x 10-6) receptor (Verhoeckx et 
al., 2005).  Zilpaterol [(rac)-1] is a 1:1 mixture of (+)-1 and (-)-1 as hydrochlorides.  
Competitive binding assays using recombinant human β2-AR subtype receptors to 
determine the affinities of (rac)-1 and its enantiomers revealed that the β2-AR subtype 
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receptor activity stems from the (-)-1enantiomer alone, as the (+)-1 displaced only 3% of 
the ligand at the β2-AR subtype receptor (Kern et al., 2009).  
 
β-Adrenergic Agonists 
β-adrenergic agonists (β-AA) can be defined as “organic molecules” which bind 
the β-AR such that the agonist-receptor complex activates the stimulatory G-protein (Gs 
protein) (Mersmann, 1998).  To confer biological activity the β-AA must embrace 
distinct conformational configurations which include; a substituted six-member aromatic 
ring, a hydroxyl group bonded to the β-C in the R configuration, a positively charged N 
in the ethylamine side chain and a bulky substituent on the aliphatic N (Smith, 1998).  As 
mentioned earlier, ligand/receptor binding occurs at the center of the seven 
transmembrane domains and involves numerous amino acids from several of the 
domains.  More specifically, ligand/receptor binding occurs at three points on the β-AA; 
the β-C hydroxyl group, the aliphatic N and the aromatic ring with alterations or 
substitutions at any of these points having a profound effect on receptor binding 
(Spurlock et al., 1993; Patil et al., 2008).  Physiological activity depends on not only the 
“organic molecule”/receptor affinity, but also the rate of absorption, rate of metabolism, 
rate of elimination, and rate of distribution to target tissues (Smith, 1998).  These 
“organic molecules” are a class of phenothalamines similar in structure to endogenous 
epinephrines and catecholamine with pharmacological similarities (Barnes, 1995).  
However, not all phenothalamines are classified as β-AA.  Some phenothalamines bind 
the α-AR, while others are classified as β-antagonists.  Even more, some are specific for 
a specific subtype within the α1-AR, α2-AR and β-AR subfamilies (Smith, 1998). 
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The β-AA cannot pass through the cell membrane, thus ligand binding occurs on 
the plasma membrane of the cell.  Plasma membrane receptors mediate two main 
functions: 1) binding of ligands outside of the cell, and 2) the activation of an effector 
system leading to the generation of a second messenger system capable of activating 
various downstream processes (Lefkowitz et al., 1988).  The binding of a β-AA promotes 
the interaction between the intracellular domains of the β-AR and the heterotrimeric G-
protein, Gs (Strosberg, 1993).  The Gs protein is a member of the superfamily of 
regulatory GTP-ases that are collectively known as G-proteins (Voet and Voet, 2004d).  
The AR is one of the most extensively studied groups of G-protein-coupled receptors 
(Strosberg, 1993).  The G-protein-coupled receptors are not a simple on/off switch;
instead, they behave more like a rheostat that can dial in any level of activity from 
inactive to active (Kobilka and Deupi, 2007).  The heterotrimeric G-protein is comprised 
of three different subunits, α, β, and γ.  On the basis of sequence similarity, the α 
subunits have been divided into four families, Gs, q11, G12/13 and Gi/o (Neves et al., 
2002).  The Gsα subunit activates adenylate cyclase; the enzyme that converts ATP to 
cAMP, the second messenger in the system, which binds to the “regulatory units” of the 
inactive protein kinase A (PKA) holoenzyme, which in turn is “activated”, causing the 
release of the “catalytic subunits”, which in turn phosphorylates various downstream 
intracellular proteins (Mersmann, 1998; Voet and Voet, 2004d).  The catalytic subunits 
are able to diffuse into the nucleus where they phosphorylate cAMP response element 
binding (CREB) which binds to certain DNA sequences or cAMP response elements 
(CRE) which can increase or decreases the transcription of certain genes (Voet and Voet, 
2004d; Lynch and Ryall, 2008).  Proteins that can be activated by PKA phosphorylation 
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are Hormone-sensitive lipase (HSL), which is the rate limiting step in lypolysis, and 
perilipin A, which is a key regulator of triacylglycerol storage and assists the docking of 
HSL onto lipid droplets to facilitate maximal lipolysis (Mersmann, 1998; Marcinkiewicz 
et al., 2006; Granneman and Moore, 2008).  On the other hand, acetyl-CoA carboxylase, 
which is the rate limiting step in lipogenesis, is deactivated by PKA phosphorylati n 
(Tong, 2005).  Down-regulation of PKA occurs by a negative feedback mechanism as 
PKA also activates a cyclic nucleotide phosphodiesterase enzyme, which converts cAMP 
back to 5’AMP, thus reducing the amount of cAMP that can activate PKA in the cell 
(Mehats et al., 2002).  Cyclic AMP is short lived in the system.  The cAMP/PKA 
signaling pathway is a versatile pathway involved in the regulation of cardiovascular 
function, reproductive function, metabolism in adipocytes, and immune function (Tasken 
and Aandahl, 2004). 
The β-AA is effective for a limited period of time as the efficacy of β-AA can be 
altered by desensitization caused by the continuous exposure of the β-AR to the β-AA 
(Hausdorff et al., 1990b; Lynch and Ryall, 2008).  Desensitization can be defined as th  
attenuation of response despite continued presence of the stimulus (Mills, 2002b).  There 
are three mechanisms of desensitization.  The first is the functional uncoupling of the β-
AR from Gs, which involves the phosphorylation of the β-AR which occurs very rapidly 
(usually within seconds or minutes) when agonist exposure occurs and reduces the β-AR 
affinity for the agonist and is considered a completely reversible process (Mills, 2002b; 
Badino et al., 2005).  Upon agonist binding to the βAR, a conformational change to the 
βAR occurs that allows phosphorylation to take place (Kohout and Lefkowitz, 2003).  
This β-AR phosphorylation involves two kinases; protein kinase A (PKA) and the G-
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coupled receptor kinases (GRK), which consists of seven known isoforms (Kohout and 
Lefkowitz, 2003), including a specific enzyme which phosphorylates Ser and Thr 
residues in the βAR carboxy tail, GRK-2 or β-adrenergic receptor kinase1 (βARK1) 
(Mills, 2002b; Kohout and Lefkowitz, 2003).  The β-AR exhibits an increased affinity of 
Gi over Gs when phosphorylated, essentially switching the signaling pathway from Gs to 
Gi, can inhibit the production of cAMP from ATP.  The β3-AR is usually less responsive 
to desensitization than β1-AR or β2-AR; with β2-AR more readily desensitized than β1-
AR, as there are subtype differences to phosphorylation.  In human β-AR, the β1-AR 
contains one PKA site and ten βARK sites, the β2-AR contains two PKA sites and eleven 
βARK sites, and the β3-AR contains no PKA sites and three βARK sites (Hausdorff et 
al., 1990a) and is resistant to short-term uncoupling responses (Granneman, 1992).  GRK 
phosphorylation also promotes the βAR to bind arrestin.  The arrestin family consists of 
four proteins that regulate the signaling and trafficking of numerous G-protein-coupled 
receptors.  Arrestin can further block G-protein-mediated signaling, in some cases as 
much as 80% (Kohout and Lefkowitz, 2003), or lead into the second mechanism of 
desensitization which is physical sequestration of the receptor away from the cell surface 
by targeting the receptor for internalization where the receptor can be either targeted for 
degradation or recycled back to the plasma membrane (Gurevich and Gurevich, 2006; 
Moore et al., 2007).  β-AR sequestration is a reversible process which is not a significant 
mechanism underlying rapid desensitization (Hausdorff et al., 1990a; Yu et al., 1993).  
The third mechanism is down-regulation of the total number of receptors (Yu etal., 1993; 
Mills, 2002b; Badino et al., 2005).  Down-regulation was defined by Mills (2002b), as 
the decline in the total β-AR and contributes to desensitization from chronic exposure to 
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an agonist.  Down-regulation, shown to occur in both in vitro and in vivo models, 
develops more slowly, taking hours or days to occur, with the decline in binding sites 
related to potency and efficacy of the agonist.  Down-regulation of the β-AR is not 
rapidly overcome and is slower to overcome than the event of uncoupling (Mills, 2002b).  
Antagonists do not cause down-regulation in the β-AR, but have been shown to increase 
the number of β-AR in number and responsiveness (Glaubiger and Lefkowitz, 1977).  
Interestingly, work by Lanzara (2005) demonstrated that with the combination of an 
agonist and a competitive antagonist in an optimal and specific ratio maintains the active 
state and supports the concept that desensitization can be controlled in vivo at the level of 
the initial receptor response.  Intracellular homeostasis is maintained due to the ability of 
the β-AR to down-regulate following chronic activation (Lynch and Ryall, 2008).  
However, following down-regulation, transcription and translational processes are 
required to restore membrane receptor numbers (Johnson, 2006b).  Though an abundance 
of information regarding β-AR desensitization and down-regulation exists in the 
literature, the body of information about the regulation of β-AR synthesis is somewhat 
lacking (Lynch and Ryall, 2008).  
Phenothalamines are often referred to as repartitioning agents because of their 
ability to redirect nutrients away from adipose tissue and toward muscle (Ri ks et al., 
1984; Moody et al., 2000).  Enhanced muscle hypertrophy observed due to β-AA feeding 
occurs by direct, receptor-mediated changes in protein synthesis and degradation rates of 
skeletal muscle tissue.  β-AA seem to act by increasing the efficiency of growth by 
preferentially stimulating skeletal muscle growth as compared to adipose tissu .  This 
repartitioning affect is thought to be brought about by an increase in protein synthesis, a 
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decrease in muscle protein degradation or a combination of both, or by the release of free 
fatty acids from adipose tissue, which then could be used as a source of energy for amino 
acids (muscle mass) (Baxa, 2008; Chung and Johnson, 2008).  One of the major proteins 
involved in protein synthesis is myosin, the most abundant protein present in striated 
muscle cells, constituting approximately 25% of the total protein pool (Baldwin and 
Haddad, 2001).  Muscle is composed of various ratios of Type I (slow contracting, 
oxidative) and Type II (fast contracting, mixed glycolytic/oxidative) fibers (Yang and 
McElligott, 1989).  The four major myosin heavy chain (MHC) isoforms found in adult 
mammalian skeletal muscles are, MHC type I, slow fiber type, and MHC type II, fast 
fiber type, IIA (MYH2), IIX/D (MYH1), and IIB (MHY4) (Schiaffino and Reggiani, 
1994; Pette and Staron, 2000) with the contractile characteristics of the muscle 
determined by the overall contribution of each fiber type (Depreux et al., 2002).  In pigs 
when ractopamine was fed for 42 d, MHCIIA (MYH2) and IIX (MYH1) fiber types were 
decreased while MHCIIB (MHY4) fiber type, the fastest and most glycolyti  fiber type, 
was increased.  In contrast, MHCIIA (MYH2) and IIX (MYH1) fiber types were 
increased in the control pigs (Depreux et al., 2002).  Chikuni (2004) was not able to 
detect MHCIIB (MHY4) in bovine skeletal muscle.  Baxa (2008) reported no differences 
in MHC-I mRNA expression in Zilpaterol supplemented cattle; however, MHC-IIX 
(MYH1) mRNA expression was increased while MHC-IIa (MYH2) mRNA exprssion 
had a tendency to be decreased due to Zilpaterol supplementation. 
In studies where lambs (Pringle et al., 1993) and steers (Wheeler and 
Koohmaraie, 1992) were fed the β-AA L 644,969, the rapid alteration of muscle growth was 
closely related to the activity of the calpain-calpastatin system.  In lambs fed a finishing 
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diet and supplemented with or without 4 ppm of the β-AA, L644,969, and slaughtered after 
0, 2, 4, and 6 wk, Pringle et al. (1993) reported cathepsin-B activity was higher and 
cystatin-like activity was lower after 2 wk in supplemented lambs than in control lambs, 
but returned to control levels thereafter.  In steers weighing approximately 350 kg 
supplemented with 0 or 3 ppm of the β-AA, L644,969, for 6 wk in a high-concentrate diet; 
Wheeler and Koohmaraie (1992), reported higher calpastatin activity in muscle from the 
β-AA-fed steers at 0 and 7 d postmortem than control steers.  There were no differences 
in µ- or m-calpain or in cathepsins-B or -B+L or cystatin between steers supplement d 
with β-AA and control steers.  Furthermore, in steers supplemented with the β-AA 
cimaterol, calpastatin mRNA and calpain II large subunit mRNA was increased 96% and 
30%, respectively, vs. nonsupplemented steers (Parr et al., 1992).   
 Page et al. (2004) reported a significant increase in apoptosis in epididymal and 
parametrial adipose tissue in rats treated with the β-AA clenbuterol and ractopamine, 
suggesting the activation of β-AR’s can trigger the apoptotic process in adipocytes.  β-
AR signaling has also been implicated in the apoptotic process in other tissues such as 
heart and skeletal muscle; however, there is deliberation over whether apoptosis is 
promoted or inhibited in these tissues (Lynch and Ryall, 2008). 
The following figure (Figure 6) is a schematic of the mode of action for β-AA 
proposed by Ricks et al. (1984). 
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Figure 6. Mode of action for β-AA proposed by Ricks et al., (1984). 
 
The β-AA clenbuterol has been shown to increase blood flow when administered 
via close arterial infusion into the iliac artery in the hind limb in cattle, suggesting that β-
AA may have an indirect effect on muscle hypertrophy by increasing the nutri nt 
availability to specific tissues.  Also reported was a progressive net uptake of amino 
acids, as amino acid uptake was increased by 50% and 80% at d 7 and 14, respectively, 
after infusion (Byrem et al., 1998).  The increased blood flow may also allow for non-
esterified fatty acids to be carried away from adipose tissue to increase lipid degradation 
(Mersmann, 1998).  In general, when β-AA were fed to cattle, pigs, poultry, and sheep, 
an increase in muscle mass and decrease in fat mass has been reported (Mersmann, 2001; 
Sillence, 2004).  However, cattle and sheep seem to have a greater response to β-AA 
compared to swine, while poultry appear to be the least responsive (Moody et al., 2000).  
The level of responsiveness seen in poultry may be attributed to the current level of
genetic selection in the industry, as poultry may be approaching the maximum biological 
growth rate that can be achieved (Mersmann, 1998).   
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Different species of animals seem to have different responses to β-AA 
(Mersmann, 1995, 1998) as a particular β-AA may not activate the target β-AR or the 
target tissue as well in one species as another.  This may involve differences in th  
number of receptors in the tissue, the agonist affinity towards the receptor, the coupling 
of the agonist-receptor complex to the signal transduction system, the differ nces in 
delivery of the agonist to the receptor site, the differences in agonist or receptor 
deactivation, or the β-AR subtype may change with the phase of differentiation or the 
hormone environment of the cell (Mersmann, 1998).  For example, the β-AA 
ractopamine was shown to be a full agonist at the β1-AR and a partial agonist at the β2-
AR in the guinea pig (Colbert et al., 1991).  More so, the β-AA ractopamine had a higher 
affinity for middle s.c. adipose tissue than for L ngissimus muscle and Semitendinosus 
(ST) muscle in porcine; while the β-AA clenbuterol had an overall greater binding 
affinity than ractopamine for i.m. and s.c. adipose tissue as well as Longissimus muscle 
and Semitendinosus muscle (Spurlock et al., 1993).  Interestingly, several antagonists for 
β1-AR and β2-AR have been shown to be partial or full agonists for β3-AR (Mersmann, 
1998); whereas, several antagonists for β1-AR had little selectivity for β1-AR over β2-AR 
in humans (Baker, 2005). 
 
Effect of Zilpaterol Hydrochloride on Feedlot and Carcass Performance 
 Zilpaterol has been shown to have an affect not only growth performance, but also 
on carcass characteristics in several studies, including hot carcass weight (HCW), 
dressing percentage, and Longissimus muscle area.  Plascencia et al. (1999) reported 
zilpaterol to increase ADG by 29%, carcass weight by 4.5%, dressing percentage by 
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3.6% and Longissimus muscle area 2.7% with no affect on KPH, fat thickness or 
marbling score vs. control steers when zilpaterol was fed the last 42 d of the finis ing 
period.  When carcasses were adjusted to a constant weight, gross primal cuts, boneless 
closely trimmed primal cuts, and boneless closely trimmed retail cuts were increased 
1.7%, 2.9%, and 3.2%, respectively.  More recently, Hilton et al. (2009) reported 
zilpaterol supplemented cattle to have a greater subprimal yield of several cuts vs. 
control.  Furthermore, zilpaterol supplementation decreased trimable fat.  Zilpaterol 
supplementation also increased Warner-Bratzler shear force values for Longissimus 
muscle at 7, 14, and 21 d postmortem and decreased sensory-panel juiciness, tenderness, 
and flavor intensity of Longissimus muscle steaks aged for 14 d.  In a recent study where 
zilpaterol was fed to steers the last 33 d of the finishing period, ADG was increased 26% 
with significant increases reported in HCW, carcass yield, and Lo gissimus muscle area 
in zilpaterol supplemented steers vs. control.  Meat from the zilpaterol supplemented 
cattle had greater Warner-Bratzler shear force values than control steers (Plascencia et al., 
1999).  When zilpaterol was fed the last 20 d of the feeding period and paired with a 
withdrawal period of 3, 10, 17, and 24 d, steers supplemented with zilpaterol had 
carcasses with greater individual side weights and an increase in the overall percentage of 
lean than control steers.  Zilpaterol supplementation did not affect carcass fat 
determinations (Shook et al., 2009).  Furthermore, increased withdrawal time increased 
carcass weights with improvement in percent lean for some carcass cuts seen for up to 
10-d withdrawal time.  Warner-Bratzler shear force values were higher at each of three 
aging times, 7, 14, and 21 d, in steaks from steers supplemented with zilpaterol (Shook et 
al., 2009).  Vasconcelos et al. (2008) investigated the affects of supplementing zilpaterol 
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for 0, 20, 30, or 40 d before slaughter with a three day withdrawal and days on feed of 
136, 157, 177, and 198 d and showed, regardless the length of time of zilpaterol 
supplementation, steers supplemented with zilpaterol had greater HCW, greater dressing 
percent, less 12th rib fat, larger Longissimus muscle, less KPH, and lower yield grade than 
0-d control.  However, marbling scores were greater for 0-d steers and a greater 
percentage of steers graded USDA Choice or greater than zilpaterol supplemented steers.  
The percentage of USDA Select carcasses was greater in zilpaterol supplemented cattle 
than 0-d control.  These results suggest that supplementation of zilpaterol for 30 or 40 
days as compared to 20 had no substantial effects on performance and carcass 
measurements.  In looking at zilpaterol supplementation for 20 or 40 d in both steers and 
heifers, Montgomery et al. (2009a), observed final body weight (BW), ADG, and feed to 
gain (F:G) increased with zilpaterol supplementation.  Also, HCW, dressing percentage, 
and Longissimus muscle area were increased in both steers and heifers while 12th rib fat 
and KPH were not affected.  In steers and heifers quality grade was significantly 
decreased with the decrease in steers tending to be greater with 40-d zilpaterol 
supplementation vs. 20 d.  Marbling score in steers was significantly decreased with the 
decrease tending to be greater in 40-d zilpaterol supplementation vs. 20 d.  Marbling 
score in heifers had a tendency to be decreased with zilpaterol supplementation.  In cattle 
from the same study, Leheska et al. (2009) reported increases in Long ssimus muscle and 
Warner-Bratzler shear force values in both steers and heifers supplemented with 
zilpaterol.  Also, sensory panel scores of juiciness, tenderness, and flavor intensity ended 
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Previous research in our laboratory demonstrated that nutrition during the 
growing phase affects performance of beef cattle during the finishing phase.  More so, the 
nutritional background of beef steers (i.e., steers on supplemented native range or steers 
on high-gain wheat pasture) altered gene expression in s.c. and i.m. adipose tissue depots 
during the finishing phase in the feedlot.  Microarray analyses, validated by RT-PCR, 
was utilized to investigate the effects of different winter growing programs on gene 
expression in s.c. and i.m. adipose tissue depots in beef steers at the end of the growing 
phase.  Steers of similar breed, type, and age were assigned to initial harvest or one of 
three treatment diets; steers grazed on wheat pasture (WP); steers fed a orghum silage-
based growing diet (SF); or steers program fed a high-concentrate diet (PF).  SF and PF 
were fed to gain BW similar to WP.  At the end of a 112-d growing phase (GP), 6 steers
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from WP, SF, and PF were harvested, with the remaining steers from each diet placed in 
the feedlot.  A 7.6 cm3 section was dissected from the Longissimus muscle at the 12th rib 
and s.c. and i.m. adipose tissue were collected.  Total RNA was extracted and cDNA 
microarray hybridizations performed.  Preprocessing and normalization of data was 
accomplished utilizing GenePix AutoProcessor (GPAP 3.2).  Ontology analysis wa  carried 
out using GFINDer.  Ingenuity Pathways Analysis (IPA) was also utilized to identify the 
most relevant biological mechanisms, pathways and functions of the annotated genes.  A 
total of 376 genes were differentially expressed (DE) between s.c. and i.m. aipose depots.  
Almost twice the number of DE genes was observed in WP and PF diets as SF diets.  The 
data presented indicates the metabolic machinery for adipose tissue accretion was down-
regulated in i.m. adipose tissue compared to s.c. adipose tissue as genes relevant to β-
oxidation and the synthesis and transport of triacylglycerides and fatty acids were down-
regulated in i.m. adipose tissue, while genes involved in glycolysis and oxidative 
phosphorylation were up-regulated in i.m. adipose tissue compared to s.c. adipose tissue.  
The main effect of diet could possibly influence adipose tissue deposition at the end of the 
GP as fatty acid binding protein 4 (FABP4) exhibited a tendency to be influenced by diet.  
IPA metabolic and signaling pathway analysis provided insight into possible differences in 
the molecular mechanisms affecting gene expression in i.m. and s.c. adipose tissue in beef 
steers at the end of the growing phase managed under different growing diets. 
Key words: beef cattle, microarray, adipose tissue, gene expression  
 
Introduction 
The terms backgrounding and stockers are synonymous (Peel, 2000) and describe 
the production phase between the time a calf is weaned until placement into a feedlot for 
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finishing (Bock et al., 1991; Thomson and White, 2006).  Stockers are raised primarily on 
forage or pasture diets in the south central and southern U.S., while silage is the primary
diet fed in backgrounding lots in the north central and northern U.S. (McCurdy, 2006).  
Lack of available forage or pasture due to inclement weather or market conditions may 
warrant the confinement of animals to a drylot and fed a grain-based ration (Thomson and 
White, 2006).  Two alternatives to roughage or pasture based programs are; 1) program 
feeding, defined by Galyean (1999) as the use of net energy equations to calculate the 
quantities of feed required to meet the needs of maintenance plus a specific ADG and 2) 
calf-fed programs, a system where cattle are placed on an ad libitum finishing diet 
immediately following weaning (Lardy, 1998).  Due to geographical regions in the U. S., 
backgrounding/stocker programs involve a wide range of production environments and 
management skills, such that not all programs and systems are feasible for producers in the 
various locations in the U.S. (Peel, 2006).  Previous work in our laboratory demonstrated 
that nutrition during the growing phase affects the performance of beef cattl  during the 
finishing phase (Choat et al., 2003; McCurdy, 2006).  More so, using suppressive 
subtractive hybridization, we have reported different nutritional background in beef ste rs 
(i.e., steers on supplemented native range or steers on high-gain wheat pasture) altered gene 
expression in s.c. and i.m. adipose tissue depots during the feedlot phase (Ross et al., 
2005).  Therefore, the objective in the present study was to determine the effects of 
different winter growing programs on gene expression in s.c. and i.m. adipose tissue depots 




Materials and Methods 
Animals and Treatment Groups (Diet) 
Adipose tissue samples utilized in the present study were collected from aprevious 
study published by McCurdy, (2006).  A total of 260 British crossbred steers were utilized 
for this study which included fifty steers from the Oklahoma State University cow herd and 
210 steers purchased by Colorado Beef (Lamar, CO) of similar breed, type, and age 
(average initial BW: 236 ± 22.0 kg).  Four steers were randomly selected for initial serial 
slaughter (INT) and were transported to the Robert M. Kerr Food & Agricultural Products 
Center abattoir (FAPC), located on the campus of Oklahoma State University, Stillwater, 
OK.  The remaining steers were blocked by initial weight and randomly allotted to one of 
three treatment groups for winter-feeding for the growing phase (GP).  The three treatment 
groups were managed under three different growing systems.  One treatment group (WP; n 
= 64) was grazed as a single group on wheat pasture with unrestricted forage availability; 
the second treatment group (SF; n = 8 pens; 8 steers/pen) was fed a sorghum silage-ba ed 
growing diet; and the third treatment group (PF; n = 8 pens; 8 steers/pen) was program fed 
a high-concentrate diet.  Steers in the SF and PF groups were fed to gain BW at a similar 
rate as WP steers.  All steers were implanted with progesterone (USP 200 mg) and estradiol 
benzoate (20 mg) (Component E-S, VetLife, West Des Moines, IA) at the start of the GP.  
Steers from all treatment groups were weighed at 28 d intervals.  Wheat pasture grazing 
took place at the Oklahoma State University Wheat Pasture Research Unit in Logan 
County, OK, while all pen feeding was conducted at the Southeastern Colorado Research 
Center, Lamar, CO.  Steers at OSU allocated to the SF, PF, and CF groups were transported 
from Stillwater, OK to Lamar, CO (688 km), while purchased steers allocated to the WP 
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group were transported from Lamar to Stillwater prior to the beginning of the trial.  At the 
end of the growing phase (112 d), six steers were randomly selected from each of the WP, 
SF, and PF treatment groups and transported to the Rob rt M. Kerr Food & Agricultural 
Products Center (FAPC) abattoir in Stillwater, OK for slaughter. 
 
Sample Collection and RNA Extraction  
At slaughter, steers steers harvwested at FAPC were stunned with captive bolt and 
exsanguinated.  Following exsanguination, a 7.6 cm3 section was dissected from the 
Longissimus muscle between the 12th and 13th rib, from which s.c. and i.m. adipose tissue 
was collected and frozen at -80º C.  Total RNA was extracted using TRIzol reagent 
(Invitrogen, Carlsbad, CA) (4 ml TRIzol per 1 g of adipose tissue).  The adipose tissue, in 
TRIzol, was homogenized and centrifuged at 3,500 x g at 4º C for 15 min to separate 
insoluble material and excess fat.  The lower aqueous (TRIzol) phase was transferred to a 
fresh tube and 0.2 ml chloroform/ml of TRIzol was added.  Samples were centrifuged at 
3,500 x g at 4º C for 30 min and the upper aqueous phase was transferred to a fresh tube.  
Isopropyl alcohol (0.5 ml/ml of TRIzol) was added and samples were maintained at -20º C 
overnight followed by centrifugation at 3,500 x g at 4º C for 10 min.  The supernatant was 
removed and the RNA pellet washed with 75% chilled ethanol and suspended in 
DNase/RNase free water.  A subsequent phenol:chloroform:isoamyl alcohol (25:24:1; pH 
5.2) extraction of the RNA (1:1 ratio, respectively) was carried out. The 
RNA/phenol:chloroform:isoamyl alcohol mixture was centrifuged at 10,600 x g at 4º C for 
5 min and the upper aqueous phase was transferred to a fresh tube and precipitated with 
0.01 volumes of sodium acetate (3M; pH 5.2) and 2.5 volumes of chilled 98% ethanol.  The 
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samples were then maintained at -20º C overnight and centrifuged at 10,600 x g at 4º C for 
30 min.  The supernatant was removed and the RNA pellet was washed with 70% chilled 
ethanol and suspended in DNase/RNase free water and stored at -80º C.  The integrity of 
the RNA was analyzed utilizing gel electrophoresis (1.5%) and the RNA was quantified 
using a NanoDrop® ND-100 Spectrophotometer (NanaDrop Technologies, Willington, 
DE).  The low amount of s.c. and i.m. adipose deposition in steers from INT and the i.m. 
adipose deposition of WP steers warranted pooling of the RNA samples to assure the 
abundance of RNA for the planned microarray comparisons.  Three steers from each diet 
were selected for microarray comparison with the pooled s.c. and i.m. from INT repeated 
three times and individual s.c. samples from WP hybridized against the pooled i.m. sample.
 
Microarray Experiment  
A bovine specific adipose tissue cDNA array prepared by Dr. Udaya DeSilva, 
Animal Molecular Genetics, Oklahoma State University, was used in this study.  The 
printed array consisted of a 1,089 cDNA non-redundant clone library constructed from s.c. 
and visceral adipose tissue spotted onto Corning® UltraGAPS™ Coated Slides (Corning, 
NY).  Array printing procedures were adapted from published literature (Hegde t al., 
2000).  The library was sequenced, with the EST sequences submitted to GenBank.  
GenBank accession numbers and dbEST IDs are presented in a supplementary table 
available at http://www.ansi.okstate.edu/faculty/desilva/papers/table.htm.  Library 
annotation was accomplished, with EST sequences queried against the Peptide, Unigene, 
and nonredundant (nr) GenBank database (Bos Taurus) with unknown EST sequences 
queried against the nr GenBank database (mammalian). 
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The OmniGrid 100 microarrayer (Genomic Solutions Ann Arbor, MI) used to print 
the microarray slide was equipped with a print head containing 16 print tips in a 4 by 4 
fashion, with subarrays printed by the print head representing a block.  The array consisted 
of 16 blocks in a 4 by 4 design with each probe (sequence) being printed once per array. 
The array was printed in triplicate on each slide to give a final 4 by 12 block slide design; 
accordingly each probe was represented three times on the microarray slide.  The adipose 
microarray contained a positive control consisting of a pooled sample of cDNA used to 
create the library and a negative control consisting of the printing buffer.  The slides were 
left in a humidified atmosphere after printing for 6 to 8 h to facilitate probe attachment to 
the slide.  The slides were then baked at 80º C overnight and then stored in a vacuum 
desiccator at room temperature until the implementation of the hybridization protocol.   
The microarray slides were rinsed in 0.1% SDS for 5 min and then rinsed in sterile ddH2O 
for 15 s and immediately dried for 2 min using a slide centrifuge.  The microarray slides 
were then placed into a screw-top 50 ml conical vial containing a pre-warmed (48º C) 
commercial pre-hybridization buffer (BlockIt Microarray Blocking Solution, TeleChem 
Int., Sunnyvale, CA) and incubated at 48º C for 4 h.  Slides were removed and rinsed in 
sterile ddH2O for 15 s and immediately dried for 2 min using a slide centrifuge.   
To compare i.m. adipose tissue expression relative to s.c. adipose tissue expression, total 
RNA (2.5 µg) from s.c.(reference sample) and i.m. (test sample) adipose tissue was reverse 
transcribed into cDNA in separate tubes using both random and dT primers and reverse 
transcriptase (Superscript II RT, Invitrogen, Carlsbad, CA).  The reaction was carried out at 
42º C for 6 h and the cDNA was subsequently labeled using the 3DNA Array 900MPX 
Expression Array Detection Kit (Genisphere, Hatfield, PA).  The cDNA was then purified 
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using the Qiagen MinElute PCR Purification Kit (Qiagen Inc., Valencia, CA).  Following a 
poly-T tailing reaction, the “tagged” cDNA was ligated to the 3DNA Capture Sequence, a 
31-mer sequence specific for each the Alexa Fluor™ 546 and Alexa Fluor™ 647 and 
subsequently purified as previously described.  For the primary hybridization (hybridizing 
the tagged cDNA to the array), the hybridization solution (75 ul) consisting of: 10.0 µl of 
cDNA/3DNA Capture Sequence of each the Alexa Fluor™ 546 and Alexa Fluor™ 647; 
40.0 µl of the supplied 2X formamide-based hybridization buffer; 2.0 µl LNA dT blocker 
and 13µl nuclease-free water was denatured at 80º C for 10 min and deposited to a pre-
hybridized array slide under a 24 x 60 mm lifterslip (Erie Scientific, Portsmouth, NH).  The 
array was then incubated at 48º C for 18 h in a humidified hybridization cassette.  
Following incubation the lifterslip was allowed to wash off in a 2X sodium 
chloride/sodium citrate (SSC) /0.2% sodium dodecyl sulfate (SDS) solution prewarm d to 
48 º C.  The array slides were then washed in 2X SSC/0.2% SDS, 60º C,15 min; 2X SSC, 
RT,15 min; and 0.2X SSC, RT, 15 min.  Following the final wash, the array slide was 
immediately dried for 2 min using a slide centrifuge.  For the secondary hyb idization, the 
hybridization solution (75 ul) consisting of: 2.5 µl of the fluorescent 3DNA Capture 
Reagent (capture reagent is complement to the capture sequence of the primary 
hybridization) of each the Alexis Fluor™ 546 (reference sample) and Alexa Fluor™ 647 
(test sample); 40.0 µl of the supplied 2X formamide-based hybridization buffer and 30 µl 
nuclease-free water was deposited to the array under a 24 x 60 mm LifterSlip (E ie 
Scientific, Portsmouth, NH).  The array was then incubated at 48º C for 4 h in a 
hybridization cassette.  The array slide was washed and dried as previously described and 
stored in a light-proof container until image acquisition. 
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Microarray Data Analysis  
To compare i.m. adipose tissue expression (Alexa 647) relative to s.c. adipose tissue 
(Alexa 546), hybridization signals were captured by scanning the microarray slides with 
lasers at two wavelengths, Alexa 546 (s.c.) and Alexa 647 (i.m.), using a ScanArray™ 
Express confocal laser scanner (PerkinsElmer Life Sciences Inc., Boston, MA) at a pixel 
size resolution of 10 microns with the resulting images saved as 16 bit TIFF images.  For 
each slide, the laser power and photomultiplier tube (PMT) gain were adjusted to minimize 
variation between channels.  Using a local background subtraction method (spots with 
foreground intensity minus background intensity), the commercial software package 
GenePix™ Pro 4.0 (Axon Instruments Inc., Union City, CA) was used to analyze the signal 
intensity values of each feature (spot) in the Alexa Fluor™ 546 and Alexa Fluor™ 647 
channels.  The GenePix Pro Result (GPR) files generated from the results of the image 
analysis from each biological and technical replication were used for further downstream 
analysis and ratio calculations.  Preprocessing and normalization of data was accomplished 
utilizing the R-project statistical environment (http://www.r-project.org) with the 
Bioconductor and LIMMA packages (http://www.bioconductor.org) through the GenePix 
AutoProcessor (GPAP 3.2) website (http://darwin.biochem.okstate.edu/gpap32/) (Weng 
and Ayoubi, 2004).  Background correction was performed using Robust Multi-array 
Average (RMA) algorithm (Allison et al., 2006) available in the Bioconductor/LIMMA 
package.  Following background correction, poor quality features were removed by 
filtering.  Such poor quality features were defined as features displaying n intensity value 
of 200 Relative Fluorescence Units (RFU) or less in both the Alexa Fluor™ 546 and Alexa 
Fluor™ 647 channels, as well as features flagged bad, not found or absent by GenePix™ 
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Pro 4.0 were removed from the analysis.  Two different normalization methods were 
utilized in the analysis to adjust and balance for the technical or systemic variation between 
the features within an array and between arrays for differences not caused by tr atment.  
Lowess (locally weighted Least squares regression) - global intensity normalization, was 
used to balance the variation associated with dye bias within each array (Yang et al., 2001; 
Yang et al., 2002).  To balance the effect of the Alexa Fluor™ 546 and Alexa Fluor™ 647 
dye bias intensity between arrays, quantile normalization was utilized (Bolstad et al., 
2003).  Following data preprocessing, the expression ratio for each feature (gene) was 
calculated using the following formula where a two-fold change is represented by a log2 
ratio >1.0 (up-regulation) or < -1.0 (down-regulation) with M value (log2 expression ratio) 
= log2 (F647-B647intensity/F546-B546intensity).  Using GPAP 3.2, a moderated t-test was used 
to identify the differentially expressed array elements along with their M value (log2 ratio), 
their P-value obtained from the moderated t-statistic after false discovery rat  (FDR) 
adjustment using the Benjamini and Hochberg method (Benjamini and Hochberg, 1995), 
and the number of individual features (log2 ratio) used for each gene.  Array elements 
where > 50% of the total features across arrays was used to calculate the v rage log2 ratio, 
a |t| > 2, an M-value |M|> +0.9 (representing a fold change of 1.87), and an adjusted P-
value < 0.01 were considered significantly differentially expressed and included for further 
analysis using the Genome Functional Integrated Discoverer (GFINDer) 





Gene Ontology Analysis  
The web based program GFINDer (Masseroli et al., 2004) was utilized in this study 
and is a program designed to retrieve annotations for a list of submitted genes, perform
categorization and present the results for use in gene ontology and pathway analysis where 
possible.  Entrez Gene is the National Center for Biotechnology Information (NCBI) 
database for gene-specific information (Maglott et al., 2005, 2007).  The Entrez gen  ID of 
the differentially expressed genes retrieved from NCBI was used for the n ology analysis.  
The annotation terms were generated with emphasis based on gene ontology assessment for 
molecular function and biological process rather than cellular component (Ashburner et al., 
2000). 
 
Ingenuity Pathway Analysis  
To further understand the extent of how genes may interact within the context of 
metabolic or signaling pathways, Ingenuity Pathways Analysis (IPA) (Ingenuity® Systems, 
http://www.ingenuity.com) was utilized to identify the most relevant biological 
mechanisms, pathways, and functions of the differentially expressed genes identified 
through GPAP 3.2.  IPA enables the visualization and exploration of gene interaction and 
relies on the most current known relationships among human, mouse and rat genes and 
proteins.  A data set of differentially expressed genes from INT and diets of GP containing 
gene ID and corresponding expression values was uploaded into the IPA application.  To 
gain a better understanding of the interactions between genes within a biological system, an 
arbitrary M-value of |M| > +0.59 (or a fold change of 1.50) and a P-value < 0.01 were 
assigned as parameters for this analysis.  Each gene ID was mapped to its corresponding 
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gene object in the Ingenuity Pathways Knowledge Base (IPKB).  These genes, called focus 
genes, were overlaid onto a global molecular network developed from information 
contained in the IPKB.  Networks of these focus genes were algorithmically generated 
based on their connectivity and assigned a network score.  IPA arbitrarily sets the 
maximum number of focus genes in each network at thirty-five.  The functional analysis of 
an entire dataset or single network identifies the biological functions and/or diseases that 
were most significant to the genes in the dataset or network.  IPA uses a Fischer’s exact test 
to calculate a P-value determining the probability that each biological function and/or 
disease assigned to that dataset or network is due to chance alone.  The network score is the 
negative log of this P-value and is a numerical value used to rank networks according to 
how relevant they are to the differentially expressed genes in the input dataset.  The 
network score takes into account the number of focus genes in the network and the size of 
the network.  The network score is not an indication of the quality or biological relevance 
of the network; it simply calculates the approximate “fit” between eachnetwork and the 
focus genes from the input data set.  For example, a score of “6” would indicate a P=10-6 
chance of genes appearing in the network solely by chance.  A network pathway is a 
graphical representation of the molecular relationships between genes/ products.  
Genes or gene products are represented as nodes, and the biological relationship between 
two nodes is represented as an edge (line).  All edges are supported by at least one 
reference from the literature, a textbook, or from information stored in the IPKB.  The 
intensity of the node color indicates the degree of up- (red) or down- (green) regulation.  
Nodes are displayed using various shapes to represent the functional class of the gene
product.  Edges are displayed with various labels that describe the nature of the relationship 
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between the nodes. For a gene to be network eligible, it must meet the criteria specified in 
the analysis parameters and also have at least one other full-length, wild-type gene or 
protein in IPKB that interacts (directly or indirectly) with this gene.  Ingenuity combines 
eligible genes into networks that maximize their specific interconnectedness with each 
other relative to all molecules to which they are connected.  The network algorithm 
optimizes for specific connectivity, so when a "hub" molecule is included in a network it 
connects a higher fraction of network eligible molecules relative to all molecules to which 
the "hub" molecule is connected with additional molecules from IPKB used to specifically 
connect and merge two or more smaller networks.   
IPA pathway analysis identifies the pathways from the IPA library most significant 
to the data set.  The significance of the association between the data set and the pathway is 
measured in two ways: 1) a ratio of the number of genes from the data set that map to the 
pathway divided by the total number of genes that map to the pathway; and 2) Fischer’s 
exact test is used to calculate a P-value determining the probability that he association 
between the genes in the dataset and the pathway is explained by chance alone. 
 
Quantitative RT-PCR Validation of Microarray  
Validation of the i.m. adipose tissue expression relative to s.c. adipose tissue 
expression values generated from the microarray experiment was carried out using two-step 
SYBR green qRT-PCR.  Gene specific primers for thirteen different candidate genes 
selected for microarray data validation were designed using Primer 3 (Rozen and 
Skaletsky, 2000) and analyzed using Oligo Analyzer 3.1 (Integrated DNA Technologies), 
 71 
http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/.  All primer sequences, 
annealing temperatures and product size are presented in Table 3.1.  
Total RNA (1 ug) from s.c. and i.m. adipose tissue depots from each individual 
animal for the diet and phase randomly selected for validation was reverse transcribed 
using the QuantiTect® Reverse Transcription Kit (QIAGEN Inc., Valencia, CA) using 
oligo-dT and random primers in a total volume of 20 ul.  RT- PCR reactions were carried 
out in duplicate, using a MyiQ Real-Time PCR detection system (Bio-Rad Laboratories, 
Hercules, CA) in a 15 ul reaction consisting of: 7.5 ul of 2X PerfeCTa™ SYBR Green 
SuperMix for iQ™ (Quanta BioSciences, Inc. Gaithersburg, MD), 400 nM forward primer, 
400 nM reverse primer and 100 ng of cDNA.  18S ribosomal RNA was assayed as a 
normalization control for all samples assayed.  A standard curve with five serial dilution 
points was included for each gene along with a no-template control.  Thermal cycling 
conditions were 95º C for 2.5 min followed by 38 repetitive cycles of 95º C for 15 s, 
variable annealing temperature for 30 s, and 72º C for 30 s.  Immediately following RT-
PCR, a melt curve analysis was conducted by bringing the reaction to 95º C for 1 min, 55º 
C for 1 min, then increasing the temperature by 0.5º C from 55º C to 94.5º C.  Gene 
expression between depots for the diet and phase selected for validation was evaluated 
using the comparative CT method.  A cycle threshold (CT) value was assigned to each 
reaction at the beginning of the logarithmic phase of the PCR amplification.  A ∆CT value 
was calculated for each sample by subtracting the mean 18S ∆CT value of each sample 
from the corresponding gene of interest mean ∆CT value (Livak and Schmittgen, 2001).  
The ∆∆CT was calculated by setting the i.m. ∆CT value of the two depots as an arbitrary 
constant to subtract from the s.c. mean ∆CT depot values (Hettinger et al., 2001).  Relative 
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expression levels between the two adipose depots were calculated as fold changes, wher  
each cycle of the PCR represented a two-fold change.  The assay specific effi iency for 
each gene was not used in the calculation of the relative expression levels.  Fold change
(FC) gene expression was calculated using the formula: FC = 2 −∆∆CT. 
 
Quantitative RT-PCR analysis for selected genes  
Five genes from the adipose related category; acyl-CoA synthetase medium-chain 
family member 1 (ACSM1), CD36 molecule (thrombospondin receptor) (CD36), fatty acid 
binding protein 4 (FABP4), stearoyl-CoA desaturase (delta-9-desaturase) (SCD , 
hydroxyacyl-Coenzyme A dehydrogenase (HADH); three genes from the carbohydrate 
metabolism category, glucose phosphate isomerase (GPI), lactate dehydrogenase B 
(LDHB), and pyruvate kinase, muscle (PKM2); one gene from the binding category, four 
and a half LIM domains 1(FHL1); and one gene from the transcription/translation cegory, 
Y box binding protein 1 (YBX1), were measured for their mRNA expression between 
adipose depots across diets using quantitative RT-PCR and analyzed using the comparative 
CT method.  The ∆∆CT was calculated by setting the highest mean ∆CT value as an arbitrary 
constant to subtract from all other mean ∆CT depot values (Hettinger et al., 2001).  Relative 
expression levels between the depots across diets were calculated as fold changes, where 
each cycle of the PCR represented a two-fold change.  Fold change (FC) gene expression 
was calculated using the formula: FC = 2 −∆∆CT.  The ∆CT values were analyzed by analysis 
of variance (ANOVA) and means were compared using the Least squares means 
(LSMEANS) of PROC MIXED of SAS 9.1.3 (SAS Institute Inc, Cary, North Carolina).  




Performance and Carcass Merits  
Performance and carcass merits previously reported by McCurdy (2006) indicated 
average daily gain (ADG) was greater for WP and PF steers than for SF steers (P = 0.009), 
with gains of 1.15, 1.10, and 1.18 kg/d for WP, SF, and PF steers, respectively.  At the end 
of the GP, 12th-rib Longissimus muscle area was smaller for SF (60.3 cm2) steers compared 
with WP (63.8 cm2) and PF steers (65.0 cm2) (P < 0.05).  No other significant differences 
in carcass characteristics were observed. 
 
Microarray and Ontology analysis 
Three hundred sixty-eight of 1,089 array elements, or 34%, were observed to be 
differentially expressed between s.c. and i.m. adipose tissue depots in the INT and/or one 
of the diets of the GP.  The Clone ID, Gene Symbol, Gene Name, Entrez Gene ID, dEST 
ID, GenBank Accession number, M-value, GO/KEGG ID, and GO term/KEGG pathway 
for the genes in INT and each diet of GP are presented in the appendices (Appendices 
Table A1). 
Of the 368 array elements, 45 had a non-significant (E value >1e-15) or ambiguous 
match in the previously described NCBI databases and were grouped under the category 
“No Biological Data Available” (Rhee et al., 2008).  Three hundred twenty-three a ray 
elements were observed to significantly (E value < 1e-15) correspond to specific annotated 
genes in the NCBI databases and were used for ontology analysis using GFINDer and 
Entrez Gene.  One hundred sixteen array elements were not associated with any functional 
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or biological annotation, even though they had significant matches in the NCBI databases 
and were grouped under “Other”.  Based on results of the Bovine ontology analysis, 207 
differentially expressed genes were organized into 15 functional/biological categories.  
Eighty-three of the 207 differentially expressed genes were detected in biochemical 
pathways for Bos Taurus defined by Kyoto Encyclopedia of Genes and Genomes (KEGG), 
http://www.genome.jp/kegg/, (Kanehisa and Goto, 2000).  
Almost twice the number of differentially expressed genes were observed in the WP 
and PF diets than SF diet (200 and 196 vs. 104, respectively) with the number of 
differentially expressed genes in INT (146) being intermediate (Table 3.2).  WP and PF 
diets had a greater number of differentially expressed genes involved in binding than INT 
or SF diet.  Furthermore, WP steers had a greater number of differentially expressed genes 
involved in cell cytoskeletal/adhesion/extracellular matrix related functions than INT or SF 
and PF diets.  Fewer differentially expressed genes in SF were involved in oxi oreductase, 
signal transduction and transporter functions than WP and PF, whereas the number of 
differentially expressed adipose related genes was similar between INT and WP, SF, and 
PF steers.  The number of differentially expressed genes relating to transcription/translation 
was similar across INT and diets of the GP.  The percent of differentially expressed genes 
not associated with any functional or biological annotation (those classified as “Other”) for 
INT and WP, SF and PF steers was 32.19, 32.50, 25.0 and 37.24%, respectively.  
 
Quantitative RT-PCR Validation of Microarray  
Eleven differentially expressed genes were selected for microarray validation.  
Comparisons between the results of the expression profiles determined by microarray and 
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RT-PCR for each gene from diets of GP selected for validation are presented in Table 3.3.  
Microarray analysis indicated acyl-CoA synthetase medium-chain family member 1 
(ACSL1), branched chain aminotransferase 2, mitochondrial  (BCAT2), CD36 molecule 
(CD36), fatty acid binding protein 4 (FABP4), lactate dehydrogenase B (LDHB), and 
stearoyl-CoA desaturase (SCD), to be down-regulated in the i.m. adipose tissue in 
respective diets of GP.  RT-PCR verified the down-regulated pattern of expression of these 
genes in i.m. adipose tissue.  Microarray analysis indicated four and a half LIM domains 1 
(FH1), glucose phosphate isomerase (GPI), N-myristoyltransferase 1 (NM1), pyruvate 
kinase, muscle (PKM2), and Y box binding protein 1 (YBX1) to be up-regulated in the i.m. 
adipose tissue in respective diets of the GP.  The RT-PCR results verified the same up-
regulated expression pattern of these genes in the i.m. adipose tissue in respective diets of 
the GP. 
 
Quantitative RT-PCR Analysis for Selected Genes   
Results for the RT-PCR analysis for mRNA expression measured for eleven 
differentially expressed genes for all experimental animals between d pots across diets at 
the end of the growing phase are presented in (Figure 3.1 a-k).  Four genes from the 
adipose related category, ACSM1, FABP4, HADH and SCD were significantly (P < 0.05) 
affected by depot, while CD36 had a tendency (P < 0.065) to be influenced by depot.  
FABP4 also had a tendency to be influenced by diet with mRNA expression approximately 
sevenfold higher in SF and PF steers compared to WP steers with no differences b tween 
INT and WP, SF, or PF steers.  The mRNA expression for ACSM1, FABP4, SCD, and 
CD36 was down-regulated approximately 10 fold, 13 fold, 20 fold, and three fold, 
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respectively, in i.m. adipose tissue compared to s.c. adipose tissue.  The mRNA expression 
for HADH was up-regulated approximately 3.5 fold in the i.m. adipose tissue compared to 
s.c. adipose tissue.  Two genes from the carbohydrate metabolism category, GPI and 
PKM2, were significantly (P < 0.05) affected by depot, while LDHB had a tendency (P < 
0.09) to be influenced by depot.  GPI and PKM2 mRNA expression was up-regulated 
approximately seven and 96 fold, respectively, in i.m. adipose tissue compared to s.c. 
adipose tissue.  LDHB mRNA expression was down-regulated approximately three fold in 
i.m. adipose tissue compared to s.c. adipose tissue.  The mRNA expression for FHL1, from 
the binding category, and YBX1, from the transcription/translation category was also 
affected by depot as mRNA expression was up-regulated approximately eight fold and five 
fold in the i.m. adipose tissue compared to s.c. adipose tissue, respectively. 
 
Ingenuity Pathway Analysis  
The objective of IPA network generation is to hypothesize, using the most pertinent 
information available in the literature, how network eligible genes in a data set interact in a 
biological system.  In this study, networks were generated through IPA using the datas t of 
differentially expressed genes identified through GPAP 3.2.  An arbitrary M-value of > 
+0.59 or < -0.59 (representing a fold change of > +1.50 or < -1.50) and a P-value < 0.01 
were implemented as cut-off parameters in the analysis.  Of the 323 array elements 
observed to significantly correspond to specific annotated genes, 213 were IPA network 
eligible and 185 were eligible for functional/pathway analysis.   
Networks are ranked by how relevant they are to the genes of the dataset with a 
higher score indicating a lower probability of finding the observed number of genes in a 
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given network by random chance.  An abbreviated summary of the top networks generated 
by IPA for INT and WP, SF and PF diets of GP, including number of focus genes, network 
score and the top three network molecular/cellular functions, disease/disorder or 
physiological system development and function is presented in Table 3.4.    
Eighteen networks were generated for INT with nine consisting of one focus gene.  
The most significant network for INT (IPA score: 52; focus genes: 26) had functions 
pertaining to cell-to-cell signaling and interaction (P-value, 3.83-3 to 4.75-8) and lipid 
metabolism (P-value, 3.83-3 to 9.75-8).  Twenty-three networks were generated for WP, 12 
of which had one focus gene.  The principal network for WP (IPA score: 44; focus genes: 
24) included functions associated with cell morphology (P-value, 3.95-2 to 1.92-3) and cell 
death (P-value, 4.75-2 to 1.40-3) with cell-to-cell signaling (P-value, 3.94-3 to 2.72-8) and 
connective tissue disorders (P-value, 1.73-2 to 1.15-6) foremost functions for network 2 (IPA 
score: 41; focus genes: 23).  SF diet consisted of nineteen IPA generated networks with 11 
consisting one focus gene.  Lipid metabolism and small molecule biochemistry were 
functions pertaining to Network 1(IPA score: 52; focus genes: 26) (P-value, 3.95-2 to 3.69-4 
and 3.95-2 to 3.69-4), Network 2 (IPA score: 39; focus genes: 21) (P-value, 1.97-3 to 4.41-8 
and 1.97-3 to 4.41-8), and Network 3 (IPA score: 52; focus genes: 16) (P-value, 1.97-3 to 
1.02-11 and 1.97-3 to 1.02-11).  Twenty-two networks were generated for PF steers, 13 of 
which contained one focus gene.  Top functions of network 1 (IPA score: 51; focus genes; 
26) encompassed DNA replication, recombination and repair (P-value, 4.82-2 to 1.69-4) and 
cell death (P-value, 2.19-1 to 4.64-4).   
IPA currently listed 32 functions under the heading of “molecular and cellular 
functions” which were subdivided into lower level ancillary function “categories”.  Figure 
 78 
3.2 ranks, by significance, the top 10 global molecular and cellular functions associated 
across all generated networks for INT and each diet of GP, respectively.  This represents a 
broad overview of the biology associated with each diet.  In general, a P-value < 0.05 
indicates a significant nonrandom association between genes of the dataset and a given 
function.  Significance, expressed as the negative log10 of the P-value calculated for each 
function, is represented on the y-axis.  Differences were observed between INT and diets of 
GP in the ranking of functions and the number of genes associated with those functions.  
Lipid metabolism, molecular transport and small molecule biochemistry were top-ranked 
functions for both SF and PF diets of GP.  Cell death and cellular growth and proliferati n 
were top-ranked functions for INT and WP diet, respectively, followed by lipid 
metabolism, molecular transport and small molecule biochemistry, respectively.   
Functional comparison, as well as metabolic and signaling pathway comparison between 
treatments, is a tool that allows for further determination of whether and to what exten  a 
given function or pathway is affected by a treatment.  Results of the comparative functional 
analysis between INT and diets of GP are presented in Figure 3.3.  When evaluating these 
results, one must keep in mind the possibility of genes within the makeup of the function to 
be different between treatments without altering the significance of that function.  Amino 
acid metabolism, energy production, free radical scavenging, gene expression, protein 
folding, protein synthesis, protein trafficking, and RNA post-transcriptional modification 
are functions displaying obvious variations between INT and diets of GP.  IPA contains a 
total of 158 pathways in its library; 80 metabolic pathways and 78 signaling pathways.  
Metabolic pathway analysis and signaling pathway analysis comparing INT and diets of the 
GP are presented in Figures 3.4 and 3.5, respectively.  Variations between diets (P < 0.10) 
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can be seen in a number of metabolic and signaling pathways.  Using IPA comparisn and 
network analysis, differentially expressed genes exclusive to INT and WP, SF and PF diets, 
respectively, were also investigated.  These IPA identified genes along with their 
associated networks are presented in Tables 3.5 through 3.8, respectively.   
 
Discussion 
During the GP, ADG across diets were greater for WP and PF diets than for SF 
steers (P = 0.009), with gains of 1.15, 1.10, and 1.18 kg/d as previously reported by 
McCurdy (2006).  However, results from a companion metabolism experiment showed 
similar metabolizable energy (ME) intake among treatment diets.  Be ides a smaller 12th-
rib Longissimus muscle being reported for WP steers compared with SF and PF steers, no 
other differences were observed in carcass characteristics at the end of the GP.  Despite the 
fact that twice the number of differentially expressed genes were observed in WP and PF 
steers than SF steers and the top IPA generated functions for networks 1, 2, and 3 for SF 
steers pertained to lipid metabolism and small molecule biochemistry, the number of 
differentially expressed adipose related genes were similar between INT and diets of the 
GP with the majority being down-regulated in i.m. adipose tissue compared with s.c.   
Adipose related genes (Figure 3.6) included those genes involved in lipid binding, 
transport, and metabolism as well as the metabolites secreted from adipose tissue. Gene 
expression of acyl-CoA synthetase medium-chain family member 1 (ACSM1), also known 
as butyrate-CoA ligase, was significantly altered by depot and was down-regulated nearly 
10 fold in i.m. adipose tissue compared to s.c. adipose tissue.  Synthetase refers to a 
reaction that utilizes an ATP and forms an acyl-AMP intermediate (Mashek et al., 2004) 
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and ACSM1 is involved in the reaction which is significant in the activation of fatty acids.  
Before fatty acids can be oxidized, they first must be “activated” or “primed” for the 
reaction by combining the fatty acid with Co-A to form fatty acyl Co-A.  The fatty acyl 
group is then able to be transported into the mitochondrial matrix where it undergoes beta-
oxidation.  Acetyl-CoA can then feed directly into the TCA cycle, or if p opionyl-CoA, be 
catabolized via a number of different pathways that convert it into pyruvate, acetate, or 
succinyl-CoA, which in turn, can enter the TCA cycle.  However, acyl-CoA can function as 
ligands for transcription factors or enter several other pathways such as de novo synthesis 
of triacylglycerol and phospholipids, reacylation pathways, and cholesterol and retinal 
esterification (Coleman et al., 2002; Mashek et al., 2004).  ACSM1 can also function as a 
GTP-dependent lipoate-activating enzyme that generates the substrate for lipoyltransferase 
(Fujiwara et al., 2001).  There are six members of the medium-chain Acyl-Co A family
(Mashek et al., 2004).  These members catalyze the ligation of medium chain fatty acids, 
that is acids from C4 to C11 and the corresponding 3-hydroxy- and 2,3- or 3,4-unsaturated 
acids (in vitro), with CoA to produce medium-chain Acyl-Co A (Inka Lindner, 2006).  
Though the most common substrates of the medium-chain acyl CoA synthetase family are 
fatty acids, xenobiotic carboxylic acids and bile salts can also serve as substrates (Mashek 
et al., 2004).  In the mouse, medium chain acyl Co-A synthetase was found to be inhibitd 
by nonsteroidal anti-inflammatory drugs (NSAIDs) (Kasuya et al., 2001).  Also in the 
mouse, aspirin and salicylic acid were shown to decrease the mitochondrial activation and 
the β-oxidation of long chain fatty acids (palmitate) (in vivo) by 50 and 65%, respectively, 
(Deschamps et al., 1991). 
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Stearoyl-CoA desaturase (SCD) gene expression was also significantly affected by 
depot and was down-regulated nearly 20 fold in i.m. adipose tissue compared to s.c. 
adipose tissue.  This is consistent with other finding in the literature where SCD activity 
appears to be essential for subsequent development of lipogenic activity of s.c. adipose 
tissue in growing steers (Smith et al., 2006b; Hausman et al., 2009), as s.c. adipose tissue 
was shown to have approximately twice the SCD catalytic activity as i.m. adipose tissue 
and also a greater concentration of MUFA than i.m. adipose tissue (Archibeque et al., 
2005).  However, in many breeds there has been shown to be nearly a linear increase i.m. 
adipose tissue deposition over time on a finishing diet and in many breeds this increa e in 
i.m. adipose deposition was consistent with the increase in adipose tissue MUFA and SCD 
activity (Hausman et al., 2009).  Furthermore, when comparing s.c. adipose tissue from the 
mid-loin region of pasture-fed cattle or cattle placed in the feedlot fed a diet consisting of 
sorghum, roughage, and 5% whole cottonseed for 100, 200, or 300 d, SCD activity was 
shown to be 60 to 85% higher in cattle from a pasture-fed diet than cattle on the feedlot 
diet.  This suggests that feeding whole cottonseed reduced the activity of SCD (Yang et al., 
1999) as cattle from the pasture-fed diet had lower total saturated fatty acids and higher 
total unsaturated fatty acids in adipose tissue than cattle in the feedlot (Yang et al., 1999).  
No diet affects were observed for SCD mRNA gene expression in the present study. 
CD36 molecule (thrombospondin receptor) (CD36) gene expression was 
significantly affected by depot and was shown to down-regulated over 3.5 fold in i.m. 
adipose tissue compared to s.c. adipose tissue.  In in vitro studies using 3T3-L1 cells, no 
CD36 protein was detected in preadipocytes; however, CD36 was detected in 3 day post-
differentiated cells (Qiao et al., 2008).  CD36 has been identified as an important marker of 
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preadipocyte differentiation into adipocytes as CD36 mRNA expression was induced 
during the differentiation process and fatty acid uptake coincided with the up-regulated 
expression of CD36 (Abumrad et al., 1993; Sfeir et al., 1997).  CD36 has been shown to be 
regulated by all three peroxisome proliferator receptors (PPAR) α, γ, and δ in a tissue 
specific manner (Hajri and Abumrad, 2002).  More so, CD36 contains a CCAAT/enhancer 
binding protein (C/EBP)  response element and C/EBP α and β were shown to increase 
CD36 expression with C/EBPα being a more potent inducer of CD36 than 
C/EBPβ indicating C/EBPα involvement in regulating CD36 expression at the 
transcriptional level (Qiao et al., 2008).  One of the main functions of CD36 is to facilitate 
the translocation of fatty acids in adipocytes as well as in heart and muscle cells (Nicholson 
et al., 2000; Febbraio et al., 2001; Su and Abumrad, 2009).  With CD36 being regulated by 
PPARγ and C/EBP; the up-regulation of expression of CD36 in the s.c. fat seems logical as 
it follows a similar pattern of expression as seen for other adipose related genes involved in 
fatty acid transport.  Also, there is evidence that CD36 gene expression can differ between 
depots as CD36 gene expression in weaning piglets was shown to be higher in visceral 
adipose tissue as compared to s.c. and i.m. adipose tissue (Shu et al., 2008).  Conversely, in 
a study using non-obese human subjects, CD36 gene expression was found to be up-
regulated in s.c. adipose tissue as compared to omental adipose tissue (vanBeek et al., 
2007).   
In the present experiment FABP4 gene expression was shown to be significantly 
affected by depot, with a tendency to be influenced by diet.  FABP4 gene expression was 
down-regulated over 14 fold in i.m. adipose tissue compared to s.c. adipose tissue with a 
tendency for gene expression to be higher in SF and PF diets as compared to the WP diet.  
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Similar findings were obsserved in porcine where FABP4 transcript and protein c ntent 
was shown to be lower in i.m. adipocytes as compared to s.c. adipocytes when adipose cells 
were compared at the same size and same age (Gardan et al., 2007).  Previous work by 
Moore al. (1991), showed activity of FABP4 in the Longissimus muscle not to be a good 
index for the determination of i.m. fat accretion in bovine.  However, FABP4 
polymorphisms have been shown to be associated with marbling and s.c. fat depth in cattle 
(Michal et al., 2006) and for fatness traits and i.m. fat accretion in pigs (Chmurzynska, 
2006; Damon et al., 2006). 
Hydroxyacyl-CoA dehydrogenase (HADH), an enzyme involved in the beta-
oxidation of fatty acids through the oxidation of straight chain 3-hydroxyacyl CoA’s 
(Rakheja et al., 2002; Song-Yu Yang, 2005), was altered by depot and was shown to be 
down-regulated over four fold in s.c. adipose tissue compared with i.m. adipose tissue.  
HADH is also present in the degradation pathways of the branched chain amino acids, 
valine, leucine, and isoleucine (Kanehisa and Goto, 2000), which can provide the acetyl 
CoA necessary for fatty acid biosynthesis in adipose tissue (Labrecque et al., 2009).    
Lactate is formed from pyruvate, involving the enzyme lactate dehydrogenase.  In 
the present experiment, lactate dehydrogenase B (LDHB) was shown to be down-regulated 
3.5 fold in i.m. adipose tissue compared with s.c. adipose tissue.  DiGirolamo et al. (1992) 
reviewed the role of adipose tissue lactate production and its physiological importance to 
the body’s energy balance in the human and rat.  Lactate production by the adipocyte was 
reported to be modulated, in part, by adipocyte size and density, anatomical location, 
glucose concentration, insulin levels, and nutrition and suggested the role of lactate 
production needed to be added to the evolving list of functions of the adipocyte tissue.  
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LDHB has been shown to be highly expressed in porcine s.c. adipose tissue (Chen et al., 
2006) and has also been shown to be a precursor of fatty acid metabolism and 
glycerogenesis in bovine adipose tissue (Whitehurst et al., 1978).  The rate of fatty acid 
synthesis, when either lactate or acetate was the precursor, was observed to be greater in 
subcutaneous adipose tissue than in intermuscular or intramuscular tissue (Whitehurst et 
al., 1981).  In vitro studies have shown adipose tissue from steers fed a corn-based diet to 
have a greater conversion of glucose to lactate than a hay-based diet; however, there was 
no difference between s.c. and i.m. adipose depots in lactate production within the two
diets (Rhoades et al., 2007). 
Two genes involved in carbohydrate metabolism, glucose phosphate isomerase 
(GPI) and pyruvate kinase, muscle (PKM2) were both significantly altered by depot and 
were shown to up-regulated by seven fold and 90 fold, respectively, in i.m. adipose tissue 
compared to s.c. adipose tissue.  IPA indicated other genes involved in carbohydrate 
metabolism including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and malate 
dehydrogenase 2 (MDH2), which displayed an up-regulated pattern of expression in i.m. 
adipose tissue compared to s.c. in respective diets (Figure 3.7).  Glucose phosphate 
isomerase (GPI) is a dimeric enzyme involved in the second step of glycolysis which 
catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate 
(Voet and Voet, 2004a).  Limitations in the GPI reaction or the phosphofructokinase (PFK) 
reaction can result in an increase in the glucose-6-phosphate level causing feedback 
inhibition of hexokinase and possibly a lower rate of glycolysis and fructose-6-phosphate 
being formed as a product of the pentose phosphate pathway resulting in the generation of 
NADPH for biosynthetic processes (Kugler and Lakomek, 2000; Voet and Voet, 2004c).  
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In ruminants, as much as 50 to 80% of NADPH needed for fatty acid synthesis in adipose 
tissue is produced by the pentose phosphate pathway (Vernon, 1981).  Pyruvate kinase 
(PK) catalyzes the last step in the glycolysis pathway, which is the dephosphorylation of 
phosphoenolpyruvate to pyruvate and is responsible for producing the second ATP 
generated within the glycolytic pathway (Voet and Voet, 2004a).  PK leads to either 
anaerobic fermentation or oxidative phosphorylation of pyruvate (Jurica et al., 1998) and 
can also serve as the control switch between the glycolysis and gluconeogenesis pathways 
in certain tissues (Voet and Voet, 2004a).  IPA comparative metabolic pathway established 
genes involved in oxidative phosphorylation also displayed an up-regulated pattern of 
expression in i.m. adipose tissue of respective diets in four complexes of the electron 
transport chain (Figure 3.8).  The down-regulation of LDHB and genes related to he beta-
oxidation, synthesis, transport, and storage of fatty acids in i.m. adipose tissue, along with 
the up-regulation of glycolytic enzymes and components of oxidative phosphorylation in 
i.m. adipose tissue of respective diets, suggest that fatty acid and triglyceride synthesis and 
transport is attenuated in i.m. adipose tissue compared with s.c.  Moreover, lactate is a 
possible substrate for glycerogenesis for use in triglyceride synthesis in s.c. adipose tissue.  
Acetyl-CoA, via beta oxidation, and the contribution of lactate allowing for anaerobic 
metabolism in s.c. may permit the sparing of glucose for repartitioning as an energy 
substrate for i.m. adipose tissue.  Previous data reported by Smith and Crouse (1984) 
showed i.m. adipocytes used glucose as the primary substrate for fatty acid synthesis, 
whereas s.c. adipocytes utilized acetate and lactate for incorporation into fatty acids.   
IPA showed the expression of other adipose related genes relevant to the synthesis 
of triglycerides and fatty acids such as diacylglycerol O-acyltransferase homolog 2 
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(DGAT2) (Yen et al., 2005), mitochondrial glycerol phosphate acyltransferase (GPAM) 
(Igal et al., 2001), adiponectin, C1Q and collagen domain containing (ADIPOQ) 
(Kadowaki and Yamauchi, 2005; Karbowska and Kochan, 2006) and prostaglandin-
endoperoxide synthase 2 (PTGS2) (Williams and DuBois, 1996) to be down-regulated in 
i.m. adipose tissue compared with s.c. adipose tissue.  Furthermore, adipose related genes 
involved in the transport of fatty acids and lipids including, clusterin (CLU) (Lee et al., 
2008a), and macrophage scavenger receptor 1 (MSR1) (Wang et al., 2007) were also 
shown to be down regulated in i.m. adipose tissue compared with s.c. adipose tissue 
according to IPA.  
IPA revealed transmembrane 7 superfamily member 2 (TM7SF2), isopentenyl-
diphosphate delta isomerase 1 (IDI1), and niemann-pick disease, type C2 (NPC2) gene 
expression, up-regulated in i.m compared to s.c. in WP steers.  These genes are shown to be 
involved with pre- and post-squalene intermediates in cholesterol homeostasis or the 
biosynthesis pathway (Ory, 2004; Bennati et al., 2006; Xu et al., 2007; Zheng et al., 2007).  
In humans, 3β-hydroxysterol ∆14-reductase, encoded by the TM7SF2 gene, catalyzes the 
reduction of the ∆14-double bond of post-squalene sterol intermediates during cholesterol 
biosynthesis pathway (Bennati et al., 2006).  IDI1 is involved in the isomerization of the 
double bond of isopentenyl diphosphate to form dimethylallyl diphsophate which, through 
further successive reactions, forms squalene, a precursor to cholesterol (Zheng et al., 2007).  
NPC2 has been shown to bind cholesterol and is thought to be involved with the 
intracellular movement of cholesterol out of the lysosome throughout the cell extremities 
(Ory, 2004; Xu et al., 2007).  In adipocytes, the intracellular level of 
cholesterol is controlled by two processes: biosynthesis and transport 
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into the cell from circulating lipoproteins complexes (Kouznetsova et al., 
2006).  Cholesterol is utilized in the synthesis of steroids and is an essential component 
of cell membranes (Villagra et al., 2007) with quiescent cells synthesizing very little 
cholesterol; however, in proliferating cells, synthesis can be detected in the G1 phase of the 
cell cycle (Chen, 1984).  Furthermore, cells restricted of cholesterol have been shown to 
arrest at the G2 phase of the cell cycle (Martinez-Botas et al., 1999).  However, in in vitro 
studies using human s.c. adipose tissue Tilvis et al. (1982) reported squalene to be 
synthesized and stored in high concentrations with only a small fraction converted to 
cholesterol with approximately 80% in the lipid droplet and 20% bound to microsomal 
membranes.  
Spermidine/spermine N1-acetyltransferase 1 (SAT1), up-regulated in i.m. ad pose 
tissue compared with s.c. in INT, WP and SF diets, is the regulatory enzyme that catalyzes 
the transfer of acetyl groups from acetyl-CoA to spermidine and spermine, which marks 
these polyamines for reutilization or export out of the cell (Casero et al., 1991; Wallace et 
al., 2003; Niranen, 2006; Pegg, 2008).  The polyamines spermadine and spermine can 
influence transcription and translation (Parker and Gerner, 2002) and also play an essential 
role in cell growth and proliferation as well as amino acid synthesis and the synthe is of 
nucleic acids with a suggested role in programmed cell death, as inadequate polyamine 
concentrations lead to cell-cycle arrest (Wallace et al., 2003; Niranen, 2006).  Strict 
regulatory control of polyamines is maintained between biosynthesis, degradation, and 
uptake of the amines (Wallace et al., 2003; Niranen, 2006).  In vitro studies have also 
shown polyamines to negatively regulate the post-transcriptional expression of COX-2, as 
depletion of polyamines caused a time-dependent increase in COX-2 mRNA expression 
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(Parker and Gerner, 2002).  RT-PCR showed no significant differences in prostaglandin-
endoperoxide synthase 2 (PTGS2) mRNA expression between s.c. and i.m. adipose tissue 
depots.  Mesenchymal stem cells (MCSs) are multi-potent stem cells which can serve as 
precursors for many cell types including bone, cartilage, adipocytes, and most connective 
tissues (Rosen and MacDougald, 2006; Chen et al., 2008).  MSCs have been isolated from 
bone marrow as well as many other tissues, including adipose tissue (Zuk et al., 2002; 
Izadpanah et al., 2006).  Tjabringa et al. (2008) reported treatment of adipose-tissue derived 
MSCs with the polyamine spermine, regulated the differentiation of these cell  towards the 
osteogenic linage including an observed up-regulation of osteopontin.  Interestingly, Jell et 
al. (2007) reported the over expression of SAT1 in mice decreased white adipose acetyl and 
malonyl CoA pools and increased glucose and palmitate oxidation whereas in SAT1–
knockout mice, an increase in acetyl and malonyl CoA pools, a decrease in glucose and 
palmitate oxidation and an accumulation of body fat was observed. 
In the present study, the principal IPA generated functions (Table 3.4) for networks 
1 and 2 of WP diet pertained to cell morphology, cell death, cell-to-cell signaling and 
connective tissue disorders.  The majority of differentially expressed genes involved in cell 
cytoskeletal/extracellular matrix related functions displayed a down-regulated pattern of 
expression in i.m. adipose tissue compared with s.c. including: collagen, type I, alpha 
1(COL1Al); collagen, type I, alpha 2 (COL1A2); collagen, type III, alpha 1 (COL3Al); 
collagen, type IV, alpha 1 (COL4A1); collagen type VI, alpha 2 (COL6A1); fibronectin 
1(FN1); and secreted protein, acidic, cysteine-rich (osteonectin) (SPARC).  Adipocyte 
differentiation, or adipogenesis, is a multistep process regulated by a milieu of hormones 
and transcription factors and is paralleled by morphological changes as a result of 
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reorganization in the cytoskeletal network and alterations in components of the 
extracellular matrix (Nakajima et al., 1998; Rosen and Spiegelman, 2000; Kawaguchi et al., 
2003).  A basement membrane composed of collagens and other extracellular matrix 
components support each adipocyte (Pierleoni et al., 1998), the size of which varies 
dramatically under physiological conditions (Farnier et al., 2003).  Simplistically, the 
adipocyte is a lipid storage container whose morphology is supported by components of the 
extracellular matrix (Pierleoni et al., 1998; Wang  et al., 2008).  Most adipose tissu s form 
at sites of loose connective tissues (Rosen and Spiegelman, 2000).. More so, i.m. adipose 
tissue has been shown to develop within perimysium connective tissue alongside myofibers 
(Moody and Cassens, 1968).  This study showed down-regulation in both adipogenic and 
extracellular matrix genes in i.m. adipose tissue and may be interpreted as support of 
previous work by Wang et al. (2008) who looked at genes to be used as potential 
biomarkers for i.m. adipose tissue development.  The fore mentioned author suggested that 
expansion of the extracellular matrix might be a prerequisite for i.m. fat developm nt since 
current work (Wang et al., 2008) showed the expression pattern of genes involved with 
connective tissue (COL1Al, COL1A2, COL3Al and FN1) and genes that influence the 
synthesis and interaction with the extracellular matrix (SPARC and FMOD) mirrored that 
of adipogenic related genes.  
Insulin-like growth factor binding protein 6 (IGFBP6) and 5 (IGFBP5) were shown 
by IPA to be up-regulated in i.m. adipose tissue compared with s.c. in network 4 of WP 
(Table 3.6) and network 2 of PF (Table 3.8), respectively.  IGFBP6 has been shown to have 
a ~50 fold higher affinity for IGF-II than for IGF-I (Rechler and Clemmons, 1998).  IGF-I 
has been shown to not only be involved in the stimulation of cell proliferation and cell 
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differentiation in bone, muscle and cartilage but also in the differentiation of adipocytes 
(Boney et al., 1994).  More recently, it has been suggested that IGF-I and IGF-II both play 
distinctive roles on the development of adipocytes (Gardan et al., 2008)  The action of IGF-
I and IGF-II can either be inhibited or enhanced by IGF-binding proteins depending on the 
cell type and binding protein involved (Clemmons, 1992).  Furthermore, there have been 
considerable differences shown in the pattern of IGF-binding proteins produced by 
preadipocytes from different species (Butterwith, 1997).   
The majority of genes categorized under signal transduction were down-regulated 
in i.m. adipose tissue compared with s.c.  IPA signaling pathway analysis ascertained 
possible differences between diets in the notch signaling pathway.  Further evaluation using 
IPA showed genes involved in this signaling pathway, MFNG-, RFNG-, and LFNG O-
fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (Moloney et al., 2000; Yang et al., 
2005), and nicastrin (NCSTN) (Li et al., 2003), to be up-regulated in i.m. adipose tissue 
compared with s.c. adipose tissue in WP steers.  Notch is a transmembrane protei  inv lved 
in regulating cell signaling during development which functions to receive extrac llular 
signals at the cell surface, and regulate gene expression in the nucleus (Lai, 2004; Nichols 
et al., 2007).  Garces et al., (1997) reported the requirement of Notch-1 function for the 
commitment of in vitro 3T3-L1 preadipocyte cells to undergo adipogenesis.  However, 
studies have concluded that Notch most likely blocks adipogenesis through the induction of 
Hes-1, which primarily functions as a transcription repressor in in vitro 3T3-L1 
preadipocytes (Ross et al., 2004; Ross et al., 2006).  In contrast to both the studies of 
Garces and Ross, Nichols et al. (2004) ruled out the possibility of Notch signaling plying 
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an essential role in adipogenesis in ES cells, as a deficiency for Notch-1 s ill allowed the 
ability to differentiate into adipocytes.   
The number of differentially expressed genes relating to transcription/translation 
was attenuated in INT, WP and SF diets compared to PF.  More so, IPA generated 
functions for network 1 of PF diet included DNA replication, recombination and repair and 
cell death (Figure 9).  In the present study, RT-PCR revealed YBX1 expression to be up-
regulated approximately five fold in i.m. adipose tissue compared with s.c.  YBX1 has been 
shown to be a regulator of gene expression affecting transcription and translation in a 
positive and negative manner, as in vitro studies have shown translation stimulated by low 
concentrations of YBX1with high concentrations of YBX1 restricting translation 
(Davydova et al., 1997; Matsumoto and Wolffe, 1998; Nekrasov et al., 2003).  YBX1 has 
been shown to directly bind the protein tyrosine phosphatase-1B (PTP1B) enhancer and 
induce PTP1B expression (Fukada and Tonks, 2003).  PTP1B has been shown to act as a 
negative regulator of insulin signaling by dephosphorylating the phosphotryosine residues 
of insulin receptor kinase (Fukada and Tonks, 2003).  YBX1 has also been reported to 
inhibit cell death through aberrant expression of protein 53 (p53) (Homer et al., 2005) and 
shown to have the strongest induction (130 fold) of the differently expressed genes in 
visceral adipose tissue of rats fed a high-fat diet (López et al., 2004).  More recently, in 
vitro studies have shown YBX1 to stimulate microtubule assembly in the cell and through 
its interaction with tubulin, contribute to the regulation of mRNA’s (Chernov et al., 2008).  
Proliferating cell nuclear antigen (PCNA) expression was up-regulated in i.m. adipose 
tissue compared with s.c in all diets in the present study.  PCNA interacts with many p53 
proteins and is involved in both DNA replication and DNA repair (Warbrick, 2000; 
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Paunesku et al., 2001).  In the absence or aberration in levels of PCNA, cell apoptosis can 
occur.  Furthermore, PCNA action in the cell is induced by p53 such that DNA replication 
occurs if PCNA is abundant in the cell and p53 is absent.  Conversely, DNA repair takes 
place if PCNA is abundant and p53 presence is high in the cell (Paunesku et al., 2001).  
Another gene that plays a pivotal role in the regulation of transcription and suggested roles 
in cell cycle progression and cell proliferation is Histone deacetylase 3 (HDAC3) (Zhang et 
al., 2005; Villagra et al., 2007), which was found to be up-regulated in INT, WP and PF 
steers.  HDAC3 has also been shown to deaceylate non-histone substances such as ReLA, 
which in turn regulates the duration of NKκB signaling action by allowing IκB to interact 
with RelA, allowing its export out of the nucleus (Karagianni and Wong, 2007). 
RT-PCR revealed four-and-a-half-LIM Domains 1 (FHL1) expression to be up-
regulated over 15 fold in i.m. adipose tissue compared with s.c. adipose tissue.  Although 
FHL1 is highly expressed in skeletal and cardiac muscle (McGrath et al., 2006); FHL1 has 
been shown to be expressed in bovine, porcine, and human adipose tissue (Wang et al., 
2005a; vanBeek et al., 2007; Labrecque et al., 2009).  Although the exact function of FHL1 
remains ambiguous, it does belong to a large family of LIM-proteins that function in 
cytoskeletal organization, cell lineage specification, the regulation of gene transcription, 
cell proliferation, cell differentiation and apoptosis (Bach, 2000; Kadrmas and Beckerle, 
2004).  As FHL1 has been shown to be highly expressed in adipocytes and not 
preadipocytes, it could serve as a marker for adipocyte differentiation (vanBeek et al., 
2007).  FHL1 has also been reported to interact with receptor interacting protein of 140 
kDa (RIP140) which itself is known to interact with estrogen receptor-α (Lin et al., 2009).  
Recently, FHL1 and RIP140 were shown to synergistically inhibit the transcription of the 
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estrogen response element of the pS2 gene, whose expression is restricted to breast canc r 
cells (Lin et al., 2009).  However, RIP140-null mice have shown to accumulate less fat in 
their adipose tissue and are resistant to high-fat diet-induced obesity and show imprved 
glucose tolerance and insulin sensitivity (Leonardsson et al., 2004). 
SF diet had the fewest number of differentially expressed genes relating to 
transporter functions with INT, WP and PF diet exhibiting about equal numbers of up- and 
down-regulated genes.  Besides the transcripts mentioned in the above discussion, several 
others are worth mentioning which were differentially expressed between i.m. and s.c. 
adipose tissues in the different ontology categories including; casein kinase 1, lpha 
1(CSNK1A1), growth hormone releasing hormone (GHRH), adrenergic, beta, receptor 
kinase 2 (ADRBK2), angiotensin II receptor, type 1(AGTR1), glutamate-cysteine ligase, 
catalytic subunit (GCLC), and asparagine-linked glycosylation 11 homolog (ALG11).  
These genes are only six of approximately 60 array elements shown to be down-regulated 
in all diets of the GP and up-regulated in only the WP diet of the finishing phase (Stein et 
al. unpublished data). 
To our knowledge, the data presented is the first to use microarray analyses to 
evaluate the effect of different growing diets on adipose tissue depots at the end of the 
growing period in beef steers.  The interactions between genes involved in adipocyte 
differentiation and diet differences still remain ambiguous.  However, IPA metabolic and 
signaling pathway analysis generated in this study, has provided insight into possible 
differences in the molecular mechanisms affecting development of i.m. and s.c. adipose 
tissue in beef steers managed under different growing diets.  As genes outside the dataset 
known to interact with the differentially expressed genes observed in this study were 
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included in the Ingenuity Pathway Analysis, elucidation of possible differences between 
diets and depots for future analysis is warranted as these genes may not have been included 
in the adipose specific microarray used in this study.  Further investigation and validation is 
needed to evaluate network genes not included in the microarray and discern the 
differences observed between diets in the fore-mentioned functional analyses (Figure 3.3) 
and a number of the metabolic (Figure 3.4) and signaling (Figure 3.5) pathways such a; 
arachidonic acid metabolism, pyruvate metabolism, eicosinoid signaling and notch 
signaling.  
In conclusion, almost 35% of the 323 array elements that had significant matches in 
the NCBI databases could not be associated with any functional or biological annotation.  
However, despite these insufficiencies, gene expression profiling suggests differences in 
the metabolic activity between s.c. and i.m. adipose tissue in the GP, even though there 
were no differences observed in carcass characteristics at the end of the GP.  Most of the 
genes evaluated using RT-PCR seemed to be influenced by the main affect of depot and 
there seemed to be a similar pattern of expression observed within functional ategories 
and depots.  The data presented indicates the metabolic machinery for adipose tissue 
accretion was down-regulated in i.m. adipose tissue compared to s.c. adipose tissue and the 
main affect of diet can influence adipose tissue deposition at the end of the GP as FABP4 
exhibited a tendency to be influenced by the main affect of diet.  When using gene 
expression profiling as a measurement of cellular function, one must keep in mind that 
mRNA expression levels do not always correspond to the translated protein levels or active 
protein in the cell and further investigation and validation is needed to evaluate the 





Table 3.1. Sequences, accession number, and melting temperatures of the bovine specific   
primers for the selected target genes of interest.  Accession number is from the 







Primer Sequence  Size (bp) Tm used Product Size (bp) GenBank Accession
ACSM1 Forward AAGGAAACATTGGCATCAGG 20
Reverse AGTCCCCACATTCCACTTCA 20
BCA2 Forward TCCCTGTTCCTTGGTTTCTG 20
Reverse GTGGTCGGTGAATGTCTTCC 20
CD36 Forward CAATGGAAAGGACGACATAAG 21
Reverse TGGAAATGAGGCTGCATCTGT 21
FABP4 Forward AAGCTGCACTTCTTTCTCACC 21
Reverse GACCACACCCCCATTCAAAC 20
FHL1 Forward GCAACAAGGGTTTGGTAAAGG  21
Reverse AGAGGGCAAGGACACAAGG 19
GPI Forward TGGGCATATTCTGGTGGACT 20
Reverse GACCTCTGGCATCACATCCT 20
HADH Forward TCCGTTTGAGCTTCTCGATT 20
Reverse CTTACAGGGCTTCGTCCTTG 20
LDHB Forward GCTGTGTGGAGTGGAGTGAA 20
Reverse ATACACGGAAGGCTCAGGAA 20
NM1 Forward AGAGAAGGTTGGGCTGGTGT 20
Reverse GTTCAGTTCTGCTCCCCTTG 20
PKM2 Forward TTGGGTCGGGTAGTTCAGAG 20
Reverse ACAAAGGAAGGGAAGCAGGA  20
PTGS2 Forward ATGTATGAGTGTAGGATTTGACCAG 25
Reverse GGGAGTGGGTTTCAGGAGTAA 21
SCD Forward CCTGTGGAGTCACCGAACCT 20
Reverse TGTTGCCAATGATCAGGAAGAC 22
YBX1 Forward CGCAGTGTAGGAGATGGAGA  20
Reverse CGTGGATAGCGTCTGTAATGG  21
210 bp XM_00178762555 C





102 bp62 C BC109602.1
BC114055.1149 bp62 C
60 C 121 bp NM_174010
62 C 197 bp NM_174314
56 C
55 C 234 bp NM_174445.2
149 bp NM_174815.2
66 BP  AB075020.1 60 C
56 C
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Table 3.2. The number of differentially expressed up- and down-regulated genes in each  
      of the functional categories in Initial and Wheat Pasture, Silage Fed, and 






Up Down Up Down Up Down Up Down
Adipose Related 3 13 4 14 1 13 1 12
Apoptosis/Cell Death 2 1 1 1 1 1 2 1
Binding 12 7 15 12 9 7 15 10
Carbohydrate Metabolism 3 0 4 2 2 1 3 1
Cell Growth/Differentiation 0 1 1 5 0 1 1 4
Cell Cytoskeletal/ Adhesion/ ECM Related 2 3 2 7 1 1 2 2
Hydrolase/Transferase/Catalytic/Activity 0 6 5 4 1 5 3 6
Nucleic Acid Metabolism 0 1 0 2 0 1 0 2
Oxidative Phosphorylation 1 0 3 0 2 0 5 0
Oxidoreductase Activity 2 2 5 3 1 3 4 3
Protein Synthesis:Turn Over/AA Metabolism 3 3 4 5 3 4 5 2
Response to Stress/Stimuli 1 1 1 1 2 0 1 1
Signal Transduction 2 8 3 8 0 4 4 5
Transcription/Translation 9 5 9 7 5 8 12 6
Transporters 4 4 4 3 1 0 5 5
Other 17 30 32 33 8 18 33 40
61 85 93 107 37 67 96 100








Table 3.3. Comparison of mRNA expression (i.m. relative to s.c.) detected in the cDNA  
microarray analysis to mRNA expression detected in RT-PCR.  Fold change 





Microarray    RT-PCR 
ACSM1 Wheat Pasture -2.39 (±.07)   -8.81 (±.94) 
BCA2 Wheat Pasture -2.44 (±.09)   -4.31 (±1.5) 
CD36 Program Fed -4.78 (±.33)   -4.28 (±.32) 
FABP4 Program Fed -8.11 (±.16) -16.79 (±.80) 
FHL1 Silage Fed   5.13 (±.14)  68.59 (±1.36) 
GPI Wheat Pasture   2.34 (±.46)    9.06 (±.73) 
LDHB Wheat Pasture -3.07 (±.44)   -5.93 (±.71) 
NM1 Wheat Pasture   2.01 (±.20)    1.50 (±80) 
PKM2 Silage Fed   4.40 (±.21)    2.53 (±.80) 
SCD Silage Fed -5.69 (±.26) -12.55 (±.97) 







(a) Relative fold difference in acyl-CoA synthetase medium-chain family member 1 
(ACSM1) gene expression in s.c. (green) and i.m. (red) adipose tissue depots in steers at 
the end of the Growing Phase.  The gene expression level for the i.m. adipose tissue was et 
as baseline and fold difference was calculated as described in Material nd Methods.  
Columns with different superscripts differ significantly (P < 0.001).   
(b) Relative fold difference in CD36 molecule (thrombospondin receptor) (CD36) gene 
expression in s.c. (green) and i.m. (red) adipose tissue depots in steers at the end of th  
Growing Phase.  The gene expression level for the i.m. adipose tissue was set as baseline 
and fold difference was calculated as described in Material and Methods.  Columns with 
different superscripts differ significantly (P < 0.065).   
(c) Relative fold difference in stearoyl-CoA desaturase (SCD) geneexpression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.0002) 
 
(d) Relative fold difference in hydroxyacyl-Coenzyme A dehydrogenase (HADH) gene 
expression in s.c. (green) and i.m. (red) adipose tissue depots in steers at the end of the 
Growing Phase.  The gene expression level for the s.c. adipose tissue was set as ba line 
and fold difference was calculated as described in Material and Methods.  Columns with 
different superscripts differ significantly (P < 0.05). 
 
(e) Relative fold difference in fatty acid binding protein 4, (FABP4) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.001).   
(f) Relative fold difference in fatty acid binding protein 4, (FABP4) gene expression in 
Initial and Wheat Pasture, Silage-fed and Program-fed diets in steers at the end of the 
Growing Phase.  The gene expression level for the Wheat Pasture diet was s t as baseline 
and fold difference was calculated as described in Material and Methods.  Columns with 
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Figure 3.1.  
(g) Relative fold difference in glucose phosphate isomerase (GPI) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the s.c. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.004).   
(h) Relative fold difference in pyruvate kinase, muscle (PKM2) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the s.c. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P< 0.001).   
(i) Relative fold difference in lactate dehydrogenase B (LDHB) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.09) 
 
(j) Relative fold difference in Y box binding protein 1 (YBX1) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  The 
gene expression level for the s.c. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.034).   
 
(k) Relative fold difference in four and a half LIM domains 1(FHL1) gene expression in 
s.c. (green) and i.m. (red) adipose tissue depots in steers at the end of the Growing Phase.  
The gene expression level for the s.c. adipose tissue was set as baseline and fold difference 
was calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.005). 
  
 
(g)                                                               





     
(j) 






Table 3.4. Principal Networks generated for Initial, Wheat Pasture, Silage-fed, and  
                  Program-fed diets of the Growing Phase using Inginuity Pathway Analysis.   
                  Focus genes were overlaid into a globular molecular network deveolped from  
                  information contained in the IPA Knowledge Base.  Networks of these focus  









Top Network Molecular or Cellular Function, Disease or Disorder, or Physiological                                                     
System Development and Function
INT 1 51 26 Cell-To-Cell Signaling and Interaction, Immune and Lymphatic System Development and Function, Lipid Metabolism
2 38 21 Cancer, Gastrointestinal Disease, Reproductive System Disease
3 33 19 Immune Response, Hematological Disease, Infectious Disease
4 28 17 Gene Expression, Free Radical Scavenging, Lipid Metabolism
5 24 15 Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry
6 20 13 Cellular Assembly and Organization, Cell Cycle, DNA Replication, Recombination, and Repair
7 18 12 Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry
8 15 11 Post-Translational Modification, Cell Death, Neurological Disease
9 12 9 Cell Morphology, Dermatological Diseases and Conditions, Hair and Skin Development and Function
WP 1 44 24 Cell Morphology, Nervous System Development and Functio , Cell Death
2 41 23 Cell-To-Cell Signaling and Interaction, Connective Tissue Disorders, Dermatological Diseases and Conditi s
3 29 18 Cancer, Respiratory Disease, Reproductive System Disease
4 27 17 Cellular Movement, Hematological System Development and Function, Lipid Metabolism
5 23 15 RNA Post-Transcriptional Modification, Energy Production, Nucleic Acid Metabolism
6 23 15 Free Radical Scavenging, Genetic Disorder, Neurological Disease
7 21 14 Post-Translational Modification, Genetic Disorder, Skeletal and Muscular Disorders
8 19 13 Cancer, Cell Death, Gene Expression
9 19 13 Carbohydrate Metabolism, Small Molecule Biochemistry, Lipid Metabolism
10 15 11 Cellular Assembly and Organization, Cellular Compromise, Hematological Disease
11 8 7 Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry
SF 1 52 26 Lipid Metabolism, Small Molecule Biochemistry, Ophthalmic Disease
2 39 21 Lipid Metabolism, Small Molecule Biochemistry, Cell-To-Cell Signaling and Interaction
3 27 16 Lipid Metabolism, Small Molecule Biochemistry, Carbohydrate Metabolism
4 23 14 Drug Metabolism, Molecular Transport, Small Molecule Biochemistry
5 21 13 Post-Translational Modification, Protein Folding, Cellular Assembly and Organization
6 21 13 Cellular Assembly and Organization, Cell Cycle, DNA Replication, Recombination, and Repair
7 21 13 Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry
8 11 8 Free Radical Scavenging, Genetic Disorder, Neurological Disease
PF 1 51 26 DNA Replication, Recombination, and Repair, Cell Death, Embryonic Development
2 36 20 Lipid Metabolism, Small Molecule Biochemistry, Cardiovascular System Development and Function
3 29 17 Hematological Disease, Immunological Disease, Respiratory Disease
4 24 15 Gene Expression, Lipid Metabolism, Molecular Transport
5 22 14 Genetic Disorder, Neurological Disease, Free Radical S venging
6 20 13 Lipid Metabolism, Small Molecule Biochemistry, Organ Development
7 18 12 Cellular Assembly and Organization, Cancer, Cellular Growth and Proliferation
8 14 10 Genetic Disorder, Skeletal and Muscular Disorders, Cellular Assembly and Organization









Table 3.5. Networks were generated for Initial using
                 are highlighted in yellow.  Genes highlighted in bold are focus genes.
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 Inginuity Pathway Analysis.  Genes differentially expressed
  Genes in regular print were
 only in Initial 







Table 3.6. Networks were generated for the Wheat Pasture 
                 differentially expressed only in the Wheat Pasture
                 in bold are focus genes. Genes in regular print were used to connect to other genes in the
 
 
           
        
104 
105
diet of the Growing Phase using Inginuity Pathway Analysis.
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Table 3.7. Networks were generated for the Silage
                  differentially expressed only in the 





                




-fed diet of the Growing Phase using Inginuity Pathway Analysis.
Silage-fed diet of the Growing Phase are highlighted in yellow.
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Table 3.8. Networks were generated for the Program
                 differentially expressed only in the Program
                  in bold are focus genes.  Genes in regular print were used to connect to other genes in the 
 
       






-fed diet of the Growing Phase using Inginuity Pathway Analysis. 
-fed diet of the Growing Phase are highlighted in yellow. 
network.
 Genes 




      
Figure 3.2. The top ten molecular and cellular functions associated with all generat d networks for Intital and Wheat  
                    Pasture,Silage-fed, and Program-fed diets of the Growing Phase.  Threshold signifiacnce(P <0.05) expressed  
                    as the negative log10 of the P-value calculated using the right-tailed Fischer’s exact test is represented by 
                    the orange bar.  Numbers at top of each graph are the number of genes associated with that function. 





Figure 3.3. Comparative Functional Analysis of differentialy expressed genes comparing 
                               Initial,Wheat Pasture, Silage
                               Significance (P < 0.05), expressed as the negative log
                               each function
                   bar. 
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 using the right- tailed Fischer’s exact test, is represented by the orange 
 
 
Growing Phase.            






Figure 3.4. Metabolic pathway comparison between Initial, 
                               Silage-f d, and Program
                               (P < 0.10), expressed as the negative log
                   function using the right
                   bar. 
 





-fed diets of the Growing Phase.  Significance 
10 of the P-value calculated for each 











             Figure 3.5. Signaling pathway comparison between Initial, 
                                fed, and Program
                                the negative log
                    right-ailed Fischer’s exact test
 
 











-fed diets of Growing Phase.  Significance (P < 0.10), 
10 of the P-value calculated for each function












Figure 3.6. Heat map of genes in the Adipose Related ontology category.  Boxes colored  
   with shades of red represent genes up-regulated in i.m. adipose tissue compared 
to s.c. adipose tissue and boxes with shades of green represent down-regulted 
genes in i.m. adipose tissue compared to s.c. adipose tissue.  Black boxes 
















Acyl-CoA synthetase medium-chain family member 1 [Bos taurus]
ELOVL family member 5, elongation of long chain fatty acids  [Bos taurus]
Clusterin [Bos taurus]
Diacylglycerol O-acyltransferase homolog 2 (mouse) [Bos taurus]
Mitochondrial glycerol phosphate acyltransferase [Bos taurus]
CD36 molecule (thrombospondin receptor) [Bos taurus]
Fatty acid binding protein 4, adipocyte [Bos taurus]
Spermidine/spermine N1-acetyltransferase 1 [Bos taurus]
Stearoyl-CoA desaturase (delta-9-desaturase) [Bos taurus]
Adiponectin, C1Q and collagen domain containing [Bos taurus]
Niemann-Pick disease, type C2 [Bos taurus]
Predicted: Phospholipase D1, phosphatidylcholine-specific [Homo sapiens]
Caveolin 1, caveolae protein, 22kDa [Bos taurus]
Predicted: Prostaglandin-endoperoxide synthase 2  [Bos taurus]
Transmembrane 7 superfamily member 2 [Bos taurus]
Macrophage scavenger receptor 1 [Bos taurus]
Lipoprotein lipase [Bos taurus]
Chemokine (C-X-C motif) ligand 16 [Bos taurus]
Hydroxyacyl-Coenzyme A dehydrogenase [Bos taurus]
Acyl-CoA synthetase long-chain family member 1 [Bos taurus]
Lysophospholipase I [Bos taurus]
Apolipoprotein E [Bos taurus]




Figure 3.7. Heat map of genes in the Carbohydrate Metabolism ontology category.  Boxes  
   colored with shades of red represent genes up-regulated in i.m. adipose tissue 
compared to s.c. adipose tissue and boxes with shades of green represent down-
regulted genes in i.m. adipose tissue compared to s.c. adipose tissue.  Black 
































Glyceraldehyde-3-phosphate dehydrogenase [Bos taurus]
Predicted: similar to Pyruvate kinase,muscle  [Bos taurus]
Asparagine-linked glycosylation 11 homolog (S. cerevisiae, alpha-1,2-mannosyltransferase) [Bos taurus]
Lactate dehydrogenase B [Bos taurus]
UDP-glucose pyrophosphorylase 2 [Bos taurus]
Malate dehydrogenase 2, NAD (mitochondrial) [Bos taurus]






Figure 3.8. Heat map of genes in the Oxidative Phosphorylation ontology category.  Boxes  
   colored with shades of red represent genes up-regulated in i.m. adipose tissue 
compared to s.c. adipose tissue and boxes with shades of green represent down-
regulted genes in i.m. adipose tissue compared to s.c. adipose tissue .  Black 






























UQCRC1 protein [Bos taurus]
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa [Bos taurus]
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) [Bos taurus]
NADHdehydrogenasesubunit 4L [Bos taurus]
Cytochrome c oxidase subunit III [Bos taurus]
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H [Bos taurus]
NADHdehydrogenase(ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) [Bos taurus]
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Figure 3.9. Network 1 of theWheat Pasture diet of the Growing Phase depiciting genes  
involved in apoptosis of eukaryotic cells and cell morphology.  Dataset was   
analyzed by the Ingenuity Pathways Analysis software.  Node color indicates 
the expression level of the genes; green = down-regulation in i.m. adipose tissue 
when compared to s.c. adipose tissue and red = up-regulated in i.m. when 











Figure 3.10. Network 1 of the Program Fed diet of the Growing Phase depiciting genes  
                    involved in DNA Replication, Recombination, and Repair.  Dataset was 
analyzed by the Ingenuity Pathways Analysis software.  Node color indicates 
the expression level of the genes; green = down-regulation in i.m. adipose 
tissue when compared to s.c. adipose tissue and red = up-regulated in i.m. 

















Effects of winter growing programs on gene expression in different adipose tissue 
depots in beef steers at the end of the finishing phase 
 
D.R. Stein1, A. Pillai1, C.R. Krehbiel1, G.W. Horn1, M. McCurdy 2, J. J. 
Wagner3, J.B. Morgan1, R.D. Geisert5 P.J. Ayoubi4 and U.E. DeSilva1 
 
1 OSU Dept. of Animal Science, 2Nutrition Service Associates, Kenmore, QLD, 
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Previous research in our laboratory demonstrated that nutrition during the growing 
phase affects the performance of beef cattle during the finishing phase.  Mor  so, the 
nutritional background in beef steers (i.e., steers on supplemented native range or steers on 
high-gain wheat pasture) altered gene expression in s.c. and i.m. adipose tissue depots 
during the finishing phase in the feedlot.  Microarray analyses, validated by RT-PC , was 
utilized to investigate the ffects of different winter growing programs on gene expression 
in s.c. and i.m. adipose tissue depots in beef steers at the end of the subsequent finishing 
phase (FP).  Steers of similar breed, type, and age were assigned to initial harvest or one of 
four treatment diets; steers placed in the feedlot after weaning and fed a high-concentrate 
diet (CF); steers grazed on wheat pasture (WP); steers fed a sorghum silage-based growing 
diet (SF); or steers program fed a high-concentrate diet (PF).  SF and PF were fed to gain 
BW similar to WP.  At the end of a 112-d growing phase (GP), 6 steers from WP, SF, and 
PF were harvested, with the remaining steers of each diet placed in the feedlot.  At the end 
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of FP, steers from all treatment groups were harvested at a common 12th rib fat (1.27 cm) 
as determined by ultrasound.  Days on feed were 123, 104, and 104, for WP, SF, and PF 
steers, respectively.  CF steers were on feed for a total of 196 d, 112 of which coincides 
with the time the WP, SF, and PF steers were on respective diets of the GP.  A 7.6 cm3 
section was dissected from the Longissimus muscle at the 12th rib from which s.c. and i.m. 
adipose tissue were collected.  Total RNA was extracted and cDNA microarray 
hybridizations performed.  Preprocessing and normalization of data was accomplished 
utilizing GenePix AutoProcessor (GPAP 3.2).  Ontology analysis was carried out using 
GFINDer.  Ingenuity Pathways Analysis (IPA) was also used to identify the most relevant 
biological mechanisms, pathways and functions of the annotated genes.  A total of 248 
genes were differentially expressed (DE) between s.c. and i.m. adipose tissue depots in at 
least one of the four treatment diets of FP.  The number of differentially expressed genes 
observed in WP steers was almost four times greater than SF steers (145 vs. 41), almost 
three times greater than PF steers (145 vs. 55) and almost twice the number in CF steers 
(145 vs. 82).  WP steers had a greater number of differentially expressed genes involved in 
binding, cell growth and differentiation, signal transduction and transcription/translation 
functions than steers on the SF, PF and CF diets.  However, the number of differentially 
expressed adipose related genes was only slightly attenuated in SF and PF steers as 
compared to WP and CF steers.  The data presented indicates the metabolic machinery for 
adipose tissue accretion was down-regulated in the i.m. adipose tissue depot compared to 
the s.c. adipose tissue depot and the main affect of previous diet could possibly influence 
gene expression at the end of the FP as HADH, GPI, PKM2, and FHL1 were influenced or 
had a tendency to be influenced by diet, with PTGS2 having a tendency to be influenced by 
a diet x depot interaction.  IPA metabolic and signaling pathway analysis also provided 
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insight into possible differences in the molecular mechanisms affecting gene expression in 
s.c. and i.m. adipose tissue depots in beef steers managed under different growing diets at 
the end of the subsequent finishing phase. 
Key words: beef cattle, microarray, adipose tissue, gene expression  
 
Introduction 
The terms backgrounding and stockers are synonymous (Peel, 2000) and describe 
the production phase between the time a calf is weaned until placement into a feedlot for 
finishing (Bock et al., 1991; Thomson and White, 2006).  Stockers are raised primarily on 
forage or pasture diets in the south central and southern U.S., while silage is the primary
diet fed in backgrounding lots in the north central and northern U.S. (McCurdy, 2006).  
Lack of available forage or pasture due to inclement weather or market conditions may 
warrant the confinement of animals to a drylot and fed a grain-based ration (Thomson and 
White, 2006).  Two alternatives to roughage or pasture based programs are; 1) program 
feeding, defined by Galyean (1999) as the use of net energy equations to calculate the 
quantities of feed required to meet the needs of maintenance plus a specific ADG, and 2) 
calf-fed programs, a system where cattle are placed on an ad libitum finishing diet 
immediately following weaning (Lardy, 1998).  Due to geographical regions in theU. S., 
backgrounding/stocker programs involve a wide range of production environments and 
management skills, such that not all programs and systems are feasible for producers in the 
various locations in the U.S. (Peel, 2006).  Nutrition during the growing phase has been 
shown to affect the performance of cattle during their finishing phase as hot carcass weight, 
Longissimus muscle area, and marbling score were greater for steers grazing winter wheat 
compared to steers grazing native range prior to feedlot placement (Choaet al., 2003).  
Cattle fed grain-based diets have been shown to have increased i.m. fat compared with 
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those fed forage-based diets as marbling scores were significantly lower for steers grazed 
on summer pasture and then fed for either 45 or 75 d in the feedlot compared to steers 
taken to the feedlot immediately after weaning (Schaake et al., 1993).  Furthermore, steers 
fed a diet consisting of 68% high-moisture corn and 25% alfalfa silage had increased i.m. 
fat compared to cattle fed a 95% alfalfa silage diet for the same number of days on feed 
(Mandell et al., 1998).  Additionally, grazing-based growing programs prior to feedlot 
entry resulted in cattle with lower marbling scores compared to calves placed directly in a 
drylot and fed a silage-based diet followed by a corn diet (Hedrick et al., 1983).  Using
suppressive subtractive hybridization, we have reported different nutritional background in 
beef steers (i.e., steers on supplemented native range or steers on high-gain w eat pasture) 
altered gene expression in s.c. and i.m. adipose tissue depots during the feedlot phase (Ross 
et al., 2005).  Thus, it is important to determine the effects of background, previous 
nutrition and management systems throughout the production phases on marbling and 
subsequent quality of the carcass.  Therefore, the objective in the present study was to 
determine the ffects of different winter growing programs on gene expression in s.c. and 
i.m. adipose tissue depots in beef steers at the end of the finishing phase. 
 
Materials and Methods 
Animals and Treatment Groups (Diet) 
Adipose tissue samples used in the present study were collected from previous work 
by McCurdy (2006).  A total of 260 British crossbred steers were used for this study which 
included 50 steers from the Oklahoma State University cow herd and 210 steers purchased 
by Colorado Beef (Lamar, CO) of similar breed, type, and age (average initial BW=236 ± 
22.0 kg).  Four steers were randomly selected for initial serial slaughter (INT) and were 
transported to the Robert M. Kerr Food & Agricultural Products Center abattoir (FAPC), 
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located on the campus of Oklahoma State University, Stillwater, OK.  The remaining steers 
were blocked by initial weight and randomly allotted to one of four treatment groups for 
winter feeding or growing phase (GP).  One group of steers was placed in th  feedlot (CF; 
n = 8 pens; 8 steers/pen) immediately on arrival and adapted to an ad libitum high-
concentrate finishing diet.  Steers in this treatment group underwent a three tier adaptation 
period consisting of a 49% and 74% concentrate diet, each fed for 5 d, followed by an 88% 
concentrate (finisher) diet.  The three remaining treatment groups were managed under 
three different growing systems.  One treatment group (WP; n = 64) was grazed as a single 
group on wheat pasture with unrestricted forage availability; the second treatment group 
(SF; n = 8 pens; 8 steers/pen) was fed a sorghum silage-based growing diet; and the third 
treatment group (PF; n = 8 pens; 8 steers/pen) was program fed a high-concentrate diet.  
Steers in the SF and PF groups were fed to gain BW at a similar rate as WP steers. All 
steers were implanted with progesterone (USP 200 mg) and estradiol benzoate (20 mg)
(Component E-S, VetLife, West Des Moines, IA) at the start of the GP.  Steers from all 
treatment groups were weighed at 28 d intervals.  Wheat pasture grazing took place at the 
Oklahoma State University Wheat Pasture Research Unit in Logan County, OK, while all 
pen feeding was conducted at the Southeastern Colorado Research Center, Lamar, CO. 
Steers at OSU allocated to the SF, PF, and CF groups were transported from Stillwater, OK 
to Lamar, CO (688 km), while purchased steers allocated to the WP group were transported 
from Lamar to Stillwater prior to the beginning of the trial.  At the end of the growing 
phase (112 d), six randomly selected steers from each of the WP, SF, and PF treatmen  
groups were transported to the Robert M. Kerr Food & Agricultural Products Center 
(FAPC) abattoir in Stillwater, OK for slaughter.  The remaining steer  in the WP group 
were shipped from Stillwater, OK to Lamar, CO.   
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Finishing Phase  
Steers from the WP, SF, and PF treatment groups shipped to Lamar CO were adapted to the 
same high-concentrate finishing diet as the CF steers and placed in the feedlot (n = 8 pens; 
8 steers/pen).  Steers in the WP and SF groups were adapted to the finishing diet as 
previously described for the CF treatment group; PF steers immediately rec ived the 74% 
concentrate diet for 5 d followed by the 88% concentrate finisher.  Steers on the growing 
diets (WP, SF, and PF) were re-implanted with Revalor-S at the start of the finishing 
program.  Calf-fed steers were re-implanted with Revalor-S at d 84 of the finishing period.  
Days on feed were 123, 104, and 104, for WP, SF, and PF steers, respectively.  CF steers 
were on feed for a total of 196 d, 112 of which coincided with the time the WP, SF, and PF 
steers were on respective diets of the GP.  At the end of the finishing phase, steers from all 
treatment groups were harvested at a common 12th rib fat (1.27 cm) as determined by 
ultrasound.  Six randomly selected steers from each of the WP, SF, PF and CF treatment 
groups were transported to the FAPC abattoir for the final serial slaughter group.  The 
remaining steers in all treatments were slaughtered commercially at the Swift plant in 
Cactus, TX and complete carcass data was collected by the National Cattleman’s Beef 
Association’s carcass data collection service.  
 
Sample Collection and RNA Extraction  
At slaughter, steers harvwested at FAPC were stunned with captive bolt and 
exsanguinated.  Following exsanguination, a 7.6 cm3 section was dissected from the 
Longissimus muscle between the 12th and 13th rib, from which s.c. and i.m. adipose tissue 
was collected and frozen at -80º C.  Total RNA was extracted using TRIzol reagent 
(Invitrogen, Carlsbad, CA) (4 ml TRIzol per 1 g of adipose tissue).  The adipose tissue, in 
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TRIzol, was homogenized and centrifuged at 3,500 x g at 4º C for 15 min to separate 
insoluble material and excess fat.  The lower aqueous (TRIzol) phase was transferred to a 
fresh tube and 0.2 ml chloroform/ml of TRIzol was added.  Samples were centrifuged at 
3,500 x g at 4º C for 30 min and the upper aqueous phase was transferred to a fresh tube.  
Isopropyl alcohol (0.5 ml/ml of TRIzol) was added and samples were maintained at -20º C 
overnight followed by centrifugation at 3,500 x g at 4º C for 10 min.  The supernatant was 
removed and the RNA pellet washed with 75% chilled ethanol and suspended in 
DNase/RNase free water.  A subsequent phenol:chloroform:isoamyl alcohol (25:24:1; pH 
5.2) extraction of the RNA (1:1 ratio, respectively) was carried out. The 
RNA/phenol:chloroform:isoamyl alcohol mixture was centrifuged at 10,600 x g at 4º C for 
5 min and the upper aqueous phase was transferred to a fresh tube and precipitated with 
0.01 volumes of sodium acetate (3M; pH 5.2) and 2.5 volumes of chilled 98% ethanol.  The 
samples were then maintained at -20º C overnight and centrifuged at 10,600 x g at 4º C for 
30 min.  The supernatant was removed and the RNA pellet was washed with 70% chilled 
ethanol and suspended in DNase/RNase free water and stored at -80º C.  The integrity of 
the RNA was analyzed using gel electrophoresis (1.5%) and the RNA was quantified using 
a NanoDrop® ND-100 Spectrophotometer (NanaDrop Technologies, Willington, DE).  
Four steers from each diet were selected for microarray comparison.   
 
Microarray Experiment   
A bovine specific adipose tissue cDNA array prepared by Dr. Udaya DeSilva, 
Animal Molecular Genetics, Oklahoma State University, was used in this study.  The 
printed array consisted of a 1,089 cDNA non-redundant clone library constructed from 
subcutaneous and visceral adipose tissue spotted onto Corning® UltraGAPS™ Coated 
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Slides (Corning, NY).  Array printing procedures were adapted from published literature 
(Hegde et al., 2000).  The library was sequenced, with the EST sequences submitted to 
GenBank.  GenBank accession numbers and dbEST IDs are presented in a supplementary 
table available at http://www.ansi.okstate.edu/faculty/desilva/papers/table.html.  Library 
annotation was accomplished, with EST sequences queried against the Peptide, Unigene, 
and nr GenBank database (Bos Taurus) with unknown EST sequences queried against the 
nr GenBank database (Mammalian).   
The OmniGrid 100 microarrayer (Genomic Solutions Ann Arbor, MI) used to print 
the microarray slide was equipped with a print head containing 16 print tips in a 4 by 4 
fashion, with subarrays printed by the print head representing a block.  The array consisted 
of 16 blocks in a 4 by 4 design with each probe (sequence) being printed once per array. 
The array was printed in triplicate on each slide to give a final 4 by 12 block slide design; 
accordingly each probe was represented three times on the microarray slide.  The adipose 
microarray contained a positive control consisting of a pooled sample of cDNA used to 
create the library and a negative control consisting of the printing buffer.  The slides were 
left in a humidified atmosphere after printing for 6 to 8 h to facilitate probe attachment to 
the slide.  The slides were then baked at 80º C overnight and then stored in a vacuum 
desiccator at room temperature until the implementation of the hybridization protocol. 
The microarray slides were rinsed in 0.1% SDS for 5 min and then rinsed in sterile ddH2O 
for 15 s and immediately dried for 2 min using a slide centrifuge.  The microarray slides 
were then placed into a screw-top 50 ml conical vial containing a pre-warmed (48º C) 
commercial pre-hybridization buffer (BlockIt Microarray Blocking Solution, TeleChem 
Int., Sunnyvale, CA) and incubated at 48º C for 4 h.  Slides were removed and rinsed in 
sterile ddH2O for 15 s and immediately dried for 2 min using a slide centrifuge. 
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To compare i.m. adipose tissue expression relative to s.c. adipose tissue, total RNA 
(2.5 µg) from s.c. (reference sample) and i.m. (test sample) adipose tissue wa r verse 
transcribed into cDNA in separate tubes using both random and dT primers and reverse 
transcriptase (Superscript II RT, Invitrogen, Carlsbad, CA).  The reaction was carried out at 
42º C for 6 h and the cDNA was subsequently labeled using the 3DNA Array 900MPX 
Expression Array Detection Kit (Genisphere, Hatfield, PA).  The cDNA was then purified 
using the Qiagen MinElute PCR Purification Kit (Qiagen Inc., Valencia, CA).  Following a 
poly-T tailing reaction, the “tagged” cDNA was ligated to the 3DNA Capture Sequence, a 
31-mer sequence specific for each the Alexa Fluor™ 546 and Alexa Fluor™ 647 and 
subsequently purified as previously described.  For the primary hybridization (hybridizing 
the tagged cDNA to the array), the hybridization solution (75 ul) consisting of: 10.0 µl of 
cDNA/3DNA Capture Sequence of each the Alexa Fluor™ 546 and Alexa Fluor™ 647; 
40.0 µl of the supplied 2X formamide-based hybridization buffer; 2.0 µl LNA dT blocker 
and 13µl nuclease-free water was denatured at 80º C for 10 min and deposited to a pre-
hybridized array slide under a 24 x 60 mm lifterslip (Erie Scientific, Portsmouth, NH).  The 
array was then incubated at 48º C for 18 h in a humidified hybridization cassette.  
Following incubation the lifterslip was allowed to wash off in a 2X sodium 
chloride/sodium citrate (SSC)/0.2% sodium dodecyl sulfate (SDS) solution prewarm d to 
48 º C. The array slides were then washed in 2X SSC/0.2% SDS, 60º C,15 min; 2X SSC, 
RT,15 min; and 0.2X SSC, RT, 15 min.  Following the final wash, the array slide was 
immediately dried for 2 min using a slide centrifuge.  For the secondary hybridization, the 
hybridization solution (75 ul) consisting of 2.5 µl of the fluorescent 3DNA Capture 
Reagent (capture reagent is complement to the capture sequence of the primary 
hybridization) of each the Alexis Fluor™ 546 (reference sample) and Alexa Fluor™ 647 
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(test sample), 40.0 µl of the supplied 2X formamide-based hybridization buffer and 30 µl 
nuclease-free water was deposited to the array under a 24 x 60 mm LifterSlip (E ie 
scientific, Portsmouth, NH).  The array was then incubated at 48º C for 4 h in a 
hybridization cassette.  The array slide was washed and dried as previously described and 
stored in a light-proof container until image acquisition. 
 
Microarray Data Analysis 
To compare i.m. adipose tissue expression (Alexa 647) relative to s.c. adipose tissue 
(Alexa 546), hybridization signals were captured by scanning the microarray slides with 
lasers at two wavelengths, Alexa 546 (s.c.) and Alexa 647 (i.m.), using a ScanArray™ 
Express confocal laser scanner (PerkinsElmer Life Sciences Inc., Boston, MA) at a pixel 
size resolution of 10 microns with the resulting images saved as 16 bit TIFF images.  For 
each slide, the laser power and photomultiplier tube (PMT) gain were adjusted to minimize 
variation between channels.  Using a local background subtraction method (spots with 
foreground intensity minus background intensity), the commercial software package 
GenePix™ Pro 4.0 (Axon Instruments Inc., Union City, CA) was used to analyze the signal 
intensity values of each feature (spot) in the Alexa Fluor™ 546 and Alexa Fluor™ 647 
channels.  The GenePix Pro Result (GPR) files generated from the results of the image 
analysis from each biological and technical replication were used for further downstream 
analysis and ratio calculations.  Preprocessing and normalization of data was accomplished 
utilizing the R-project statistical environment (http://www.r-project.org) with the 
Bioconductor and LIMMA packages (http://www.bioconductor.org) through the GenePix 
AutoProcessor (GPAP 3.2) website (http://darwin.biochem.okstate.edu/gpap32/) (Weng 
and Ayoubi, 2004).  Background correction was performed using Robust Multi-array 
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Average (RMA) algorithm (Allison et al., 2006) available in the Bioconductor/LIMMA 
package.  Following background correction, poor quality features were removed by 
filtering.  Such poor quality features were defined as features displaying n intensity value 
of 200 Relative Fluorescence Units or less in both the Alexa Fluor™ 546 and Alexa 
Fluor™ 647 channels, as well as features flagged bad, not found, or absent by GenePix™ 
Pro 4.0 and were removed from the analysis.  Two different normalization methods were 
utilized in the analysis to adjust and balance for the technical or systemic variation between 
the features within an array and between arrays for differences not caused by tr atment.  
Lowess (locally weighted Least squares regression) - global intensity normalization, was 
used to balance the variation associated with dye bias within each array (Yang et al., 2001; 
Yang et al., 2002).  To balance the effect of the Alexa Fluor™ 546 and Alexa Fluor™ 647 
dye bias intensity between arrays, quantile normalization was utilized (Bolstad et al., 
2003).  Following data preprocessing, the expression ratio for each feature (gene) was 
calculated using the following formula where a two-fold change is represented by a log2 
ratio >1.0 (up-regulation) or < -1.0 (down-regulation):  M value (log2 expression ratio) = 
log2 (F647-B647intensity /F546-B546intensity).  Using GPAP 3.2, a moderated t-test was used 
to identify the differentially expressed array elements along with their M value (log2 ratio), 
their P-value obtained from the moderated t-statistic after false discovery rat  (FDR) 
adjustment using the Benjamini and Hochberg method (Benjamini and Hochberg, 1995), 
and the number of individual features (log2 ratio) used for each gene.  Array elements 
where > 50% of the total features across arrays was used to calculate the av rage log2 ratio, 
a |t| > 2, an M-value |M|> +0.9 (representing a fold change of 1.87), and an adjusted P-
value < 0.01 were considered significantly differentially expressed and included for further 
analysis using the Genome Functional Integrated Discoverer (GFINDer) 
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(http://www.medinfopoli.polimi.it/GFINDer/) and Entrez Gene 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene). 
 
Gene Ontology Analysis 
The web based program GFINDer (Masseroli et al., 2004) was used in this study 
and is a program designed to retrieve annotations for a list of submitted genes, perform
categorization and present the results for use in gene ontology and pathway analysis where 
possible.  Entrez Gene is the National Center for Biotechnology Information (NCBI) 
database for gene-specific information (Maglott et al., 2005, 2007).  The Entrez gene ID of 
the differentially expressed genes retrieved from NCBI was used for the n ology analysis.  
The annotation terms were generated with emphasis based on gene ontology assessment for 
molecular function and biological process rather than cellular component (Ashburner et al., 
2000).  
 
Ingenuity Pathway Analysis   
To further understand the extent of how genes may interact within the context of 
metabolic or signaling pathways, Ingenuity Pathways Analysis (IPA) (Ingenuity® Systems, 
http://www.ingenuity.com) was utilized to identify the most relevant biological 
mechanisms, pathways and functions of the differentially expressed genes identified 
through GPAP 3.2.  IPA enables the visualization and exploration of gene interaction and 
relies on the most current known relationships among human, mouse and rat genes and 
proteins. 
A data set of differentially expressed genes from the four diets of FP containing 
gene ID and corresponding expression values was uploaded into the IPA application.  To 
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gain a better understanding of the interactions between genes within a biological system, an 
arbitrary M-value of |M| > +0.59 (or a 1.50 fold change) and a P-value < 0.01 were 
assigned as parameters for this analysis.  Each gene ID was mapped to its corresponding 
gene object in the Ingenuity Pathways Knowledge Base (IPKB).  These genes, called focus 
genes, were overlaid onto a global molecular network developed from information 
contained in the IPKB.  Networks of these focus genes were algorithmically generated 
based on their connectivity and assigned a network score.  IPA arbitrarily sets the 
maximum number of focus genes in each network at thirty-five.  The functional analysis of 
an entire dataset or single network identifies the biological functions and/or diseases that 
were most significant to the genes in the dataset or network.  IPA uses a Fischer’s exact test 
to calculate a P-value determining the probability that each biological function and/or 
disease assigned to that dataset or network is due to chance alone.  The network score is the 
negative log of this P-value and is a numerical value used to rank networks according to 
how relevant they are to the differentially expressed genes in the input dataset.  The 
network score takes into account the number of focus genes in the network and the size of 
the network.  The network score is not an indication of the quality or biological relevance 
of the network; it simply calculates the approximate “fit” between each network and the 
focus genes from the input data set.  For example, a score of “6” would indicate a P=10-6 
chance of genes appearing in the network solely by chance.  A network pathway is a 
graphical representation of the molecular relationships between genes/ products.  
Genes or gene products are represented as nodes, and the biological relationship between 
two nodes is represented as an edge (line).  All edges are supported by at least one 
reference from the literature, a textbook, or from information stored in the IPKB.  The 
intensity of the node color indicates the degree of up- (red) or down- (green) regulation.  
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Nodes are displayed using various shapes to represent the functional class of the gene
product.  Edges are displayed with various labels that describe the nature of the relationship 
between the nodes. For a gene to be network eligible, it must meet the criteria specified in 
the analysis parameters and also have at least one other full-length, wild-type gene or 
protein in IPKB that interacts (directly or indirectly) with this gene.  Ingenuity combines 
eligible genes into networks that maximize their specific interconnectedness with each 
other relative to all molecules to which they are connected.  The network algorithm 
optimizes for specific connectivity, so when a "hub" molecule is included in a network it 
connects a higher fraction of network eligible molecules relative to all molecules to which 
the "hub" molecule is connected with additional molecules from IPKB used to specifically 
connect and merge two or more smaller networks.   
IPA pathway analysis identifies the pathways from the IPA library that were most 
significant to the data set.  The significance of the association between the data set and the 
pathway is measured in two ways; 1) a ratio of the number of genes from the data st that
map to the pathway divided by the total number of genes that map to the pathway; and 2) 
Fischer’s exact test is used to calculate a P-value determining the probability that the 
association between the genes in the dataset and the pathway is explained by chance alone. 
 
Quantitative RT-PCR Validation of Microarray  
Validation of the i.m. adipose tissue expression relative to s.c. adipose tissue 
expression values generated from the microarray experiment was carried out using two-step 
SYBR green qRT-PCR.  Gene specific primers for ten different candidate genes s lected 
for microarray data validation were designed using Primer 3 (Rozen and Skaletsky, 2000) 
and analyzed using Oligo Analyzer 3.1 (Integrated DNA Technologies), 
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http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/.  Primer sequences, 
annealing temperatures and product size are presented in Table 4.1.  Total RNA (1 ug) 
from s.c. and i.m. adipose tissue depots from each individual animal for the diet and phase 
selected for validation was reverse transcribed using the QuantiTect® Reverse 
Transcription Kit (QIAGEN Inc., Valencia, CA) using oligo-dT and random prime s in a 
total volume of 20 ul. RT- PCR reactions were carried out in duplicate, using a MyiQ Real-
Time PCR detection system (Bio-Rad Laboratories, Hercules, CA) in a 15 ul reaction 
consisting of: 7.5 ul of 2X PerfeCTa™ SYBR Green SuperMix for iQ™ (Quanta 
BioSciences, Inc. Gaithersburg, MD), 400 nM forward primer, 400 nM reverse primer and 
100 ng of cDNA.  18S ribosomal RNA was assayed as a normalization control for all 
samples assayed.  A standard curve with five serial dilution points was included for each 
gene along with a no-template control.  Thermal cycling conditions were 95º C for 2.5 min 
followed by 38 repetitive cycles of 95º C for 15 s, variable annealing temperature for 30 s, 
and 72º C for 30 s. Immediately following RT-PCR, a melt curve analysis was conducted 
by bringing the reaction to 95º C for 1 min, 55º C for 1 min, then increasing the 
temperature by 0.5º C from 55º C to 94.5º C.  Gene expression between depots for the diet 
and phase selected for validation was evaluated using the comparative CT method.  A cycle 
threshold (CT) value was assigned to each reaction at the beginning of the logarithmic 
phase of the PCR amplification.  A ∆CT value was calculated for each sample by 
subtracting the mean 18S ∆CT value of each sample from the corresponding gene of 
interest mean ∆CT value (Livak and Schmittgen, 2001).  The ∆∆CT was calculated by 
setting the IM ∆CT value of the two depots as an arbitrary constant to subtract from the SC
 
mean ∆CT depot values (Hettinger et al., 2001).  Relative expression levels between the two 
depots were calculated as fold changes, where each cycle of the PCR represent d a two-
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fold change.  The assay specific efficiency for each gene was not used in th calculation of 
the relative expression levels. Fold change (FC) gene expression was calculated using the 
formula: FC = 2 −∆∆CT. 
 
Quantitative RT-PCR Analysis for Selected Genes   
Five genes from the adipose related category; acyl-CoA synthetase medium-chain 
family member 1 (ACSL1), CD36 molecule (CD36), fatty acid binding protein 4, 
(FABP4), stearoyl-CoA desaturase (SCD), and prostaglandin-endoperoxide synthase 2 
(PTGS2); three genes from the carbohydrate metabolism category; glucose phosphate 
isomerase (GPI), lactate dehydrogenase B (LDHB), and pyruvate kinase, muscle (PKM2); 
and one gene from the binding category, four and a half LIM domains 1 (FH1) were 
measured for their mRNA expression between depots across diets using quantitative RT-
PCR and analyzed using the comparative CT method.  The ∆∆CT was calculated by setting 
the highest mean ∆CT value as an arbitrary constant to subtract from all other
 mean ∆CT 
depot values (Hettinger et al., 2001).  Relative expression levels between the depots across 
diets were calculated as fold changes, where each cycle of the PCR represented a two-fold 
change.  Fold change (FC) gene expression was calculated using the formula: FC = 2 −∆∆CT.  
The ∆CT values were analyzed by analysis of variance (ANOVA) and means were 
compared using the Least squares means (LSMEANS) of PROC MIXED of SAS 9.1.3 








Performance and Carcass Merits 
Performance and carcass merits previously reported by McCurdy (2006) showed 
ADG during the FP to be greater (P < 0.05) for steers in SF than PF (2.02 vs. 1.85 kg/d, 
respectively, and ADG for steers in PF greater (P < 0.01) than steers in WP or CF (1.85 vs. 
1.64 and 1.63 kg/d, respectively).  Final weight was greater (P < 0.001) for steers that were 
managed in a growing program than for calf-fed steers (avg. =579 vs. 559 kg, respectiv ly); 
however, hot carcass weight did not differ among treatment diets (P =0.12).  Dressing 
percentage was greater (P < 0.05) for WP, PF, and CF steers than for SF steers and 
Longissimus muscle area was smaller (P < 0.05) for CF than SF and PF steers, with WP 
steers intermediate.  Yield grades were lower for WP and CF steers, 3.19 and 3.39 
respectively, than for SF and PF steers, 2.76 and 2.94, respectively.  Steers in SF group had 
higher (P < 0.01) marbling scores compared with WP and CF with PF steers being 
intermediate.  Days on feed during the finishing phase were 123, 104, and 104, for WP, SF, 
and PF steers, respectively.  CF steers were on feed for a total of 196 d, 112 of which 
coincides with the time the WP, SF, and PF steers were on respective diets of th  GP. 
 
Microarray and Ontology Analysis 
Two hundred forty-eight of 1089 array elements, or 23%, were found to be differentially 
expressed (DE) between s.c. and i.m. adipose tissue depots in at least one of the four 
treatment diets of the FP.  Clone ID, gene symbol, gene name, Entrez gene ID, dEST ID, 
GenBank accession number, M-value, GO/KEGG ID, and GO term/KEGG pathway for 
genes in each diet of FP are presented in the appendices (Appendices Table A2).   
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Of the 248 array elements of FP, 29 had a non-significant (E value >1e-15) or 
ambiguous match in the previously described NCBI databases and were grouped under the 
category “No Biological Data Available” (Rhee et al., 2008).  Two hundred ninetee  array 
elements were observed to significantly (E value < 1e-15) correspond to specific annotated 
genes in the NCBI database and were used for ontology analysis using GFINDer and 
Entrez Gene.  Seventy-nine array elements were not associated with any functional or 
biological annotation even though they had significant matches in the NCBI databases and 
were grouped under “Other”.  Based on results of the Bovine ontology analysis, 140 
differentially expressed genes were organized into 15 functional/biological categories.  
Fifty-six of the 140 differentially expressed genes were detected in biochemical pathways 
for Bos Taurus defined by Kyoto Encyclopedia of Genes and Genomes (KEGG), 
http://www.genome.jp/kegg/, (Kanehisa and Goto, 2000).  The number of differentially 
expressed genes observed in WP steers was almost four times greater than SF steers (145 
vs. 41), almost three times greater than PF steers (145 vs. 55) and almost twice the number 
in CF diet (145 vs. 82) (Table 4.2).  WP steers had a greater number of differentially 
expressed genes involved in binding, cell growth and differentiation, signal transduction 
and transcription/translation functions than SF, PF and CF steers.  However, the number of 
differentially expressed adipose related genes was slightly attenuated in SF and PF steers as 
compared to WP and CF steers.  The percent of differentially expressed genes not 
associated with any functional or biological annotation (those classified as “Other”) for 





Quantitative RT-PCR Validation of Microarray 
Nine differentially expressed genes were selected for microarray validation.  
Comparisons between the results of the expression profiles determined by microarray and 
RT-PCR for each gene from diets of FP selected for validation are presented in Table 4.3.  
Microarray analysis indicated acyl-CoA synthetase medium-chain family member 1 
(ACSL1), CD36 molecule (CD36), fatty acid binding protein 4 (FABP4), lactate 
dehydrogenase B (LDHB), and stearoyl-CoA desaturase (SCD) to be down-regulated in 
i.m. adipose tissue in respective diets of the FP.  RT-PCR verified the down-regulated 
pattern of expression of these genes in i.m. adipose tissue.  Microarray analysis i dicated 
four and a half LIM domains 1 (FH1), glucose phosphate isomerase (GPI), pyruvate kinase, 
muscle (PKM2), and prostaglandin-endoperoxide synthase 2 (PTGS2) to be up-regulated in 
i.m. adipose tissue depot in respective diets of the FP.  RT-PCR verified the up-regulated 
expression pattern of these genes in i.m. adipose tissue depot with the exception of GPI in 
CF steers where RT-PCR results indicated an opposite direction of expression from the 
microarray analysis.   
 
Quantitative RT-PCR Analysis of Selected Genes 
Results of the RT-PCR analysis of mRNA expression measured for all experimental 
animals between depots across diets at the end of the FP for ACSM1, CD36, SCD, HADH, 
FABP4, PTGS2, LDHB, GPI, PKM2, and FHL1 and are shown in (Figure 4.1 a-m).  Four 
genes from the adipose related category, ACSM1, CD36, FABP4, and SCD were 
significantly (P < 0.05) affected by depot and were down-regulated approximately four, 
five, four, and 20 fold, respectively, in the i.m. adipose tissue compared to s.c. adipose 
tissue.  HADH had a tendency (P < 0.09) to be influenced by diet where mRNA expression 
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was greater in SF and PF steers compared to WP steers with CF steers not significantly 
different from the SF, PF or WP steers.  PTGS2 had a tendency (P < 0.09) to be influenced 
by a diet x depot interaction where mRNA expression was greater in the i.m. adipose tissue 
of WP steers than the other adipose tissue depots in the other steers except the i.m. adipose 
tissue of PF steers.  Three genes from the carbohydrate metabolism category, GPI, PKM2, 
and LDHB were significantly affected by depot (P < 0.05).  PKM2 was also significantly 
affected by diet with GPI having a tendency to be influenced by diet (P < 0.06).  GPI and 
LDHB mRNA expressions were down-regulated approximately three and four fold, 
respectively, in i.m. adipose tissue compared to s.c. adipose tissue.  PKM2 mRNA 
expression was up-regulated over 15 fold in the i.m. adipose tissue compared to s.c. 
adipose tissue.  PKM2 mRNA expression was greater in SF and PF steers compared to WP 
steers with the CF steers not significantly different from either t SF and PF or WP steers.  
GPI mRNA expression was greater in PF steers compared to WP steers, with SF and CF 
steers not significantly different from either the PF or WP steers.   
FHL1 mRNA expression was affected by depot (P < 0.03) with a tendency to be 
influenced by diet (P < 0.06).  The mRNA expression was up-regulated approximately four 
fold in i.m. adipose tissue compared to s.c. adipose tissue.  FHL1 mRNA expression was 
greater in SF and PF steers compared to the WP steers with CF steers not significantly 
different from either the SF and PF or WP steers.   
 
Ingenuity Pathway Analysis 
The objective of IPA network generation is to hypothesize, using the most pertinent 
information available in the literature, how network eligible genes in a data set interact in a 
biological system.  In this study, networks were generated through IPA using the dataset of 
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differentially expressed genes identified through GPAP 3.2.  An arbitrary M-value of          
> +0.59 or < -0.59 (representing a fold change of > +1.50 or < -1.50) and a P-value < 0.01 
were implemented as cut-off parameters in the analysis.  Of the 219 array elements shown 
to significantly correspond to specific annotated genes, 146 were network eligible while 
132 were eligible for functional/pathway analysis.   
Networks are ranked by how relevant they are to the genes of the dataset with a 
higher score indicating a lower probability of finding the observed number of genes in a 
given network by random chance.  A summary of the top networks generated by IPAfor
diets of FP, including number of focus genes, network score and the top three network 
molecular/cellular functions, disease/disorder or physiological system development and 
function is presented in Table 4.4. 
Fourteen networks were generated for WP diet with six containing one focus gene 
while five major networks were generated for CF diet with five possessing only one gene.  
The most significant networks of both the WP (IPA score=45; 23 focus genes) and CF 
(IPA score=34; 17 focus genes) diets included functions pertaining to cellular movement 
(P-value, 2.82-3 to 1.08-8) (P-value, 5.91-3 to 2.47-7) and cellular growth and proliferation (P-
value, 1.75-1 to 1.55-8) (P-value, 1.41-1 to 5.87-7).  The down-regulated nuclear factor of 
kappa light polypeptide gene enhancer in B-cells 1 (p105) (NFKB1), along with ERK and 
AP1, were central to both networks of WP and CF diet.  Eight networks, four of which 
contained only one focus gene, were generated for SF and PF diets.  The most significant 
network in both SF (IPA score=39; 18 focus genes) and PF (IPA score=44; 20 focus genes) 
diets included functions associated with lipid metabolism (P-value, 4.02-3 to 6.54-6; P-value, 
4.02-3 to 6.54-6) and molecular transport (P-value, 5.08-3 to 2.52-7; P-value, 3.94-3 to 2.52-7).  
ERK, H3F3A, AP1, and P38 MAP-K were central molecules to these networks. 
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IPA currently listed 32 functions under the heading of “molecular and cellular 
functions” which are subdivided into lower level ancillary function “categories”.  Figure 
4.2 ranks, by significance, the top 10 global molecular and cellular functions associated 
across all generated networks for each respective diet of the FP, respectively.  This 
represents a broad overview of the biology associated with each diet.  In general, a P-v ue 
< 0.05 indicates a significant nonrandom association between genes of the dataset and a 
given function.  Significance, expressed as the negative log10 of the P-value calculated for 
each function, is represented on the y-axis.  Differences were observed between diets of FP 
in the ranking of those functions and also in the number of genes and the pattern of 
expression associated with those functions.  Lipid metabolism was the top-ranked fu ction 
for both SF and PF diets while cellular growth and proliferation and cellular move ent 
were top-ranked for both WP and CF diets with lipid metabolism being ranked fourth in 
both WP and CF diets.  Functional comparison, as well as metabolic and signaling pathway 
comparison between treatments, is a tool that allows for further determination of whether 
and to what extent a given function or pathway is affected by a treatment.  Results of the 
comparative functional analysis between diets of FP are presented in Figure 4.3.  The 
possibility does exist for genes within the makeup of the function to change between 
treatments without altering the significance value for that function.  Amino acid 
metabolism, energy production, protein synthesis, RNA post-translational modification and 
vitamin and mineral metabolism are functions displaying obvious variations between diets 
of the FP.   
IPA contains a total of 158 pathways in its library, 80 metabolic pathways and 78 
signaling pathways.  Metabolic pathway analysis and signaling pathway analysis 
comparing diets of the FP are presented in Figures 4.4 and 4.5, respectively.  Metabolic and 
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signaling pathways exhibited a number of significant variations (P < 0.10) in gene 
expression between diets of the FP. 
Using IPA comparison and network analysis, differentially expressed genes 
exclusive to WP, SF, PF and CF diets, respectively, were also investigated.  Fifty-three 
differentially expressed genes were exclusive to WP steers with no differentially expressed 
genes exclusive to SF steers.  These IPA identified genes along with their associated 
networks are presented in Tables 4.5 through 4.7, respectively.   
 
Discussion 
Steers from all treatment diets were harvested at a common 12th rib fat (1.27 cm) as 
determined by ultrasound.  Days on feed for WP, SF, and PF steers of FP were 123, 104, 
and 104, respectively.  CF steers were on feed for a total of 196 d, 112 of which coincides 
with the time WP, SF, and PF steers were on respective diets of the GP.  Steers in th  SF 
group had higher marbling scores compared with WP and CF, with PF steers being 
intermediate.  Dressing percentage was greater for WP, PF, and CF steers than for SF steers 
while yield grades were lower for WP and CF steers, 3.19 and 3.39 respectively, than for 
SF and PF steers, 2.76 and 2.94, respectively.   
The number of differentially expressed genes observed in WP steers of the FP was 
over four times greater than SF diet (146 vs. 35), almost three times greater than PF diet 
(146 vs. 54) and almost twice the number as CF diet (146 vs. 82).  Interestingly, the 
number of differentially expressed adipose related genes was slightly attenuated in SF and 
PF diet as compared to WP and CF diets.  The WP and CF diets shared common functions 
in their most significant network, respectively, which included cellular movement and 
cellular growth and proliferation.  SF and PF diets shared common functions in their most 
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significant network, respectively, which included lipid metabolism and molecular transport.  
More so, SF and PF diets shared common functions for networks 2 and 4 as well; network
2 included lipid metabolism, carbohydrate metabolism and small molecule biochemistry 
while network 4 included cell cycle, cellular assembly and organization, and DNA 
replication, recombination and repair.   
Adipose related genes (Figure 4.6) included those involved in lipid binding, 
transport, and metabolism as well as the metabolites secreted from adipose tissue.  Acyl-
CoA synthetase medium-chain family member 1 (ACSM1) is involved in a key reaction in 
the activation of fatty acids.  RT-PCR revealed gene expression for ACSM1, also known as 
butyrate-CoA ligase, to be significantly altered by depot and was down-regulat d over 4 
fold in i.m. adipose tissue compared to s.c. adipose tissue.  The term synthetase or ligase, 
refers to a reaction that utilizes an ATP and forms an acyl-AMP intermediate (M shek et 
al., 2004).  Before fatty acids can be oxidized they first must be “activated” for the reaction 
by combining the fatty acid with Co-A to form fatty acyl Co-A.  The fatty cyl group can 
then be transported into the mitochondrial matrix, where it undergoes beta-oxidation.  
Acetyl-CoA can feed directly into the TCA cycle, or if propionyl-CoA, it can be 
catabolized via a number of different pathways that convert it into pyruvate, acetate, or 
succinyl-CoA, which in turn, can enter the TCA cycle.  However, acyl-CoA can also 
function as ligands for transcription factors or enter several other pathways such as de novo 
synthesis of triacylglycerol and phospholipids, reacylation pathways, and cholesterol and 
retinal esterification (Coleman et al., 2002; Mashek et al., 2004).  ACSM1 can also 
function as a GTP-dependent lipoate-activating enzyme that generates the substrate for 
lipoyltransferase (Fujiwara et al., 2001).  There are six members of the medium-chain 
Acyl-Co A family (Mashek et al., 2004) which catalyze the ligation of medium chain fatty 
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acids, [acids from C4 to C11 and the corresponding 3-hydroxy- and 2,3- or 3,4-unsaturated 
acids (in vitro)]  with CoA to produce medium-chain Acyl-Co A (Inka Lindner, 2006).  
Though the most common substrates of the medium-chain acyl CoA synthetase family are 
fatty acids, xenobiotic carboxylic acids and bile salts can also serve as substrates (Mashek 
et al., 2004).  In the mouse, medium chain acyl Co-A synthetase was shown to be inhibited 
by nonsteroidal anti-inflammatory drugs (NSAIDs) (Kasuya et al., 2001).  Also in the 
mouse, aspirin and salicylic acid were shown to decrease the mitochondrial activation and 
the β-oxidation of long chain fatty acids (palmitate) in vivo by 50 and 65%, respectively, 
(Deschamps et al., 1991). 
In the present experiment, CD36 molecule (CD36) gene expression was 
significantly affected by depot and was down-regulated over 5 fold in i.m. adipose tissu  
compared to s.c. adipose tissue.  In in vitro studies using 3T3-L1 cells, no CD36 protein 
was detected in preadipocytes; however, CD36 was detected in cells 3 days post-
differentiation (Qiao et al., 2008).  CD36 has been identified as an important marker of 
preadipocyte differentiation into adipocytes as CD36 mRNA expression was induced 
during the differentiation process and fatty acid uptake coincided with the up-regulated 
expression of CD36 (Abumrad et al., 1993; Sfeir et al., 1997).  CD36 has been shown to be 
regulated by all three peroxisome proliferator receptors (PPAR), α, γ, and δ, in a tissue 
specific manner (Hajri and Abumrad, 2002).  More so, CD36 contains a CCAAT/enhancer 
binding protein (C/EBP) response element and C/EBP α and β were shown to increase 
CD36 expression with C/EBPα being a more potent inducer of CD36 than 
C/EBPβ indicating C/EBPα involvement in regulating CD36 expression at the 
transcriptional level (Qiao et al., 2008).  One of the main functions of CD36 is to facilitate 
the translocation of fatty acids in adipocytes as well as in heart and muscle cells (Nicholson 
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et al., 2000; Febbraio et al., 2001; Su and Abumrad, 2009).  With CD36 being regulated by 
PPARγ and C/EBP; the up-regulation of expression of CD36 in the s.c. seems consistent, as 
it follows a similar pattern of expression as seen for other adipose related genes involved in 
fatty acid transport.  Also, there is evidence that CD36 gene expression can differ between 
depots, as CD36 gene expression in weaning piglets was shown to be higher in visceral 
adipose tissue as compared to s.c. and i.m adipose tissue (Shu et al., 2008).  Conversely, in 
a human study using non-obese subjects, CD36 gene expression was shown to be up-
regulated in s.c. adipose tissue as compared to omental adipose tissue (vanBeek et al., 
2007) 
Stearoyl-CoA desaturase (SCD) gene expression was also shown to be significantly 
affected by depot in the present experiment, and was down-regulated over 20 fold in i.m. 
adipose tissue compared to s.c. adipose tissue.  This is consistent with other findingsin the 
literature where SCD activity appears to be essential for subsequent development of 
lipogenic activity of s.c. adipose tissue in growing steers (Smith et al., 2006b; Hausman et 
al., 2009).  Subcutaneous adipose tissue was shown to have approximately twice the SCD 
catalytic activity as i.m. adipose tissue and a greater concentration of MUFA than i.m. 
adipose tissue (Archibeque et al., 2005).  However, in many breeds a nearly linea incr se 
in i.m. adipose deposition has been shown with time on a finishing diet, with this increase 
in i.m. adipose deposition being consistent with an increase in adipose tissue MUFA and 
SCD activity (Hausman et al., 2009).   
Furthermore, in comparing s.c. adipose tissue from the mid-loin region of pasture-
fed cattle or cattle placed in the feedlot and fed a diet consisting of sorghum, roughage, and 
5% whole cottonseed for 100, 200, or 300 d SCD activity was observed to be 60 to 85% 
higher in cattle from the pasture-fed diet than cattle on the feedlot diet suggestin  that 
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feeding whole cottonseed reduced the activity of SCD (Yang et al., 1999).  Cattle from the 
pasture-fed diet had lower total saturated fatty acids and higher total unsaturated fatty acids 
in adipose tissue than cattle in the feedlot (Yang et al., 1999).  No diet affects were 
observed for SCD mRNA gene expression in the present study. 
Hydroxyacyl-CoA dehydrogenase (HADH), an enzyme involved in the beta-
oxidation of fatty acids through the oxidation of straight chain 3-hydroxyacyl CoA’s 
(Rakheja et al., 2002; Song-Yu Yang, 2005), was significantly altered by diet and was 
shown to be up-regulated in both SF and PF diets compared to WP diet.  There was not a 
significant difference observed between the CF and WP diets.  HADH is also present in the 
degradation pathways of the branched chain amino acids, valine, leucine, and isoleucine 
(Kanehisa and Goto, 2000), which can provide the acetyl-CoA necessary for fatty acid 
biosynthesis in adipose tissue (Labrecque et al., 2009). 
In the present experiment, FABP4 gene expression was shown to be significantly 
affected by depot with gene expression down-regulated over 4 fold in i.m. adipose tissue 
compared to s.c. adipose tissue.  Similar findings were found in porcine where FABP4 
transcript and protein content were shown to be lower in i.m. adipocytes as compared to 
s.c. adipocytes when adipose cells were compared at the same size and same age (Gard n et 
al., 2007).  Previous work by Moore et al., (1991) showed the activity of FABP4 in the 
Longissimus muscle not to be a good index for the determination of i.m. fat accretion in 
bovine.  However, FABP4 polymorphisms have been shown to be associated with marbling 
and s.c. fat depth in cattle (Michal et al., 2006), and for fatness traits and i.m. fat accretion 
in pigs (Chmurzynska, 2006; Damon et al., 2006). 
Prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase 
(COX), had a tendency to be affected by a diet x depot interaction where mRNA 
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expression was greater in the i.m. adipose tissue of WP than other adipose tissue depots in 
other diets except the i.m. adipose tissue of PF diet.  The i.m. adipose tissue depot of PF 
was greater than the s.c. adipose depot of WP diet with no difference in the other adipose 
tissue depots in the other diets.  There are two isoforms of PTGS: a constitutive PTGS1 (or 
COX-1) and an inducible PTGS2 (or COX-2) which differs in their regulation of 
expression and tissue distribution (Petersen et al., 2003; Yan et al., 2003).  PTGS2 
catalyzes the conversion of arachidonic acid to prostaglandin H2 a d is the rate-limiting 
step in the formation of prostanoids which include PGF2α, PGJ2, PGI2, and PGE2 (Morita, 
2002; Yan et al., 2003; Lu et al., 2004).  Three classes of enzymes essentially regulate the 
numerous signaling pathways of arachidonic acid; the first being COX, which initiates the 
synthesis of prostaglandins (PG’s); the second are the lipooxygenases, which initiate the 
synthesis of leukotrienes (LK); and the third, cytochrome P450’s, which initiate the 
synthesis of hydroxyeicosatetraenoic acids (HETE) and epoxyeicosatetraenoic acids (EET).  
The differences in the biological activity of the products generated by these enzymes are 
due to the insertion of oxygen at different positions in the arachidonic acid molecule. 
Arachidonic acid has been shown to inhibit adipocyte differentiation (Petersen et 
al., 2003) and is itself, along with the prostinoids, a ligand for PPARγ.  The inhibition of in 
vitro adipocyte differentiation by arachidonic acid was reversed by the addition of COX 
inhibitors suggesting that prostaglandins may be the key to mediating this inhibition of 
adipocyte differentiation.  Also, when adipocyte differentiation was inhibited by 
arachidonic acid, COX-2 expression was sustained at an elevated level with the in ibition 
being reversed by the addition of the nonselective COX inhibitor, indomethacin (Petersen 
et al., 2003).  COX isoforms being involved in the inhibition of in vitro of adipocyte 
differentiation, with COX-2 isoform appearing to be the mediator of the inhibition, has also 
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been shown by other researchers (Yan et al., 2003).  Furthermore, de novo fatty acid 
synthesis, diacylglycerol acyltransferase (DGAT) activity, and triacylglycerol accumulation 
were suppressed in adipocytes in vitro treated with arachidonic acid.  The nonselective 
COX inhibitor indomethacin, restored DGAT activity and the accumulation of 
triacylglycerol; however, de novo fatty acid synthesis was not restored which resulted in 
the increased incorporation of arachidonic acid into cellular triacylglycerols (Petersen et al., 
2003). 
The function of PTGS (COX) and prostaglandins in the regulation of adipocyte 
differentiation is difficult to understand as the different prostaglandins exert distinct effects 
on adipocyte differentiation.  Early work revealed rapidly growing cultures of 3T3-L1 
preadipocyte cells produced significant amounts of prostaglandins, mainly PGE2, when 
incubated with arachidonic acid; however, PGE2 synthesis declined when cells reached 
confluency, suggesting the involvement in either the induction or maintenance of 
differentiation (Hymann et al., 1982).  PGI2 and PGE2 have been shown to  behave in an 
autocrine/paracrine manner (Aubertv et al. 2000; Boone et al., 2000) with the PGI2 receptor 
present mainly in preadipocytes while the PGE2 receptor is mostly present in mature 
adipocytes (Boone et al., 2000).  PGI2 is an efficient activator of cAMP production in 
preadipocytes and can enhance cell differentiation (Négrel et al., 1989), while PGE2 
decreases cAMP concentrations and avoids lipolysis (Boone et al., 2000).  Thus, PGI2 and 
PGE2 may increase adipose tissue accretion through the enhancement of hyperplasia and 
hypertrophy (Boone et al., 2000).  More so, PGI2 and its analogue carbacyclin (cPGI2) have 
been shown to up-regulate the expression of C/EBPβ and C/EBPα in OB1771 and 3T3-
F442A preadipocytes (Aubertv et al., 2000).  Vassaux et al. (1992) described PGI2, which 
is able to activate the three PPAR isoforms, γ,α δ, (Brun et al., 1996; Hertz et al., 1996), as 
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an adipogenic-hyperplastic effector of adipocyte precursor cells, and PGE2 as an anti-
lipolytic-hypertrophic effector of adipocytes and also suggested the two might contribute in 
concert in adipose tissue development.  More recently, Sugimoto et al. (2004) suggested 
that PGE2 inhibited adipocyte differentiation by acting on the EP4 receptors as PGE2 was 
shown to inhibit or suppress the differentiation-associated expression of certain gnes such 
as GHRH, ADIPOQ, DGAT1, G3PDH, and HADH.  In the present study, HADH was not 
influenced by depot but was influenced by diet and was up-regulated in both SF and PF 
steers compared to WP steers with no significant difference observed between the CF and 
WP steers.  Adipose tissue is an important source of angiotensinogen, the precursor of the 
vasoconstrictor angiotensin II (Lu et al., 2007).  Angiotensin II plays an important role in 
the cell cycle progression in human preadipocytes (Crandall et al., 1992) and can stimulate 
the production of PGI2 and PGE2 (Boone et al., 2000).  It is worth noting that in the present 
study, the microarray analysis showed angiotensin II receptor, type-1 to be up-regulated in 
the i.m. adipose tissue in the WP steers and down-regulated in the SF, PF, and CF steers.  
The pattern of expression for angiotensin II receptor, type-1 seen in the microarray needs to 
be verified by RT-PCR. 
PGF2α is also unable to affect cAMP production (Négrel et al., 1989) and has been 
reported to inhibit adipocyte differentiation (Serrero et al., 1992; Miller et al., 1996; 
Petersen et al., 2003).  PGD2, whose hydration products are PGJ2, ∆
12-PGJ2, and 15-deoxy-
∆
12,14-PGJ2 (Lu et al., 2004), is also unable to affect cAMP production (Négrel et al., 
1989).  However, PGJ2 and PGF2α have been reported to have opposing effects on PPARγ, 
the central regulator of adipogenesis (Reginato et al., 1998; Fajas et al., 2003), with PGJ2 
functioning as an activating ligand for PPARγ, and PGF2α functioning in the inhibitory 
phosphorylation of PPARγ through activation of mitogen-actived protein kinase (Kliewer 
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et al., 1995; Reginato et al., 1998).  Furthermore, the treatment of 3T3-L1 cells with 
aspirin, a COX inhibitor, attenuated triacylglycerol accumulation, with the addition of 
PGD2, 15d-PGJ2 and PGE2 reversing the effect, while PGF2α had an additional inhibitory 
effect on triacylglycerol accumulation (Lu et al., 2004).  In characterizing depot differences 
in mRNA expression of enzymes involved in prostaglandin D and J2 synthesis between 
different adipose tissue depots in humans, prostaglandin synthase-1 (PGHS1 or COX-1) 
and prostaglandin D synthase (PTGDS) were shown to be up-regulated 2.1 and 3.2 fold, 
respectively, in omental (OM) adipose tissue as compared to s.c. adipose tissue while 
human prostaglandin transporter (hPGT) was expressed in OM adipose tissue and was 
undetectable in s.c. adipose tissue (Quinkler et al., 2006).  Also,the expression of 17β-
hydroxysteroid dehydrogenase 5 (ARK1C3), which catalyzes PGD2 to PGF2α, was down-
regulated in OM adipose tissue compared to s.c. adipose tissue by 3.2 fold, further adding 
complexity to differences seen in depots in the generation of prostaglandin metabolit s that 
can act as agonists or antagonists of PPARγ (Quinkler et al., 2006). 
The COX enzyme is the target of many nonsteroidal anti-inflammatory drugs 
(NSAIDs) including aspirin (Fajas et al., 2003).  Some NSAIDs inhibit both COX-1 and 
COX-2 while others are selective only for COX-2.  Celecoxib (Celebrex ®), an NSAID 
that is highly selective for COX-2 inhibition, is approximately 7.6 times more selective for 
COX-2 inhibition over COX-1 (Silverstein et al., 2000).  In rats fed a high fat diet for 14 
weeks, Celecoxib was found to reduce fat accumulation by decreasing fatty acid s nthase 
expression through the down-regulation of the c-Jun N-terminal kinase-1 (JNK1) (Lu and 
Archer, 2007).  Rofecoxib (Vioxx), another COX-2 selective NSAID, administered for a 
six week period in mice fed a high fat diet resulted in a reduction in body weight and a 
reduction in s.c. and gonadal adipose tissue mass with no significant difference in food
 148 
intake (Lijnen et al., 2008).  Also, the adipocytes were smaller in the gonadal adipose tissue 
after Vioxx treatment compared to placebo, with no differences in adipocyte size being 
observed in the s.c. adipose tissue (Lijnen et al., 2008). 
The IPA analysis revealed possible variations between diets of the FP in 
arachidonic acid metabolism and the eicosanoid signaling pathway (Figure 4.4 and 4.5, 
respectively).  Genes involved in arachidonic acid metabolism generated by IPA included; 
acyl-CoA synthetase short-chain family member 2; cytochrome P450, family 2, subfamily 
D, polypeptide 6; cytochrome P450 subfamily 2B; glutathione peroxidase 3 (plasma); and 
granulin.  As previously mentioned, cytochrome P450 metabolizes arachidonic acid to
HETE and EET which are intermediate compounds in the conversion of arachidonic acid to 
a number of biological active compounds including prostaglandins, thromboxanes, and 
leukotrienes (Kroetz and Zeldin, 2002).  Genes involved in eicosanoid signaling generated 
by IPA included PTGS2 and granulin.  There are four families of eicosanoids; the 
prostaglandins, the prostacyclins, the thromboxanes and the leukotrienes (Wolfe, 1982).  
Besides the presence of multiple forms of the COX enzyme, COX-1, COX-2 COX-3, and 
two smaller COX-1-derived proteins (Chandrasekharan et al., 2002) that can generate 
functional diversity in the COX enzyme class, there are multiple isoforms of other enzymes 
in these signaling pathways.  For example, two PGE2 synthase enzymes, one constitutively 
expressed and one induced (Martel-Pelletier et al., 2004), two enzymes that catalyze the 
synthesis of PGD2, several lipooxygenases isoforms, (Soberman and Christmas, 2003) and 
thirteen different isoforms of the cytochrome P450 family of enzymes (Roman and Alonso-
Galicia, 1999) have been reported in the literature.  Each of these isoforms can function 
differently by being coupled with different stimuli in different tissues (Soberman and 
Christmas, 2003).  This functional diversity also carries over into the prostaglandin 
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receptors as eight types and subtypes of receptors are conserved in mammals, each with a 
distinct tissue- and cell-specific function (Soberman and Christmas, 2003).  
Several of the differentially expressed genes in the adipose related and carbohydrate 
metabolism functional categories can be placed in the PPAR γ signaling pathway (Figure 
4.7).  Besides the previously discussed genes, CD36, FABP4, SCD, and ACMC1, which 
were shown to be down-regulated in i.m adipose tissue compared to s.c. adipose tissue, the 
microarray analysis showed adiponectin (ADIPOQ) and phosphoenolpyruvate 
carboxykinase 2 (PCK2) to be down regulated in the i.m. adipose tissue in all diets or not 
differentially expressed between adipose tissue depots, respectively.  PPARγ is a ligand 
dependent transcription factor which is the master regulator of adipogenesis (Rosen and 
MacDougald, 2006; Tontonoz and Spiegelman, 2008).  PPARγ is also a regulator of other 
cellular functions and biological processes such as carbohydrate and lipid metabolism and 
immune cell activation and is abundantly expressed in adipose tissue as well as skelet l 
muscle, heart, liver, and intestine (Lopez-Liuchi and Meier, 1998; Fernyhough et al., 2007; 
Minge et al., 2008; Nettles, 2008).  Endogenous ligands for PPARγ, which can bind at µM 
levels, include unsaturated and oxidized fatty acids, eicosanoids and prostaglandins 
(Nettles, 2008).  PPARγ functions as a heterodimer with the retinoid X receptor (RXR) 
with the required dimerization promoted by ligand binding to either PPARγ or anyone of 
the three RXR isotypes; α, β, or γ, with which PPARγ is able to dimerize (Metzger et al., 
2005; Nettles, 2008; Tontonoz and Spiegelman, 2008).  The RXR is activated by 9-cis 
retinoic acid (Metzger et al., 2005).  Three types of PPAR have identified, α, δ, and γ; with 
four isoforms of PPARγ arising from differential promoter action and alternate gene 
splicing (PPARγ(1-4); Metzger et al., 2005; Fernyhough et al., 2007).  PPARγ3 and 4 
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produce translated proteins identical to PPARγ1; thus, only two receptors result in the 
biological system, PPARγ1and 2 (Fernyhough et al., 2007).  Ligand activation of PPARγ is 
required for the induction of adipogenesis, as no factors have been discovered that promote
adipogenesis in the absence of PPARγ.  Although PPARγ is required to maintain the 
adipocyte in its differentiated state, it is not required to maintain PPARγ−dependent gene 
expression in mature adipocytes (Rosen and MacDougald, 2006). 
Glucose phosphate isomerase (GPI), the dimeric enzyme involved in the second 
step of glycolysis which catalyzes the reversible isomerization of glucose-6-phosphate to 
fructose-6-phosphate (Voet and Voet, 2004a), was significantly affected by depot (P < 
0.004).  RT-PCR indicated mRNA expression was down-regulated approximately three 
fold in the i.m. adipose tissue compared to the s.c. adipose tissue; which is opposite from 
what was reported at the end the GP (Stein et al., 2009, article in preparation).  Also, GPI 
mRNA expression had a tendency to be influenced by diet (P < 0.06) and was found to be 
greater in PF steers compared to WP steers, with SF and CF steers not significantly 
different from either the PF or WP steers.  Limitations in the GPI reaction or the 
phosphofructokinase (PFK) reaction could result in an increase in the glucose-6-phosphate 
level causing feedback inhibition of hexokinase possibly resulting in a lowerrate of 
glycolysis and a shift to fructose-6-phosphate being produced through the pentose 
phosphate pathway resulting in the generation of NADPH for biosynthetic processes such 
as fatty acid synthesis (Kugler and Lakomek, 2000; Voet and Voet, 2004c).  In ruminants, 
as much as 50 to 80% of NADPH needed for fatty acid synthesis in adipose tissue is 
produced by the pentose phosphate pathway (Vernon, 1981).  However, PFK in the 
microarray analysis was shown not to be differentially expressed between adipose tissue 
depots in respective diets.  The phosphofructokinase reaction is the rate-limiting step of 
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glycolysis that is highly regulated.  Pyruvate kinase (PK) catalyzes the last step in the 
glycolysis pathway, which is the dephosphorylation of phosphoenolpyruvate to pyruvate 
and is responsible for producing the second ATP generated within the glycolytic pathway 
(Voet and Voet, 2004a).  PK leads to either anaerobic fermentation or oxidative 
phosphorylation of pyruvate (Jurica et al., 1998) and can also serve as the control switch 
between the glycolysis and gluconeogenesis pathways in certain tissues (Voet and Voet, 
2004a).  PKM2 was significantly affected by depot (P < 0.001) and by diet (P < 0.04).  
PKM2 mRNA expression was up-regulated over 15 fold in the i.m. adipose tissue 
compared to s.c. adipose tissue.  PKM2 mRNA expression was greater in SF and PF steers 
compared to WP steers with CF steers not significantly different from either the SF and PF 
or WP steers.  PKM2 is one of four pyruvate kinase isoenzymes, M1, M2, L and R, with 
the M1 isoform being the only one of the four not allosterically controlled (Noguchi et al., 
1986; Mattevi et al., 1996; Christofk et al., 2008).  Mammalian PK is active as a tetramer 
of four identical or very similar subunits with a high affinity for the substrate, 
phosphoenolpyruvate.  The dimeric form of PK is characterized by a low affinity or 
phosphoenolpyruvate.  Fructose-1,6-bisphophate, the allosteric activator of PKM2, induces 
the inactive dimeric form to the active tetramer form.  PKM2 is the only PK isoform that 
binds phosphotyrosine peptides, which have the ability to release the allosteric activator, 
fructose-1,6-bisphophate, leading to the inhibition of the enzymatic activity of PKM2 
(Mattevi et al., 1996; Wooll et al., 2001; Christofk et al., 2008). 
The down-regulation of LDHB and genes involved in the synthesis, transport, and 
storage of fatty acids in i.m. adipose tissue along with the up-regulation of some glycolytic 
enzymes in i.m. adipose tissue of respective diets suggest that fatty acid and tr glyceride 
synthesis and transport is attenuated in i.m. adipose tissue compared with s.c..  Also, lactate 
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is a possible substrate for glycerogenesis for use in triglyceride synthe is in s.c. adipose 
tissue.  The rate of fatty acid synthesis, when either lactate or acetate was the precursor, 
was shown to be greater in subcutaneous adipose tissue than in intermuscular or 
intramuscular tissue (Whitehurst et al., 1981).  Furthermore, the contribution of lactate 
allowing for anaerobic metabolism in s.c. may permit the sparing of glucose for 
repartitioning as an energy substrate for i.m. adipose tissue.  Previous data reported by 
Smith and Crouse (1984) showed i.m. adipocytes to utilize g ucose as the primary substrate 
for fatty acid synthesis, whereas s.c. adipocytes utilized acetate and lactate incorporation 
into fatty acids.  However, without further investigation into other genes involved in the 
glycolytic pathway, pentose phosphate pathway, or in oxidative phosphorylation, it is 
difficult to speculate what implications this has on these metabolic pathways.   
In the present study, RT-PCR revealed four-and-a-half-LIM domains 1 (FHL1) 
expression to be up-regulated almost four fold in i.m. adipose tissue compared with s.c. 
adipose tissue.  FHL1 also had a tendency to be affected by diet where mRNA expression 
was greater in SF and PF steers compared to WP steers, with CF steers no  significantly 
different from SF, PF, or WP steers.  Although FHL1 is highly expressed in skeletal and 
cardiac muscle (McGrath et al., 2006), FHL1 has been shown to be expressed in bovine, 
porcine, and human adipose tissue (Wang et al., 2005a; vanBeek et al., 2007; Labrecque et 
al., 2009).  Although the exact function of FHL1 remains ambiguous, it does belong to a 
large family of LIM-proteins that function in cytoskeletal organization, cell lineage 
specification, the regulation of gene transcription, cell proliferation, cell differentiation and 
apoptosis (Bach, 2000; Kadrmas and Beckerle, 2004).  As FHL1 has been shown to be 
highly expressed in adipocytes and not preadipocytes, it could serve as a marker for 
adipocyte differentiation (vanBeek et al., 2007).  FHL1 has also been reported to interact 
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with receptor interacting protein of 140 kDa (RIP140), which itself is known to interact 
with estrogen receptor-α (Lin et al., 2009).  Recently, FHL1 and RIP140 were shown to 
synergistically inhibit the transcription of the estrogen response element of the pS2 gene, 
whose expression is restricted to breast cancer cells (Lin et al., 2009).  However, RIP140-
null mice have been shown to accumulate less fat in their adipose tissue and are resist nt to 
high-fat diet-induced obesity, and show improved glucose tolerance and insulin sensitivity 
(Leonardsson et al., 2004).  
Most economic relevant traits in the bovine are complex traits and are under the 
control of an interacting network of genes, each with a small effect, and the environment 
(Wu and Lin, 2006).  The present study clearly demonstrates that previous growing diet 
significantly influences gene expression in beef steers at the end of the subsequent finishing 
phase.  It was interesting to observe the similarities between the SF and Pdiets at the end 
of the FP as compared to WP and CF diets.  The top function from the respective list of the 
top ten molecular and cellular functions associated across all generated networks for the SF 
and PF diets of FP was lipid metabolism.  More so, SF and PF diets shared common 
functions for IPA generated network 1 which included lipid metabolism and molecular 
transport; network 2 which included lipid metabolism, carbohydrate metabolism and smll 
molecule biochemistry; and network 4 which included cellular assembly; cellular assembly 
and repair, and DNA recombination, recombination, and repair.  Days on feed were 104 for 
each the SF and PF steers compared to 123 d for WP steers.  Steers in the SF group had 
higher marbling scores compared with WP and CF steers, with PF steers being 
intermediate.  Yield grades were lower for WP and CF steers than for SF and PF steers.  
ADG during the FP was greater for steers in SF than PF and ADG for steers in PF was 
greater than steers in WP or CF.  The number of differentially expressed gen s was greatly 
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attenuated in the SF and PF steers compared to the WP and CF steers, as the number of 
differentially expressed genes in the WP steers was almost four times greater than SF steers 
(145 vs. 41), almost three times greater than PF steers (145 vs. 55), and almost twice the 
number as CF steers (145 vs. 82) (Table 4.2).  Also, 53 differentially expressed genes were 
exclusive to WP steers, with no differentially expressed genes exclusive to SF steers.  
These IPA identified genes along with their associated networks are presented in Tables 4.5 
through 4.7, respectively.  In five of the ten genes evaluated using RT-PCR, mRNA
expression was influenced by diet or a diet x depot interaction.  A similar pattern of 
expression was observed in the four genes influenced by diet.  Interestingly the SF and PF 
steers had greater mRNA expression than WP steers.  In order for beef quality to be 
improved, it is important to understand the effect of diet on the regulation of preadipocyte 
proliferation and differentiation in beef cattle as the accretion of adipose tissue is controlled 
by a balance of preadipocyte (hyperplasia) and differentiation (hypertro hy) (Wan et al., 
2009).  In vitro studies showed propionate had selective adipogenic effects on bovine i.m. 
preadipocytes and s.c. adipocytes as propionate contributed to the hypertrophy of 
adipocytes within i.m. adipose tissue and to the recruitment of new adipocytes in s.c. 
adipose tissue (Wan et al., 2009).  Propionate was also shown to induce the mRNA 
expression of PPARγ and C/EBPα in both i.m. preadipocytes and s.c. adipocytes (Wan et 
al., 2009).  
In conclusion, to our knowledge, the data presented is the first to use microarray 
analyses to evaluate the effect of different growing diets on adipose tissue depots at the end 
of the finishing period in beef steers.  The interactions between genes involved in adipocyte 
differentiation and diet differences still remain ambiguous.  However, IPA metabolic and 
signaling pathway analysis generated in this study has provided insight into possible 
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differences in the molecular mechanisms affecting development of i.m. and s.c. adipose 
tissue in beef steers at the end of the finishing phase managed under different growing
diets.  As genes outside the dataset known to interact with the differentially expressed 
genes observed in this study were included in the Ingenuity Pathway Analysis, elucidation 
of possible differences between diets and depots for future analysis is warranted, as these 
genes may not have been included in the adipose specific microarray used in this study.  
Further investigation and validation is needed to evaluate network genes not included in the 
microarray and discern the differences observed between diets in the fore-mentioned 
functional analyses (Figure 4.3) and a number of the metabolic (Figure 4.4) and signaling 
(Figure 4.5) pathways.  
In addition, over 35% of the 219 array elements that had significant matches in the 
NCBI databases could not be associated with any functional or biological annotation.  
However, despite these insufficiencies, gene expression profiling suggests differences in 
the metabolic activity between s.c. and i.m. adipose tissue between diets at the end of the 
FP.  The data presented indicates the metabolic machinery for adipose tissue accretion was 
down-regulated in the i.m. adipose tissue depot compared to s.c. adipose tissue depot and 
the main affect of previous diet can influence adipose tissue deposition at the end of the FP 
as HADH, GPI, PKM2, and FHL1 were influenced by diet with PTGS2 influenced by a 
diet x depot interaction.  When using gene expression profiling as a measurement of 
cellular function, one must keep in mind that mRNA expression levels do not always 
correspond to the translated protein levels or active protein in the cell and further 
investigation and validation is needed to evaluate the candidate genes that might be 
influenced by depot, diet or their interaction.  
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Table 4.1. Sequences, accession number, and melting temperatures of the bovine specific 
primers for the selected target genes of interest.  Accession number is from the 





























Primer Sequence  Size (bp) Tm used Product Size (bp) GenBank Accession
ACSM1 Forward AAGGAAACATTGGCATCAGG 20
Reverse AGTCCCCACATTCCACTTCA 20
CD36 Forward CAATGGAAAGGACGACATAAG 21
Reverse TGGAAATGAGGCTGCATCTGT 21
FABP4 Forward AAGCTGCACTTCTTTCTCACC 21
Reverse GACCACACCCCCATTCAAAC 20
FHL1 Forward GCAACAAGGGTTTGGTAAAGG  21
Reverse AGAGGGCAAGGACACAAGG 19
GPI Forward TGGGCATATTCTGGTGGACT 20
Reverse GACCTCTGGCATCACATCCT 20
HADH Forward TCCGTTTGAGCTTCTCGATT 20
Reverse CTTACAGGGCTTCGTCCTTG 20
LDHB Forward GCTGTGTGGAGTGGAGTGAA 20
Reverse ATACACGGAAGGCTCAGGAA 20
PKM2 Forward TTGGGTCGGGTAGTTCAGAG 20
Reverse ACAAAGGAAGGGAAGCAGGA  20
PTGS2 Forward ATGTATGAGTGTAGGATTTGACCAG 25
Reverse GGGAGTGGGTTTCAGGAGTAA 21
SCD Forward CCTGTGGAGTCACCGAACCT 20
Reverse TGTTGCCAATGATCAGGAAGAC 22 60 C 66 BP  AB075020.1 
55 C 210 bp XM_001787625
55 C 234 bp NM_174445.2
56 C 136 bp  XM_590109.4
62 C 197 bp NM_174314
56 C 287 bp NM_174100.1
56 C 227 bp BC102083.1
64 C 223 bp NM_001040471.1
62 C 102 bp BC109602.1
60 C 121 bp NM_174010
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Table 4.2. The number of differentially expressed up- and down-regulated genes in each of  
                 the functional categories in Initial and Wheat Pasture, Silage Fed, and Program  




Up Down Up Down Up Down Up Down
Adipose Related 5 10 0 10 0 10 1 12
Apoptosis/Cell Death 2 2 0 0 1 0 1 0
Binding 15 4 5 4 7 1 6 2
Carbohydrate Metabolism 3 1 2 0 3 0 3 1
Cell Growth/Differentiation 4 2 0 0 0 1 0 0
Cell Cytoskeletal/ Adhesion/ ECM Related 2 1 1 1 1 1 1 4
Hydrolase/Transferase/ Catalytic/Activity 2 1 0 1 0 1 0 1
Nucleic Acid Metabolism 2 0 0 0 0 0 0 1
Oxidative Phosphorylation 1 0 1 0 0 0 1 0
Oxidoreductase Activity 3 2 0 1 0 1 2 2
Protein Synthesis:Turn Over/AA Metabolism 2 4 1 2 0 3 2 5
Response to Stress/Stimuli 1 0 0 0 0 0 1 0
Signal Transduction 10 3 0 1 2 3 2 2
Transcription/Translation 6 4 0 1 1 2 3 3
Transporters 3 2 0 1 0 1 1 1
Other 29 28 1 8 4 12 8 16
90 64 11 30 19 36 32 50




Program        
FedSilage Fed Calf Fed
41 55 82
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Table 4.3. Comparison of mRNA expression (i.m. relative to s.c.) detected in the cDNA  
microarray analysis to mRNA expression detected in RT-PCR.  Fold change 






Diet  Microarray RT-PCR 
ACSM1 Calf Fed  -2.18 (±.11) -6.23 (±1.23) 
CD36 Wheat Pasture  -4.40 (±.47) -9.89 (±.58) 
FABP4 Wheat Pasture  -3.09 (±.28) -3.84 (±.46) 
FHL1 Program Fed  2.94 (±.18) 4.76 (±.55) 
GPI Calf Fed   2.11 (±.22) -2.77 (±.58) 
LDHB Calf Fed  -2.14 (±.69) -14.72 (±.15) 
PKM2 Program Fed  4.00 (±.47) 3.43 (±.79) 
SCD Program Fed  -5.13 (±.22) -21.40 (±.70) 








Figure 4.1.  
(a) Relative fold difference in acyl-CoA synthetase medium-chain family ember 1 
(ACSM1) gene expression in s.c. (green) and i.m. (red) adipose tissue depots in steers at 
the end of the Finishing Phase.  The gene expression level for the i.m. adipose tissue wa  
set as baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (P < 0.01).   
(b) Relative fold difference in CD36 molecule (thrombospondin receptor) (CD36) gene 
expression in s.c. (green) and i.m. (red) adipose tissue depots in steers at the end of th  
Finishing Phase.  The gene expression level for the i.m. adipose tissue was set as baseline 
and fold difference was calculated as described in Material and Methods.  Columns with 
different superscripts differ significantly (P < 0.02).   
(c) Relative fold difference in stearoyl-CoA desaturase (SCD) geneexpression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.001). 
 
(d) Relative fold difference in hydroxyacyl-Coenzyme A dehydrogenase (HADH) gene 
expression in Wheat Pasture, Silage-fed, Program-fed, and Calf-fed diets in steers at the 
end of the Finishing Phase.  The gene expression level for the Wheat Pasture diet was s t as 
baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (p < 0.09).    
 
(e) Relative fold difference in fatty acid binding protein 4 (FABP4) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.019). 
 
(f) Relative fold difference in prostaglandin-endoperoxide synthase 2 (PTGS2) gene 
expression in Wheat Pasture, Silage-fed, Program-fed and Calf-fed depot x diet in ste rs at 
the end of the Finishing Phase.  The gene expression level for the Wheat Pasture diet was 
set as baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (P < 0.09). 
 
(g) Relative fold difference in lactate dehydrogenase B (LDHB) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.05).   
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(a)                                                                    (b) 
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p < 0.09 
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Figure 4.1.   
 
(h) Relative fold difference in glucose phosphate isomerase (GPI) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.004).   
(i) Relative fold difference in glucose phosphate isomerase (GPI) gene expr ssion in Wheat 
Pasture, Silage-fed, Program-fed, and Calf-fed diets in steers at the end of the Finishing 
phase.  The gene expression level for the Wheat Pasture diet was set as baseline and fold 
difference was calculated as described in Material and Methods.  Columns with different 
superscripts differ significantly (P < 0.06). 
(j) Relative fold difference in pyruvate kinase, muscle (PKM2) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the s.c. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.0001).   
(k) Relative fold difference in pyruvate kinase, muscle (PKM2) gene expression in Wheat 
Pasture, Silage-fed, Program-fed and Calf-fed diets in steers at the end of the Finishing 
Phase.  The gene expression level for the Wheat Pasture diet was set as baline and fold 
difference was calculated as described in Material and Methods.  Columns with different 
superscripts differ significantly (P < 0.04).    
 
(l) Relative fold difference in four and a half LIM domains 1(FHL1) gene expression in s.c. 
(green) and i.m. (red) adipose tissue depots in steers at the end of the Finishing Phase.  The 
gene expression level for the s.c. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  Columns with different superscripts 
differ significantly (P < 0.03).   
(m) Relative fold difference in four and a half LIM domains 1(FHL1) gene expression in 
Wheat Pasture, Silage-fed, Program-fed, and Calf-fed diets in steers at the end of the 
Finishing Phase.  The gene expression level for the Wheat Pasture diet was set as baseline 
and fold difference was calculated as described in Material and Methods.  Columns with 
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p > 0.04p < 0.04 
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Table 4.4.  Principle Networks generated for Wheat Pasture, Silage-fed, Program-fed, and 
                   Calf-fed diets of the Finishing Phase using Inginuity Pathway Analysis.  Focus   
                   genes were overlaid into a globular molecular network deveolped from  
                   information contained in the IPA Knowledge Base.  Networks of these focus  












Molecules Top Network Molecular or Cellular Function, Disease or Disorder, or Physiological System Development and Function
1 45 23 Cellular Movement, Cellular Growth and Proliferation, Skeletal and Muscular System Development and Function
2 35 19 DNA Replication, Recombination, and Repair, Carbohydrate Metabolism, Cell Morphology
3 26 15 Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry
4 26 15 Carbohydrate Metabolism, Small Molecule Biochemistry, Cancer
5 24 14 Cell Morphology, Cellular Assembly and Organiztion, Cellular Compromise
6 21 13 Cell Cycle, Cellular Assembly and Organization, Cellular Function and Maintenance
7 15 10 Molecular Transport, RNA Trafficking, Cell Cycle
8 11 8 DNA Replication, Recombination, and Repair, Energy Production, Nucleic Acid Metabolism
1 39 18 Cardiovascular Disease, Lipid Metabolism, Molecular Transport
2 36 17 Carbohydrate Metabolism, Small Molecule Biochemistry, Lipid Metabolism
3 23 12 Cellular Compromise, Developmental Disorder, Embryonic Development
4 23 12 Cellular Assembly and Organization, Cell Cycle, DNA Replication, Recombination, and Repair
1 44 20 Cardiovascular Disease, Lipid Metabolism, Molecular Transport
2 28 14 Lipid Metabolism, Small Molecule Biochemistry, Carbohydrate Metabolism
3 25 13 Cell Cycle, Hair and Skin Development and Functio , Immunological Disease
4 16 9 Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair
1 34 17 Cardiovascular Disease, Cellular Growth and Prolife ation, Cellular Movement
2 34 17 Cellular Assembly and Organization, Cardiovascular Disease, Neurological Disease
3 26 14 Cellular Function and Maintenance, Cellular Movement, Hair and Skin Development and Function
4 24 13 Cellular Growth & Proliferation, Skeletal & Muscular System Development & Function, Connective Tissue Development & Function
5 24 13 Cell Cycle, Embryonic Development, Tissue Development
 
                
                Table 4.5.  Networks were generated for 
                                  Genes differentially expressed
                                              Genes highlighted in bold are
                                  in the network. 
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the Wheat Pasture diet of the Finishing Phase using Inginuity Pathway Analysis.
 only in the Wheat Pasture diet of the Finishing Phase are highlighted in yellow.
 focus genes.  Genes in regular print were used to connect to other genes  
 
 





                       Table 4.6. Networks were generated for 
                              Analysis.  Genes differentially expressed
                              in yellow.  Genes highlighted in bold are focus genes. Genes in regular print were used to connect to other       



















the Program-fed diet of the Finishing Phase using Inginuity Pathway 
 only in the Program-fed diet of the Finishing Phase are
 
 








                           Table 4.7. Networks were generated for 
                                  Genes differentially expressed
                                  Genes highlighted in bold are focus genes.
             in the network.          
 
 
     
165 
166
the Calf-fed diet of the Finishing Phase using Inginuity Pathway Analysis.
 only in the Calf-fed diet of the Finishing Phase are highlighted in yellow.






Figure 4.2. The top ten molecular and cellular functions associated with all generat d  
networks for the Wheat Pasture, Silage-fed, Program-fed, and Calf-fed diets 
of the Finishing Phase.  Threshold signifiacnce (P < 0.05) expressed as the  
negative log10 of the P-value calculated using the right-tailed Fischer’s exact 
test, is represented by the orange bar.  Numbers at top of each graph are the 
number of genes associated with that function. 




















             Figure 4.3. Comparative Functional Analysis of differentialy expressed genes comparing  
                                the Wheat Pasture, Silage-fed, Program-fed, and Calf-fed diets of the Finishing  
                                Phase.  Significance (P < 0.05), expressed as the negative log10 of the P-value  
        calculated for each function using the right- tailed Fischer’s exact test, is  
        represented by the orange bar.         
 
                     













              Figure 4.4. Metabolic pathway comparison between the Wheat Pasture, Silage-fed,  
                                 Program-fed, and Calf-fed diets of theFinishing Phase.  Significance (P < 0.10),  
                                 expressed as the negative log10 of the P-value calculated for each function using  
                     the right- tailed Fischer’s exact test, is represented by the orange bar. 
  










Figure 4.5. Signaling pathway comparison between 
                                Program-fed,
                                expressed as the negative log
                    using the right
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the Wheat Pasture, Silage
 and Calf-fed diets of the Finishing Phase.  Significance (P < 0.10), 
10 of the P-value calculated for each function
-tailed Fischer’s exact test, is represented by the orange bar.
 










Figure 4.6. Heat map of genes in the Adipose Related ontology category.  Boxes colored  
   with shades of red represent genes up-regulated in i.m. adipose tissue 
compared to s.c. adipose tissue and boxes with shades of green represent 
down-regulted genes in i.m. adipose tissue compared to s.c. adipose tissue.  
















Figure 4.7. Diagram of the KEGG Bovine PPAR signaling pathway.  Genes highlighted 
in red are those genes found differntiallyexpressed in at least one of the diets 

























Figure 4.8. Network 1 of theSilage-fed diet of the Finishing Phase depiciting genes  
involved in lipid metabolism and molecular transport.  Dataset was analyzed 
by the Ingenuity Pathways Analysis software.  Node color indicates the 
expression level of the genes; green = down-regulation in i.m. adipose tissue 
when compared to s.c. adipose tissue and red = up-regulated in i.m. when 







Figure 4.9. Network 1 of theProgram-fed diet of the Finishing Phase depiciting genes  
involved in lipid metabolism and molecular transport.  Dataset was analyzed 
by the Ingenuity Pathways Analysis software.  Node color indicates the 
expression level of the genes; green = down-regulation in i.m. adipose tissue 
when compared to s.c. adipose tissue and red = up-regulated in i.m. when 














Effects of the β−adrenergic agonist, zilpaterol hydrochloride, on gene expression 
in muscle and adipose tissue depots in beef steers 
 
D.R. Stein1, B.P. Holland1, C.R., Krehbiel1, G.G. Hilton1, D.L. VanOverbeke1, 
P.J. Ayoubi 2, and U.E. DeSilva1 
  





Microarray analysis, validated by RT-PCR, was utilized to investigate the 
effects of the β−adrenergic agonist, zilpaterol hydrochloride, on gene expression in 
i.m., s.c., and visceral adipose tissue depots and muscle tissue in beef steers. The β-
adrenergic agonist was fed for 20 d at the end of the feeding period with a 3-d 
withdrawal period.  Ninety-six crossbred beef steers were blocked by weight and 
randomly allocated into 16 pens (6 steers/pen).  Pens were assigned to treatmen s in a 
randomized complete block design.  Main effects were the addition of 0 (CON) or 8.3 
mg/kg zilpaterol hydrochloride (ZH; DM basis) to the finishing diet for 20 d before 
estimated average harvest date plus a 3-d withdrawal period prior to harvest.  
Individual BW was measured initially, 1 d prior to ZH feeding, and 1 d prior to harvest.  
At slaughter a 7.6 cm3 section was dissected from the Longissimus muscle between the 
12th and 13th rib, from which muscle tissue and s.c. and i.m. adipose tissue was 
collected.  Visceral adipose tissue was collected at the region of the pyloric sphincter.  
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Total RNA was extracted and microarray hybridizations performed.  The array 
contained a total of 24,000 oligonucleotide probes, 70 bases in length.  Annotation for 
the genes on the array can be downloaded from Bovine Oligo Microarray Consortium 
(BOMC) at www.bovineoligo.org.  Preprocessing and normalization of data was 
accomplished utilizing GenePix AutoProcessor (GPAP 3.2).  Ontology analysis wa  
carried out using GFINDer. Carcass data were collected at harvest.   
Average daily gain (ADG) was shown not to increase during the 20-d ZH 
supplementation plus 3-d withdrawal period or over the entire feeding period.  Dry matter
intake (DMI) and gain:feed (G:F) was not affected by ZH supplementatio  over the entire 
feeding period.  For the ZH supplementation plus 3 d withdrawal period, there was a 
tendency (P = 0.09) for DMI to be decreased by ZH supplementation.  Carcass adjusted 
G:F was greater (P = 0.009) and G:F had a tendency (P = 0.08) to be greater in ZH-
supplemented steers.  Carcass merit at the end of the 3-d withdrawal showed hot carcass 
weight (HCW), dressing percentage and Longissimus muscle (LM) area to be greater in 
ZH-supplemented steers.  No other significant differences in carcass characteristics were 
observed.  No array elements were found to be differentially expressed (DE) between the 
CON steers and ZH-supplemented steers in the i.m., s.c., and visceral adipose tissue 
depots or muscle tissue when the following criteria for significant differential expression 
were used; array elements where greater than 50% of the total features across arrays were 
used to calculate the average log2 ratio; a ‘t’ > 2 (regardless of sign); an M-value > +0.9 
or < -0.9 (representing a fold change of  > 1.87 or < -1.87); and an adjusted P-value < 
0.01.  Of the eight genes selected for validation by RT-PCR in respective tissues and the 
six selected as genes of interest in respective tissues, CYC1 and βAR2 in i.m. adipose 
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tissue and βAR1 in s.c. adipose tissue were shown not to support the results of the 
microarray analysis.  RT-PCR revealed CYC1, βAR1 and βAR2 mRNA expression to be 
up-regulated three fold, four fold and four fold, respectively, in steers supplemented with 
ZH. 




The pursuit to optimize the response of β-adrenergic agonists (β-AA) and to 
define their effects on feed efficiency and carcass composition in the various livestock 
species has been an ongoing and a well documented undertaking since the early 1980’s.  
β-adrenergic agonists can be defined as “organic molecules” which bind the β-adr nergic 
receptor (β-AR) such that the agonist-receptor complex activates the stimulatory G-
protein (Gs protein) (Mersmann, 1998), a member of the superfamily of regulatory GTP-
ases that are collectively known as G-proteins (Voet and Voet, 2004d).  Cattle and sheep 
seem to have a greater response to β-AA compared to swine, while poultry appear to be 
the least responsive (Moody et al., 2000).  However, feeding β-AA to cattle, pigs, 
poultry, and sheep has resulted in an increase in muscle mass and a decrease in fat mass 
(Mersmann, 2001; Sillence, 2004), as β-adrenergic agonists seem to act by increasing the 
efficiency of growth by preferentially stimulating skeletal muscle growth as compared to 
adipose tissue.  In general, this repartitioning affect is thought to be brought about by an 
increase in protein synthesis, a decrease in muscle protein degradation or a combination 
of both or by the release of free fatty acids from adipose tissue, which then could be used 
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as a source of energy for protein synthesis (muscle mass) (Ricks et al., 1984, Mersmann, 
2001; Sillence, 2004, Baxa, 2008; Chung and Johnson, 2008).   
The β-AA is effective only for a limited period of time as the efficacy of 
adrenergic agonists can be altered by desensitization caused by the continuous expos re 
of the β- adrenergic receptor to the β-AA (Hausdorff et al., 1990b; Lynch and Ryall, 
2008).  There are three mechanisms of desensitization.  The first, the functional 
uncoupling of the β-AR from Gs, involves the phosphorylation of the β-AR which occurs 
very rapidly (usually within seconds or minutes) when agonist exposure occurs and 
decreases the β-AR affinity for the agonist, and is considered a completely reversible 
process (Mills, 2002b; Badino et al., 2005).  The second mechanism is physical 
sequestration of the receptor away from the cell surface by targeting the receptor for 
internalization where the receptor can be either targeted for degradation or recycled back 
to the plasma membrane (Gurevich and Gurevich, 2006; Moore et al., 2007).  β-AR 
sequestration is a reversible process which is not a significant mechanism underlying 
rapid desensitization (Hausdorff et al., 1990a; Yu et al., 1993).  The third is down-
regulation of the total number of receptors (Yu et al., 1993; Mills, 2002b; Badino et al., 
2005).  Down-regulation develops more slowly, taking hours or days to occur, with the 
decline in binding sites related to potency and efficacy of the agonist.  Down-regulation 
of the β-AR is not rapidly overcome and is slower to overcome than the event of 
uncoupling (Mills, 2002b).  However, following down-regulation, transcription and 
translational processes are required to restore membrane receptor numbers (Johnson, 
2006b).  Though an abundance of information regarding β-AR desensitization and down-
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regulation exists in the literature, the body of information about the regulation of β-AR 
synthesis is somewhat lacking (Lynch and Ryall, 2008).  
Different species of animals seem to have different responses to β-AA 
(Mersmann, 1995, 1998) as a particular β-AA may not activate the target β-AR or the 
target tissue as well in one species as another.  This may involve differences in th  
number of receptors in the tissue, the agonist affinity towards the receptor, the coupling 
of the agonist-receptor complex to the signal transduction system, the differences in 
delivery of the agonist to the receptor site, the differences in agonist or receptor 
deactivation, or the β-AR subtype may change with the phase of differentiation or the 
hormone environment of the cell (Mersmann, 1998).  β2-AR is the primary receptor 
(75%) found in bovine adipose tissue as compared to β1-AR (25%) (Van Liefde et al., 
1994).  β2-AR was also reported as the primary receptor in perirenal adipose tissue and 
the Longissimus muscle (Sillence and Matthews, 1994).  Messenger RNA of all three β-
AR subtypes has been shown to be expressed in bovine adipose tissue; however, β3-AR 
mRNA expression was very small or undetectable in animals after three months of age 
(Casteilla et al., 1994; Van Liefde et al., 1994).  The β2-AA zilpaterol hydrochloride (ZH) 
has a greater affinity for the β2-AR subtype receptor compared to the β1-AR subtype but 
is capable of binding both the β1-AR subtype (Ki = 1.0 x 10-5) and β2-AR subtype (Ki = 
1.1 x 10-6) receptor (Verhoeckx et al., 2005).   
Baxa (2008) hypothesized ZH supplementation could possibly alter the 
expression of myosin isoforms.  Myosin, the most abundant protein present in striated 
muscle cells, is one of the major proteins involved in protein synthesis, constituting 
approximately 25% of the total protein pool (Baldwin and Haddad, 2001).  The four 
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major myosin heavy chain (MHC) isoforms found in adult mammalian skeletal muscles 
are MHC type I; slow fiber type and MHC type II, and fast fiber type, IIA (MYH2), 
IIX/D (MYH1), and IIB (MHY4) (Schiaffino and Reggiani, 1994; Pette and Staron, 
2000)  
Zilmax® (Intervet/Schering-Plough Animal Health, Millsboro, DE) is a synthetic 
β2-AA used for increased rate of weight gain, improved feed efficiency, and increased 
carcass leanness in cattle fed in confinement for slaughter (Dikeman, 2007; Kern et al., 
2009) and contains the active ingredient zilpaterol hydrochloride.  In 2006, ZH was 
approved by the U.S. Food and Drug Administration (FDA) as a feed ingredient for catle 
during the last phase of the feeding period to improve production efficiency but it has 
been used since the 1990’s in Mexico and South Africa (Avendano-Reyes et al., 2006).  
Zilmax is administered through the feed the last 20 to 40 days of the feeding period at 
levels of 60 to 90 mg/animal/d and is required to be withdrawn 3 d prior to harvest.  In 
2008, the FDA approved ZH for use in cattle feeds in five different combinations with 
MGA® (melengestrol acetate), Rumensin® (monensin, USP), and Tylan® (tylosin 
phosphate).  Zilpaterol residue levels in cattle have been below the threshold that poses 
any human health risk (Moody et al., 2000; Anderson et al., 2004), which are 0.02, 0.05, 
0.10, and 0.10 ppm for muscle, liver, kidney, and fat, respectively (Intervet, Inc. 2006). 
Currently, no data in the literature addresses the global pattern of gene expression 
in i.m., s.c., visceral, adipose tissue depots and muscle tissue in ZH-supplemented cattle, 
which may give insight into the mechanism(s) of action of βAA.  The purpose of the 
present study was to investigate, using microarray analysis validated by RT-PCR, the 
effects of the β−AA, ZH, on gene expression in i.m., s.c., and visceral adipose tissue 
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depots and muscle tissue in beef steers fed for 20 days at the end of the feeding p riod 
with a 3-d withdrawal. 
 
Methods and Materials 
Animals and Treatment Groups  
Ninety-six crossbred beef steers were blocked by weight and randomly allocated 
into 16 pens (6 steers/pen).  Pens were assigned to treatments in a randomized complte 
block design.  Steers were implanted with Zeranol (Ralgro, Schering-Plough Animal 
Health, Kenilworth, NJ) and adapted to an 88% concentrate diet over a 21-d period, at 
which time they were program-fed to gain 1.13 kg/d (NRC, 2000) for a period of 78 d.  
Following the preconditioning/growing period, steers were weighed and reimplanted with 
Revalor S (120 mg of trenbolone acetate and 24 mg of estradiol; Intervet) and assiged to 
treatment pens.  Steers were then fed for either 95 or 123 d before ZH supplementation. 
Main effects were the addition of 0 (CON) or 8.3 mg/kg zilpaterol hydrochloride (ZH; 
DM basis) supplemented for 20 d at the end of the feeding period plus a 3-d withdrawal 
period prior to harvest.  Steers were initially fed 2% (as-fed) of initial BW a 75% 
concentrate ration and “stepped up” to a final total mixed ration over 16 d, feeding the 
75% concentrate ration and an 85% concentrate ration for seven days each.  The final 
finishing ration contained 94% concentrate.  The final finishing diet, CON, (Table 5.2) 
was formulated to meet or exceed NRC (1996) requirements and contained monensin and 
tylosin at 33.06 mg/kg and 9.92 mg/kg, respectively, on a 90% DM basis.  The final diet 
fed to the ZH pens was identical to the CON, with the exclusion of monensin and tylosin
and the addition of zilpaterol HCl.  The animal whose final BW was closest to the pen 
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average from each pen assigned to the CON and ZH treatments, was selected for 
intensive sampling at slaughter.  These animals were loaded in the evening and hauled 
less than 5 km to the Robert M. Kerr Food & Agricultural Products Center abattoir 
(FAPC), located on the campus of Oklahoma State University, Stillwater, OK for harvest. 
 
Sample Collection and RNA Extraction  
At slaughter, steers were stunned with captive bolt and exsanguinated.  Following 
exsanguination, a 7.6 cm3 section was dissected from the Longissimus muscle between 
the 12th and 13th rib, from which muscle tissue and s.c. and i.m. adipose tissue was 
collected.  Visceral adipose tissue was collected at the region of the pyloric sphincter.  
The i.m. adipose tissue was placed in 50 ml conical vials containing RNAlater® 
(Applied Biosystems/Ambion, Austin, TX) until further separation using an Olympus 
SZ30 stereomicroscope (9x - 40x zoom range).  All other tissues were frozen at -80º C.  
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). The tissue, 
in TRIzol, was homogenized and centrifuged at 3,500 x g at 4º C for 15 min to separate 
insoluble material and excess fat.  The lower aqueous (TRIzol) phase was transferred to a 
fresh tube and 0.2 ml chloroform/ml of TRIzol was added.  Samples were centrifuged at 
3,500 x g at 4º C for 30 min and the upper aqueous phase was transferred to a fresh tube.  
Isopropyl alcohol (0.5 ml/ml of TRIzol) was added and samples were maintained at -20º
C overnight followed by centrifugation at 3,500 x g at 4º C for 10 min.  The supernatant 
was removed and the RNA pellet washed with 75% chilled ethanol and suspended in 
DNase/RNase free water.  A subsequent phenol:chloroform:isoamyl alcohol (25:24:1; pH 
5.2) extraction of the RNA (1:1 ratio, respectively) was carried out.  The 
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RNA/phenol:chloroform:isoamyl alcohol mixture was centrifuged at 10,600 x g at 4º C 
for 5 min and the upper aqueous phase was transferred to a fresh tube and precipitated 
with 0.01 volumes of sodium acetate (3M; pH 5.2) and 2.5 volumes of chilled 98% 
ethanol.  The samples were then maintained at -20º C overnight and centrifuged at 10,600 
x g at 4º C for 30 min.  The supernatant was removed and the RNA pellet was washed 
with 70% chilled ethanol and suspended in DNase/RNase free water and stored at -80º C.  
The integrity of the RNA was analyzed utilizing gel electrophoresis (1.5%) and the RNA 
was quantified using a NanoDrop® ND-100 Spectrophotometer (NanaDrop 
Technologies, Willington, DE).  
 
Microarray Experiment  
A bovine oligo array designed by the Bovine Oligonucleotide Microarray 
Consortium was used in this study (Elsik et al. 2006) containing a total of 24,000 
oligonucleotide probes, 70 bases in length, which were printed in singlet on the slide.  
The array included 16,846 probes designed from ESTs that were aligned to homologous 
vertebrate proteins and to the 6X bovine genome assembly (BGA).  The probe set was 
supplemented with oligos designed from 703 predicted RefSeq genes, 5,943 reproductive 
tissue ESTs with a BGA but no protein alignment, and 504 positive and negative 
controls.  The following criteria were used in EST selection and probe design: 1) 
predicted constitutive exon, 2) polymorphism avoidance, 3) minimal distance to 3' end of 
protein coding region, and 4) optimal Tm and specificity.  Probe sequences and 
annotations are available at http://www.bovineoligo.org. 
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Global amplification (Nygaard and Hovig, 2006) of mRNA in this experiment 
was accomplished using the TargetAmp™ 1-Round Aminoallyl-aRNA Amplification Kit 
101 (Epicentre® Biotechnologies, Madison, WI).  The poly(A) RNA component of total 
RNA (500 ng) from each the reference sample (CON) and test sample (ZH) was reversed 
transcribed into first strand cDNA in separate tubes using oligo-dT primers and reverse 
transcriptase (Superscript III RT, Invitrogen, Carlsbad, CA).  The reaction was carried 
out at 50º C for 30 min.  The RNA fragments, produced from the cDNA:RNA hybrid 
using RNase H, were used to prime the second strand cDNA synthesis reaction carried 
out at 65º C for 10 min.  Aminoallyl anti-sense RNA (AA-aRNA) was then produced 
during the subsequent in vitro transcription reaction at 42º C for 4 h where 5-(3-
aminoallyl)-UTP was partially substituted for the UTP nucleotide.  The AA-aRNA was 
then purified using the Qiagen RNeasy Mini Kit (Qiagen Inc., Valencia, CA) and eluted 
with 20 ul of DNase/RNase free water.  The reference and test AA-aRNA (12.5 ul) was 
then coupled with a 15 ul aliquot of Invitrogen’s succinimidyl ester Alexa Fluor 546 and 
647 dyes (Molecular Probes Inc., Eugene, OR), respectively, in separate tubes along with 
3 ul of 1M sodium bicarbonate buffer, pH 9.0.  One vial of Alexa Fluor dye was 
resuspended in 150 ul of dimethylsulfoxide (DMSO) and divided into aliquots of 15 ul 
and stored at -80º C.  This coupling reaction was allowed to continue for 1 h in the dark 
at room temperature.  To quench the coupling reaction, 3 µl of 100 mM Tris-HCl, pH 8.0 
was added to the mixture.  The dye-labeled AA-aRNA was then purified using the 
Qiagen RNeasy Mini Kit (Qiagen Inc., Valencia, CA) and eluted with 25 ul of 
DNase/RNase free water.  The concentration of the AA-aRNA was determined using a 
NanoDrop® ND-100 Spectrophotometer (NanaDrop Technologies, Willington, DE).  
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Fold amplification of the reaction was calculated using the assumption that the Poly (A) 
RNA constitutes approximately 1% of the RNA in the total RNA.  For each sample, the 
total picomoles of Alexa Fluor 546 and 647 dye incorporation (pmol/µg) was also 
calculated.  For hybridizing the Alexa Fluor dye-labeled AA-aRNA to the array, the 
hybridization solution (80 ul) consisting of: 20.0 µl of dye-labeled AA-aRNA of each the 
Alexa Fluor™ 546 and Alexa Fluor™ 647; 40.0 µl of 2X formamide-based hybridization 
buffer was denatured at 65º C for 10 min and deposited to a pre-hybridized array slide 
under a 24 x 60 mm lifterslip (Erie Scientific, Portsmouth, NH).  The array was then 
incubated at 42º C for 18 h in a humidified hybridization cassette.  Following incubation 
the lifterslip was allowed to wash off in a 2X Sodium Chloride/Sodium Citrate (SSC) 
/0.2% sodium dodecyl sulfate (SDS) solution prewarmed to 42º C. The array slides were 
then washed in 2X SSC/0.2% SDS, 42º C,15 min; 2X SSC, RT,15 min; and 0.2X SSC, 
RT, 15 min.  Following the final wash, the array slide was immediately dried for 2 min
using a slide centrifuge and stored in a light-proof container until image acquisition. 
 
Microarray Data Analysis 
To compare zilpaterol hydrochloride supplemented animals (Alexa 647) relative 
to control animals (Alexa 546) in respective adipose and muscle tissues, hybridization 
signals were captured by scanning the microarray slides with lasers at two wavelengths, 
Alexa 546 and Alexa 647, using a ScanArray™ Express confocal laser scanner 
(PerkinsElmer Life Sciences Inc., Boston, MA) at a pixel size resolution of 10 microns 
with the resulting images saved as 16 bit TIFF images.  For each slide, the laser power 
and photomultiplier tube (PMT) gain were adjusted to minimize variation between 
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channels.  Using a local background subtraction method (spots with foreground intensity 
minus background intensity), the commercial software package GenePix™ Pro 4.0 (Axon 
Instruments Inc., Union City, CA) was used to analyze the signal intensity values of each 
feature (spot) in the Alexa Fluor™ 546 and Alexa Fluor™ 647 channels.  The GenePix 
Pro Result (GPR) files generated from the results of the image analysis from each 
biological and technical replication were used for further downstream analysis nd ratio 
calculations.  Preprocessing and normalization of data was accomplished utilizing the R-
project statistical environment (http://www.r-project.org) with the Bioconductor and 
LIMMA packages (http://www.bioconductor.org) through the GenePix AutoProcessor 
(GPAP 3.2) website (http://darwin.biochem.okstate.edu/gpap32/) (Weng and Ayoubi, 
2004).  Background correction was performed using Robust Multi-array Average (RMA) 
algorithm (Allison et al., 2006) available in the Bioconductor/LIMMA package.  
Following background correction, poor quality features were removed by filtering.  Such 
poor quality features were defined as features displaying an intensity value of 200 
relative fluorescence units (RFU) or less in both the Alexa Fluor™ 546 and Alexa
Fluor™ 647 channels, as well as features flagged bad, not found, or absent by GenePix™ 
Pro 4.0 and were removed from the analysis.  Two different normalization methods were 
utilized in the analysis to adjust and balance for the technical or systemic variation 
between the features within an array and between arrays for differences not caused by 
treatment.  Lowess (locally weighted Least squares regression) - global intensity 
normalization, was used to balance the variation associated with dye bias within eac  
array (Yang et al., 2001; 2002).  To balance the effect of the Alexa Fluor™ 546 and 
Alexa Fluor™ 647 dye bias intensity between arrays, quantile normalization was utilized 
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(Bolstad et al., 2003).  Following data preprocessing, the expression ratio for each feature 
(gene) was calculated using the following formula where a two-fold change is 
represented by a log2 ratio >1.0 (up-regulation) or < -1.0 (down-regulation) with M value 
(log2 expression ratio) = log2 (F647-B647intensity /F546-B546intensity).  Using GPAP 3.2, a 
moderated T-test was used to identify the differentially expressed array elements along 
with their M value (log2 ratio), their P-value obtained from the moderated t-statistic after 
false discovery rate (FDR) adjustment using the Benjamini and Hochberg method 
(Benjamini and Hochberg, 1995), and the number of individual features (log2 ratio) used 
for each gene.  Array elements where > 50% of the total features across array  was used 
to calculate the average log2 ratio, a |t| > 2, an M-value |M|> +0.9 (representing a fold 
change of 1.87), and an adjusted P-value < 0.01 were considered significantly 
differentially expressed and included for further analysis using the Genome Functional 
Integrated Discoverer (GFINDer) (http://www.medinfopoli.polimi.it/GFINDer/) and 
Entrez Gene (http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene). 
 
Gene Ontology Analysis  
The web based program GFINDer (Masseroli et al., 2004) was used in this study 
and is a program designed to retrieve annotations for a list of submitted genes, perform
categorization, and present the results for use in gene ontology and pathway analysis.  
Entrez Gene is the National Center for Biotechnology Information (NCBI) database for 
gene-specific information (Maglott et al., 2005, 2007).  The Entrez gene ID of the 
differentially expressed genes retrieved from NCBI was used for the ontology analysis.  
The annotation terms were generated with emphasis based on gene ontology assessment 
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for molecular function and biological process rather than cellular component (Ashburner 
et al., 2000). 
 
Quantitative RT-PCR Validation of Microarray 
 Validation of the expression values comparing ZH-supplemented animals (Alexa 
647) relative to control animals (Alexa 546) in i.m., s.c., and visceral adipose tissu
depots and muscle tissue generated from the microarray experiment was carried out using 
two-step SYBR green qRT-PCR.  Gene specific primers for candidate genes s lected for 
microarray data validation were designed using Primer 3 (Rozen and Skaletsky, 2000) 
and analyzed using Oligo Analyzer 3.1 (Integrated DNA Technologies), 
http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/.  All primer sequences, 
annealing temperatures and product size are presented in Table 5.1.  
Total RNA (1 ug) from the i.m., s.c., visceral adipose tissues and muscle tissue 
from each individual animal from CON and ZH supplementation was reverse transcribed 
using the QuantiTect® Reverse Transcription Kit (QIAGEN Inc., Valencia, CA) using 
oligo-dT and random primers in a total volume of 20 ul. RT- PCR reactions were carried 
out, in duplicate, utilizing a MyiQ Real-Time PCR detection system (Bio-Rad 
Laboratories, Hercules, CA) in a 15 ul reaction consisting of: 7.5 ul of 2X PerfeCTa™ 
SYBR Green SuperMix for iQ™ (Quanta BioSciences, Inc. Gaithersburg, MD), 400 nM 
forward primer, 400 nM reverse primer and 100 ng of cDNA.  18S ribosomal RNA was 
assayed as a normalization control for all samples assayed.  A standard curve with five 
serial dilution points was included for each gene along with a no-template control.  
Thermal cycling conditions were 95º C for 2.5 min followed by 35 repetitive cycles of 
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95º C for 15 s, variable annealing temperature for 30 s, and 72º C for 30 s. Immediately 
following RT-PCR, a melt curve analysis was conducted by bringing the reaction to 95º 
C for 1 min, 55º C for 1 min, then increasing the temperature by 0.5º C from 55º C to 
94.5º C.  Gene expression between depots for the diet and phase selected for validation 
was evaluated using the comparative CT method.  A cycle threshold (CT) value was 
assigned to each reaction at the beginning of the logarithmic phase of the PCR 
amplification.  A ∆CT value was calculated for each sample by subtracting the mean 18S 
∆CT value of each sample from the corresponding gene of interest mean ∆CT value 
(Livak and Schmittgen, 2001).  The ∆∆CT was calculated by setting the highest mean 
∆CT value as an arbitrary constant to subtract from all other
 mean ∆CT depot values 
(Hettinger et al., 2001).  Relative expression levels between the control and ZH treatment 
were calculated as fold changes, where each cycle of the PCR represented a two-fold
change.  The assay specific efficiency for each gene was not used in the calculation of the 
relative expression levels.  Fold change (FC) gene expression was calculated using the 
formula: FC = 2 −∆∆CT. 
 
Quantitative RT-PCR Analysis for Selected Genes 
The adrenergic beta-1-receptor (βAR1), adrenergic beta-2-receptor (βAR2), and 
adrenergic beta-3-receptor (βAR3) genes in the i.m., s.c., and visceral adipose tissue 
depots and MHC type II; fast fiber type IIA (MYH2) and IIX/D (MYH1) and calpastatin 
(CAST) genes in muscle tissue were measured for mRNA expression between CON and 
ZH supplementation using quantitative RT-PCR and analyzed using the comparative CT 
method.  The ∆∆CT was calculated by setting the highest mean ∆CT value as an arbitrary 
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constant to subtract from all other mean ∆CT depot values (Hettinger et al., 2001).  
Relative expression levels between the CON and ZH supplementation were calculated as 
fold changes, where each cycle of the PCR represented a two-fold change.  Fold change 
(FC) gene expression was calculated using the formula: FC = 2 −∆∆CT.  The ∆CT values 
were analyzed by analysis of variance (ANOVA) and means were compared using the 
Least squares means (LSMEANS) of PROC MIXED of SAS 9.1.3 (SAS Institute Inc, 
Cary, North Carolina). 
 
Statistical Analysis for Performance and Growth 
Data were analyzed as a completely randomized block design, with pen 
considered the experimental unit.  There were two weight blocks with 4 pens/treatment in 
each weight block.  Least squares means were calculated using the MIXED procedure of 
SAS.  The dietary inclusion of ZH was the fixed effect and weight block was included as 
a random effect. 
 
Results 
Performance and Carcass Merits  
Average daily gain (ADG) was not increased by ZH supplementation plus 3 d 
withdrawal period or over the entire feeding period (Table 5.3).  However, carcass 
adjusted ADG was greater for ZH-supplemented steers than for CON steers (P < 0.02) 
from the time of ZH supplementation to end of withdrawal, with gains of 1.89 and 1.42 
kg/d, respectively. In addition, there was a tendency (P < 0.06) for ZH supplementation to 
increase carcass adjusted ADG over the entire feeding period with gains of 1.71 and 1.60 
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kg/d, respectively, for ZH supplementation and CON.  From the time of ZH 
supplementation to end of withdrawal, there was a tendency (P < 0.09) for DMI to be 
decreased in ZH-supplemented steers (9.42 kg/d) compared with CON steers (9.93 kg/d) 
while carcass adjusted G:F was greater (P < 0.009) in ZH-supplemented steers (0.202 
kg/hd) than CON steers (0.143 kg/hd) (Fig. 5.3).  The unadjusted G:F had a tendency (P 
< 0.08) to be greater in ZH-supplemented steers (0.187 kg/kg) compared with CON steers 
(0.143 kg/kg).  DMI and G:F were not affected by ZH supplementation over the entir 
feeding period in the present study; however, carcass adjusted G:F was greater in ZH-
supplemented steers (0.179 kg/kg) compared with CON steers (0.166 kg/kg) (Table 5.3).   
Carcass merit at the end of the three day withdrawal showed hot carcass weight 
(HCW) to be greater (P < 0.005) in ZH-supplemented steers than CON steers, 374 kg/d 
vs. 360 kg/d, respectively.  Dressing percentage was greater (P < 0.05) for ZH-
supplemented steers than CON steers, 64.46% and 63.57%, respectively.  Longissimus 
muscle area was greater (P < 0.02) in ZH-supplemented steers than CON steers, 93.95 cm 
vs. 89.68 cm, respectively.  No other significant differences in carcass characteristics 
were observed (Table 5.4). 
 
Microarray and Ontology Analysis 
 No array elements were shown to be differentially expressed (DE) between the 
CON steers and ZH-supplemented steers in the i.m., s.c., and visceral adipose tissue 




Quantitative RT-PCR Validation of Microarray 
Even though no array elements were shown to be significantly differentially 
expressed between the CON steers and ZH-supplemented steers in the i.m., s.c., and 
visceral adipose tissue depots or muscle tissue using our stringent criteria; two genes, one 
up-regulated and one down-regulated, from each the i.m., s.c., and visceral adipose
tissues and muscle tissue were selected for microarray validation when the level of 
significance was placed at P-value < 0.05.  In i.m. adipose tissue, the microarray analysis 
did not find cytochrome C-1 (CYC1) or tumor necrosis factor receptor superfamily, 
member 1B (TNFRSF1B) to be differentially expressed between the CON and ZH-
supplemented steers (data not shown).  However, RT-PCR analysis of i.m. adipose tissue 
revealed CYC1 mRNA expression (Figure 5.1a) to be up-regulated threefold in ZH-
supplemented steers compared with CON steers.  TNFRSF1B was shown not to be 
significantly affected by ZH supplementation (Figure 5.1b).  In s.c. adipose tissu , heat 
shock 70kDa protein 4 (HSPA4) and SAPS domain family, member 1 (SAPS1) were not 
shown to be differentially expressed in the microarray analysis (data not shown).  RT-
PCR analysis revealed HSPA4 mRNA expression with a tendency (P < 0.09) (Figure 
5.1c) to be up-regulated in the ZH-supplemented steers compared with CON steers.  
SAPS1 was shown not to be significantly affected by ZH supplementation (Figure 5.1d).  
Angiotensin II receptor, type 1 (AGTR1) and SH3 domain binding glutamic acid-rich 
protein like 3 (SH3BGRL3) in the visceral adipose tissue and S-adenosylhomocysteine 
hydrolase (AHCY) and deoxyguanosine kinase (DGUOK) in muscle tissue were not 
differentially expressed in the microarray analysis (data not shown).  RT-PCR analysis 
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confirmed mRNA expression for AGTR1, SH3BGRL3, AHCY, and DGUOK not to be 
significantly influenced by ZH supplementation (Figures 5.1e-h). 
 
Quantitative RT-PCR Analysis for Selected Genes of Interest  
The microarray analysis did not reveal adrenergic β-1-receptor (βAR1), 
adrenergic β-2-receptor (βAR2), and adrenergic β-3-receptor (βAR3) genes in the i.m., 
s.c., and visceral adipose tissue depots and muscle tissue or the MHC type II; fast fiber 
type IIA (MYH2) and IIX/D (MYH1) and calpastatin (CAST) genes in muscle tissue to 
be differentially expressed between the CON steers and ZH-supplemented steers (data 
not shown).  RT-PCR analysis indicated that βAR1 mRNA expression was not influenced 
by ZH supplementation in the i.m. (Figure 5.1i) or visceral (Figure 5.1k) adipose tissue.  
However, in the s.c. adipose tissue, RT-PCR revealed βAR1 mRNA expression to be up-
regulated fourfold (P < 0.01; Figure 5.1j) in ZH-supplemented steers vs. CON steers.  
βAR1 mRNA expression in muscle tissue was detected in only two of the six animals of 
each the CON and ZH-supplemented treatment groups and no further statistical nalysis 
was performed.  
RT-PCR revealed βAR2 mRNA expression to be significantly affected by 
treatment in the i.m. adipose tissue (P < 0.006; Figure 5.1l) with nearly a fourfold g eater 
expression level in ZH-supplemented steers than CON steers.  βAR2 mRNA expression 
was not significantly influenced by ZH supplementation in the s.c. (Figure 5.1m)and 
visceral (Figure 5.1n) adipose tissue depots or the muscle tissue (Figure 5.1o).  
RT-PCR revealed that βAR3 was not significantly influenced by ZH 
supplementation in i.m. (Figure 5.1p) or visceral (Figure 5.1q) adipose tissue.  Underthe 
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RT-PCR parameters utilized in the experiment, βAR3 mRNA expression was detected in 
s.c. adipose tissue and muscle tissue in all ZH-supplemented-steers but in only two steers 
in the CON group and no further statistical analysis was performed.  RT-PCR revealed 
that MHC type II; fast fiber type IIA (MYH2) and IIX/D (MYH1) and calpastatin 
(CAST) mRNA expression were not significantly influenced by ZH supplementation in 
muscle tissue (Figures 5.1r, 5.1s, and 5.1t, respectively).  
 
Discussion 
Effect of Zilpaterol Hydrochloride on Carcass Characteristics 
In the present study, ZH supplementation did not increase ADG during the 20 d 
ZH supplementation plus 3-d withdrawal period or over the entire feeding period.  These 
findings are not in agreement with previous studies as ADG was increased 0.19 kg/d in 
steers supplemented with ZH for 30 d plus 5-d withdrawal (Montgomery et al., 2009b).  
Furthermore, Avendano-Reyes et al. (2006) reported an increase in ADG of 0.56 kg/d 
during ZH supplementation for 33 d plus 3 d withdrawal period, and an increase of 0.52 
kg/d was observed by Plascencia et al. (1999) for steers supplemented with ZH for 42 d 
plus 2-d withdrawal with an increase of 0.16 kg/d reported for the average of ZH-
supplemented for 20, 30, or 40 d with a 3-d withdrawal (Vasconcelos et al., 2008).  
Montgomery et al. (2009a) reported increases of 0.40 kg/d in steers and 0.215 kg/d in 
heifers for the average of ZH-supplemented for 20 and 40 d with a 5-d withdrawal.  More 
so, Baxa (2008) reported an increase in ADG of 0.11 kg/d over the entire 91 d feeding 
period which included the ZH supplementation of 30 d plus 3-d withdrawal period.  In 
the present study, when calculated using carcass adjusted final BW, ZH supplementation 
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significantly increased ADG by 0.47 kg/d during the ZH supplementation and 3 d 
withdrawal period and tended to increase ADG by 0.11 kg/d over the entire feeding 
period. 
ZH supplementation has been shown to affect DMI and G:F in different ways.  
During the ZH supplementation plus 3-d withdrawal period in the present study, G:F had 
a tendency to be greater (29%) and the carcass adjusted G:F was 41% greater in ZH-
supplemented steers compared with the CON steers with a tendency for DMI to be 
decreased by 6% by ZH supplementation.  Plascencia et al. (1999) and Avendano-Reyes 
et al. (2006) reported a 28% and 11% greater G:F, respectively, in ZH-supplemented 
steers with no differences in DMI observed.  Similarly, Baxa (2008) reported a 6.8% 
greater G:F in ZH-supplemented steers with no difference in DMI over a 91 d feeding 
period which included the ZH supplementation and 3-d withdrawal.  Montgomery et al. 
(2009b) reported a 15% greater G:F and a 3.5% decrease in DMI in ZH-supplemented 
steers.  Montgomery et al. (2009a) reported a 28% greater G:F in steers with a tendency 
for DMI to be decreased (2.3%) in the average of ZH-supplemented for 20 and 40 d with 
a 5-d withdrawal; while in heifers, a 21.2% greater G:F for ZH supplementation was 
reported with a 6% decrease in DMI.  Furthermore, Vasconcelos et al. (2008) reported a 
15% greater G:F for the average of ZH-supplemented for 20, 30, or 40 d and a linear 
increase in G:F was observed from d 20 to d 40 of ZH supplementation; also, a linear 
decrease in DMI was observed from d 20 to d 40 of ZH supplementation. 
In the present study, ZH supplementation for 20 d with a 3-d withdrawal period 
increased HCW 14 kg, Longissimus muscle area by 4.27 cm and dressing percentage by 
0.89 percentage units.  Previous studies have reported similar increases in HCW, dressing 
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percentage and Longissimus muscle area in carcasses from cattle supplemented with ZH 
compared to non-supplemented controls.  Montgomery et al. (2009b) and Plascencia et 
al. (1999) reported increases in HCW of 13 kg, respectively, in steers supplemented with 
ZH with Montgomery et al. (2009b) reporting increases in Lo gissimus muscle area of 
7.95 cm and dressing percentage of 1.2 percentage units and Plascencia et al. (1999) 
reporting an increase in dressing percentage of 2.2 percentage units with a tendency for 
Longissimus muscle area to be increased by 2.2 cm.  More so, Avendano-Reyes et al. 
(2006) reported increases in HCW of 21.9 kg, Longissimus muscle of 8.48 cm, and 
dressing percentage of 2.01 percentage units in ZH-supplemented steers.  Vasconcelo  et 
al. (2008) reported an average increase of 17.2 kg in HCW, 9.56 cm in Longissimus 
muscle area, and 1.9 percentage units in dressing percentage when ZH was fed for 20, 30, 
or 40 d.  Montgomery et al. (2009a) reported an average increase in HCW of 16.45 kg in 
steers supplemented for 20 or 40 d, with the length of ZH supplementation affecting 
Longissimus muscle area and dressing percentage as increases in Long ssimus muscle 
area of 7.9 and 8.6 cm and dressing percentage of 1.13 and 1.8 percentage units were 
observed for ZH-supplemented steers for 20 and 40 d, respectively.  In heifers, the length 
of ZH supplementation affected HCW, Longissimus muscle area, and dressing percentage 
as HCW was increased 11 and 13 kg, Longissimus muscle area was increased 5.8 and 6.9 
cm, and dressing percentage increased 1.5 and 1.6 was percentage units for ZH-
supplemented for 20 and 40 d, respectively.  Baxa (2008) reported increases in HCW of 
21 kg, Longissimus muscle area of 11.9 cm, and dressing percentage of 2.37 percentage 
units over a 91-d feeding period, which included a 30-d ZH supplementation and 3 d 
withdrawal period. 
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ZH supplementation has also been shown to affect %KPH, marbling score, and 
12th rib fat in different ways.  In the present study, no differences in %KPH, marbling 
score or 12th rib fat were observed.  Similar findings were reported by Plascencia et al. 
(1999) and Avendano-Reyes et al. (2006) who observed no differences in %KPH and 
marbling score.  However, Plascencia et al. (1999) reported no differences in 12th r b fat 
while Avendano-Reyes et al. (2006) reported a 0.29 cm decrease in 12th rib fat.  ZH 
supplementation decreased marbling score 46.5 degrees for the average of ZH-
supplemented for 20 and 40 d in steers, with a tendency for marbling score to be 
decreased in heifers (Montgomery et al., 2009a).  No differences were observed in 
%KPH and 12th rib fat in steers or heifers.  Montgomery et al. (2009b) reported that 
feeding ZH decreased %KPH by 0.07%, marbling score by 24 degrees, and 12th rib fat by 
0.095 cm.  Vasconcelos et al. (2008) reported a decrease in %KPH of 0.10% for the 
average of ZH supplementation for 20, 30, and 40 d, and a linear decrease in %KPH 
observed from d 20 to d 40 of ZH supplementation.  Also, a reduction in marbling score 
of 44 degrees was observed along with 12th rib fat reduced by 0.22 cm for the average of 
ZH supplementation for 20, 30, and 40 d.  A linear decrease in 12th rib fat was also 
observed from d 20 to d 40 of ZH supplementation.  Baxa (2008) reported decreases in 
%KPH of 0.16%, decreases in marbling score of 29.75 degrees, and decreases in 12th rib 
fat of 0.14 cm over a 91 d feeding period which included the ZH supplementation and 3-d 
withdrawal period.   
β-AA seem to act by increasing the efficiency of growth by preferentially 
stimulating skeletal muscle growth as compared to adipose tissue.  This repartitioning 
affect is thought to be brought about by an increase in protein synthesis, a decrease in 
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muscle protein degradation or a combination of both or also by the release of free fatty 
acids from adipose tissue, which then could be used as a source of energy for amino acids 
(muscle mass) (Baxa, 2008; Chung and Johnson, 2008).  The greater G:F observed in the 
ZH-supplemented animals could possibly, to a degree, be due to the decreased DMI with 
similar or increased ADG.  In studies where no changes in DMI were observed and no 
changes in %KPH, marbling or 12th rib fat were observed, it is possible, ZH 
supplementation increased carcass protein accretion and improved performance by 
improving the efficiency by which nutrients are converted to gain.  In studies wh re no 
changes in DMI were observed and decreases in %KPH, marbling or 12th rib fat were 
observed, a decrease in fat synthesis and/or an increase in fat degradation with a 
repartitioning of nutrients could have resulted in increased muscle accretion; when the 
ratio of lean to fat deposition is improved, so is feed conversion efficiency (Sillence, 
2003)  This is supported, in part, by Greife et al. (1989), where the β-AA, clenbuterol, 
decreased perirenal fat in rats and when administered to rats of different initial BW 
resulted in greater weight gains in the heavier weight rats; possibly a result of an increase 
in protein deposition from energy that was released through the mobilization of body fat 
stores caused by clenbuterol.  Dressing percentage can increase as live weight increases 
and/or as fat depth increases.  In the present study, carcass adjusted live weight was 
increased in ZH-supplemented steers with no changes in %KPH, marbling score or 12th 
rib fat between CON and ZH-supplemented steers observed.  As β-A  have been shown 
to increase blood flow in cattle (Byrem et al., 1998), β-AA may have an indirect effect on 
muscle hypertrophy by increasing the nutrient availability to specific tissues or the 
increased blood flow may allow for non-esterified fatty acids to be carried away from 
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adipose tissue increasing lipid degradation (Mersmann, 1998).  Also, Page et al. (2004) 
reported a significant increase in apoptosis in epididymal and parametrial adipose tissue 
in rats treated with different β-AA, suggesting the activation of β-AR’s can trigger the 
apoptotic process in adipocytes.  Furthermore, β-AR signaling has been implicated in the 
apoptotic process in other tissues such as heart and skeletal muscle; however, ther is 
deliberation over whether apoptosis is promoted or inhibited in these tissues (Lynch and 
Ryall, 2008). 
 
Microarray Analysis and RT-PCR Analysis for Selected Genes  
Amplified RNA has been shown to generate highly reliable microarray expression 
data of comparable quality to data generated by microarray methods that use non-
amplified mRNA samples (Jenson et al., 2003).  RT-PCR is commonly used to confirm 
the gene expression results obtained from microarray analysis.  However, no standard 
definition of validation exists and microarray and RT-PCR data often result in 
disagreement (Morey et. al., 2006).  In the present study using the TargetAmp™ 1-Round 
Aminoallyl-aRNA Amplification Kit 101 (Epicentre® Biotechnologies, Madison, WI), 
no array elements were shown to be differentially expressed (DE) between CON and ZH-
supplemented steers in the i.m., s.c., and visceral adipose tissue depots or muscle tiss e.  
By adjusting the level of significance to P < 0.05, eight genes were selected for validation 
using RT-PCR in respective tissues and six genes were selected as genes of interest.  
Only CYC1 and β2-AR in i.m. adipose tissue and β1-AR in s.c. adipose tissue did not 
support the results of the microarray analysis.  RT-PCR revealed CYC1, β1-AR and β2-
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AR mRNA expression to be up-regulated threefold, fourfold and fourfold in ZH-
supplemented steers vs. CON, respectively.  
Phenothalamines developed for use in the livestock industry target the β1- and β2- 
subtype receptors (Moody et al., 2000).  The distribution of the receptor subtypes depends 
on tissue type with the β1-AR subtype and β2-AR subtype co-expressed in most tissues 
with the ratio of these subtypes varying according to tissue type.  The β3-AR subtype has 
a more limited pattern of expression, but is found in both white and brown adipose tissue 
(Mills, 2002a).  The β2-adrenergic agonist ZH has a greater affinity for the β2-AR subtype 
receptor compared to the β1-AR subtype but is capable of binding both the β1-AR (Ki = 
1.0 x 10-5) and β2-AR subtype (Ki = 1.1 x 10-6) receptor (Verhoeckx et al., 2005).  In the 
present study, β1-AR, β2-AR, and β3-AR were selected as genes of interest as mRNA of 
all three β-AR subtypes has been shown to be expressed in bovine adipose tissue; 
however, β3 -AR mRNA expression has been reported to be very small or undetectable in 
animals after three months of age (Casteilla et al., 1994).  More so, Van Liefde et al. 
(1994) reported β2-AR as the primary receptor (75%) compared to β1-AR (25%) in 
bovine (calf) adipose tissue with both involved in lipolysis and the atypical β−AR (β3-
AR) not present.  However, mRNA of all three β-AR subtypes has been shown to be 
expressed and involved in the regulation of lipolysis in dairy cattle (Sumner and 
McNamara, 2007).  β3-AR is the strongest of the three subtypes in its ability
 to induce 
lipolysis and the β2-AR is the weakest of the three subtypes in its ability to
 induce 
lipolysis, while the β1-AR subtype is intermediate to the β3-AR and β2-AR subtypes
 
(Sumner and McNamara, 2007).  In Holstein steers, in vitro basal lipolytic rates, 
expressed as pmol glycerol released per mg protein,  were greatest in s.c. adipose tissue 
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compared to omental, perirenal and intermuscular adipose tissue (Rule et al., 1992).  β2-
AR was also reported as the primary receptor in perirenal adipose tissue and the
Longissimus muscle in bovine (Sillence and Matthews, 1994).  Transcript mRNA for β1-
AR, β2-AR, and β3-AR were present in adipocytes of porcine (McNeel and Mersmann, 
1995) and in adipocytes in humans (Seydoux et al., 1996).  β1-AR and β2-AR were 
reported to comprise nearly 95% of the β-AR in swine adipocytes with β1-AR 
representing 80% of the total β-AR (McNeel and Mersmann, 1999) and the primary 
subtype mediating lipolysis (Mills et al., 2003).  However, β2-AR was reported to be the 
predominately expressed receptor in muscle while in the adipocyte, β1-AR and β2-AR 
were reported to be expressed in almost an equal percentage (Spurlock et al., 1994; 
Sillence et al., 2005). 
In the present study, the distribution of the receptor subtypes varied between 
tissue types as RT-PCR analysis indicated β1-AR mRNA expression not to be 
significantly influenced by ZH supplementation in i.m. or visceral adipose tissue depots; 
however, β1-AR mRNA expression in the s.c. adipose tissue was up-regulated in ZH-
supplemented steers vs. CON steers.  β2-AR expression in i.m. adipose tissue was up-
regulated in ZH-supplemented steers vs. CON steers with β2-AR mRNA expression not 
influenced by ZH supplementation in the s.c. and visceral adipose tissue.  β3-AR mRNA 
expression was not influenced by ZH supplementation in i.m. or visceral adipose tissue 
with β3-AR mRNA expression detected in s.c. adipose tissue of ZH-supplemented steers 
and in only two steers in the CON group.  Also, the increased mRNA levels may not have 
been the magnitude needed to initiate the signaling cascade to bring about lipolysis as no 
changes in %KPH, marbling score, or 12th rib fat between CON and ZH-supplemented 
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steers were observed.  ZH may be weakly binding its respective receptors on respective 
tissue types triggering only the synthesis of new protein, thus the observed increase in 
respective mRNA expression.  It is unclear from the data whether β1-AR was triggering a 
response only in s.c. adipose tissue and β2-AR only in i.m. adipose tissue as in some 
studies, the β-AA is only effective for a limited period of time as the efficacy of β-AA 
can be altered by desensitization caused by the continuous exposure of the β-AR to the β-
AA (Hausdorff et al., 1990b; Lynch and Ryall, 2008).   
The increased growth in muscle tissue reported with the use of ZH in other studies 
may be through mechanisms associated with changes in the expression levels of β-AR.  
However, in Longissimus muscle of the present study, β1-AR mRNA expression was 
detected in only two of the six steers in the CON and ZH-supplemented groups, while β2-
AR mRNA expression was detected in all steers of CON and ZH-supplemented groups, 
although ZH supplementation did not influence mRNA expression.  β3-AR mRNA 
expression was detected only in ZH-supplemented steers.  Similarly, Rathmann et al. 
(2009) reported no effects of ZH supplementation on β1-AR or β2-AR mRNA in 
semimembranous muscle in steers fed 0, 20, 30, or 40 d plus 3-d withdrawal; however, a 
tendency for a linear increase in β2-AR mRNA expression as DOF increased was 
observed.  These results contradict other findings in the literature.  For exampl , Baxa 
(2008) reported no effects of ZH supplementation on β1-AR in semimembranous muscle 
of steers supplemented with ZH over a 91-d feeding period, which included a 30-d ZH 
supplementation and 3-d withdrawal period.  However, mRNA expression of β2-AR was 
significantly increased with levels nearly 1,000 times greater than β1-AR.  β3-AR mRNA 
expression was not reported in the study.  The addition of ZH to proliferating myoblasts, 
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in vitro, resulted in decreased mRNA in β1-AR, β2-AR, and β3-AR levels (Miller et al., 
2009).  In addition, Walker et al. (2007) reported β1-AR, β2-AR, and β3-AR mRNA levels 
present in Longissimus muscle and semimembranous muscle of steers supplemented with 
ractopamine for 28 d; however, β1-AR and β2-AR mRNA expression was decreased by 
ractopamine supplementation in the Longissimus muscle with no affect on β3-AR mRNA 
levels.  Winterholler et al. (2007) reported the most abundant β-AR mRNA in 
semimembranous muscle of finishing steers supplementation with ractopamine the last 28 
d on feed was β2-AR; ractopamine supplementation had no effect on the
 abundance of β1-
AR or β3-AR mRNA, but tended to increase β2-AR mRNA.  Similar to Winterholler et al. 
(2007), Sissom et al. (2007) reported that ractopamine had no effect on β1-AR mRNA 
expression in heifers supplemented with ractopamine the last 28 d on feed; however, 
there was a tendency for ractopamine supplementation to increase expression of β2-AR 
mRNA expression.  In Longissimus muscle of beef steers, Winterholler et al. (2008) 
reported ractopamine tended to increase (P = 0.09) the abundance of β1-AR mRNA, but 
did not affect β2-AR or β3-AR.   
In the present study, MHC type II, fast fiber type IIA (MYH2) and IIX/D 
(MYH1), and calpastatin (CAST) were selected as genes of interest even though the 
microarray analysis did not reveal them to be differentially expressed in Longissimus 
muscle tissue.  Baxa (2008) hypothesized ZH supplementation could possibly alter the 
expression of myosin isoforms.  The four major myosin heavy chain (MHC) isoforms 
observed in adult mammalian skeletal muscles are MHC type I, slow fiber type and MHC 
type II, fast fiber type, IIA (MYH2), IIX/D (MYH1), and IIB (MHY4) (Schiaffino and 
Reggiani, 1994; Pette and Staron, 2000).  As Baxa (2008) and Rathmann et al. (2009) 
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reported that MHC-I mRNA expression was not influenced by ZH supplementation and 
Chikuni et al. (2004) was not able to detect MHC type IIB (MHY4) in bovine skeletal 
muscle, they were not evaluated in the present study.  RT-PCR revealed MHC type II,
fast fiber type IIA (MYH2) and IIX/D (MYH1) mRNA expression were not significantly 
influenced by ZH supplementation in the Longissimus muscle tissue.  These findings do 
not agree with Baxa (2008) where ZH supplementation increased MHC-IIX (MYH1) 
mRNA expression while MHC-IIa (MYH2) mRNA expression had a tendency to be 
decreased in semimembranous muscle.  Similarly, Rathmann et al. (2009) reported a days 
on feed (DOF) x ZH duration interaction in MHC IIA (MYH2) and IIX (MYH1).  MHC 
IIA (MYH2) expression was decreased by ZH supplementation within the 177 and 198 
DOF groups.  MHC IIX (MYH1) expression was increased in the 20-d ZH group within 
the 157 DOF group and the 40-d ZH group within the 177 and 198 DOF groups. 
In pigs fed ractopamine for 42 d, MHC IIA (MYH2) and IIX (MYH1) fiber types were 
decreased while MHC IIB (MYH4) fiber type, the fastest and most glycolyti  fiber type, 
was increased.  In contrast, MHC IIA (MYH2) and IIX (MYH1) fiber types were 
increased in control pigs (Depreux et al., 2002).   
In studies where lambs (Pringle et al., 1993) and steers (Wheeler and 
Koohmaraie, 1992) were fed the β-AA, L644,969  the modification of muscle growth was 
closely related to the activity of the calpain-calpastatin system.  In steers supplemented 
with 3 ppm of the β-AA, L644,969, for 6 wk, Wheeler and Koohmaraie (1992) reported 
higher calpastatin activity in muscle from the β-AA-fed steers at 0 and 7-d postmortem 
than control steers.  Furthermore, in steers supplemented with the β-AA cimaterol, 
calpastatin mRNA and calpain II large subunit mRNA was increased 96% and 30%, 
 205
respectively, vs. nonsupplemented steers (Parr et al., 1992).  In the current study, RT-
PCR revealed calpastatin (CAST) mRNA expression not significantly influenced by ZH 
supplementation in the Longissimus muscle tissue.  These findings are in agreement with 
Baxa (2008), as CAST mRNA expression was not altered by ZH supplementation in 
semimembranous muscle.  Rathmann et al. (2009) reported similar findings as CAST 
mRNA expression was not altered by ZH supplementation in semimembranous muscle; 
however, a tendency for a linear decrease in CAST mRNA expression as ZH duration 
increased and an increase in CAST mRNA expression as DOF increased was observed. 
The Freedom of Information Summary for Zilmax (Intervet, Inc. 2006), indicates 
when cattle were fed 0.15 mg/kg BW (or 6.8 g/ton in the diet) of 14C-zilpaterol, levels of 
total residues (unchanged zilpaterol and the major metabolite, deisopropyl-zilpaterol) in  
muscle and fat after a 12 hr withdrawal to be 19±2.1 and 9.2 ppb, respectively.  Levels at 
the 24 hr withdrawal were 11±2.3 ppb and non-detectable (ND), respectively.  Levels at 
the 48 hr and 96 hour withdrawal were nondetectable in muscle and fat.  Stachel et al. 
(2003) reported similar findings when 0.15 mg of ZH per kg body weight was fed for 14 
days.  After a one day withdrawal, zilpaterol concentrations in muscle were 6.93 ug/kg 
(ppb) and after a ten day withdrawal were 0.01 ug/kg (ppb).  In sheep fed 0.15 mg of ZH 
per kg body weight for 10 d, muscle residues after a 0, 2, 5, and 9-d withdrawal were 
13.3, 0.86, 0.12, and 0.08 ng/g (ppb), respectively (Shelver and Smith, 2006).  As the 
minimum concentration of ZH, or its metabolic products, in adipose tissue and muscle 
tissues to elicit a positive growth response is unclear and the ability to detect βAR 
expression due to ZH supplementation after withdrawal periods greater than 3 d is 
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uncertain, further investigation into the mechanisms of action of ZH supplementation is 
warranted.  
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Table 5.1. Sequences, accession number and melting temperatures of the bovine specific 
primers for the selected target genes of interest.  Accession number is from the 








Primer Sequence Size (bp) Tm used Product Size (bp) GenBank Accession
BAR1 Forward ACGCTCACCAACCTCTTCAT 20
Reverse CACACAGGGTCTCAATGCTG 20
BAR2 Forward GGGGCTGCTATGTTTTGATG 20
Reverse AAATAAGAGGGGCGAGGAGA 20
BAR3 Forward GGTTGCCTTTCTTTGTGGTC 20
Reverse GTAGATGAGCGGGTTGAAGG 20
MYH1 Forward GCTCCTAATCACCACCAACC 20
Reverse TCAGCAACTTCAGTGCCATC 20
MYH2 Forward GCTGCGTCTTCTCACTTGGT 20
Reverse CCACCTTCTCTGCTCTGGAT 20
CAST Forward GGAAGCAGATCCAGAAGACG 20
Reverse GACAGAGCATCGAGGAGGAC 20
TNFRSF1B Forward GCAGGAATGAAGCCCAGTTA 20
Reverse ACCAAGACAGGACCCATCAG 20
CYC1 Forward CCAGGTAGCCAAGGATGTGT 20
Reverse CTTTCGGCTCTTGAGGACTG 20
SAPS1 Forward ATCTGAAGGGAGCAGAGTGG 20
Reverse AGCTGAAAGGTCGAGTGTGG 20
HSPA4 Forward GGCTTGCATTTCTTTTGGAC 20
Reverse TTGGATTTTTCTGCCTCCAC 20
SH3 Forward CTGTAAGCCCCCTCTTCTCC 20
Reverse AATCAACAAAGGTGCCCATC 20
AGTR1 Forward ATCCTCTGTCGTCCCCTTCT 20
Reverse GAGATCCAACCAGTCCATCC 20
AHCY Forward AGCCCATGCACTTTACCATC 20
Reverse GAGCATTCAAACACCCACAG 20
DGUOK Forward CCAGTGCTCGTGTTGGATGT 20
Reverse TGGGTGGCTTGGTATTTTCT 20
58 C 151 bp NM_001034315
58 C 171 bp NM_001014888
153 bp61 C NM_001034763
55 C 174 bp NM_174233
61 C 187 bp XM_870871
58 C 150 bp XM_001790383
205 bp NM_00104049061 C




















Table 5.2.  Ingredient and nutrient composition of experimental diets (DM basis) 
 
 Treatment1 
Item Control ZH 
Ingredient   
 Dry rolled corn 68.5 68.5 
 Corn DDGS 16.0 16.0 
 Ground alfalfa hay 6.0 6.0 
 Liquid supplement2 5.0 5.0 
 Control dry supplement3 4.5 - 
 ZH dry supplement4 - 4.5 
   
Nutrient composition5   
 DM, % 81.7 82.6 
 CP, % 14.6 14.0 
 ADF, % 7.4 8.7 
 NDF, % 16.9 17.1 
 Ca, % 0.59 0.55 
 P, % 0.38 0.36 
Zilpaterol HCl, mg/kg  None Detected 7.476 
 
1Zilpaterol hydrochloride diet was formulated to contain 7.50 mg/kg (90% DM basis) 
of zilpaterol hydrochloride (Intervet/Schering-Plough, DeSoto, KS). 
2Synergy 19/14 (Westway Feed Products, New Orleans, LA). 
3Pelleted supplement contained the following (DM basis): 44.44% ground corn, 15.68% 
wheat middlings, 28.89% limestone, 5.33% salt, 2.22% magnesium oxide, 0.07% 
manganous oxide, 2.44% potassium chloride, 0.13% zinc sulfate, 0.07% vitamin A 
(30,000 IU/g), 0.05% vitamin E (50%), 0.42% Rumensin 80 (Elanco Animal Health, 
Indianapolis, IN), and 0.25% Tylan 40 (Elanco Animal Health). 
4Pelleted supplement contained the following (DM basis): 44.73% ground corn, 15.68% 
wheat middlings, 28.89% limestone, 5.33% salt, 2.22% magnesium oxide, 0.07% 
manganous oxide, 2.44% potassium chloride, 0.13% zinc sulfate, 0.07% vitamin A 
(30,000 IU/g), 0.05% vitamin E (50%), and 0.39% zilpaterol hydrochloride premix 
(Intervet). 
5All values are from laboratory analyses and are presented on a 100% DM basis (except 
DM). 
6Determined from the average of three samples (approximately 20 kg; collected June 
18, 2007) dispensed from a Roto-Mix 184-8 mixer (Roto-Mix, Dodge City, KS) after 
25%, 50%, and 75% of the batch had been fed.  From the large samples, 4 sub-samples 
were analyzed for zilpaterol HCl content (Intervet Pharmaceutical Laboratory, 




Table 5.3. Effect of Zilpaterol hydrochloride supplementation (30 d plus 3 d withdrawal) 
on performance of steers. 
 
Item Control ZH S.E.M. Probability 
BW, kg     
Initial 357.0 356.0 19.14 0.17 
Final 566.0 577.0 5.62 0.19 
Carc. Adj. BW 565.0 579.0 4.65 0.05 
Performance, ZH to end     
ADG, kg/d 1.43 1.77 0.164 0.17 
Adj. ADG, kg/d 1.42 1.89 0.186 0.02 
DMI, kg/d 9.93 9.42 0.201 0.09 
G:F, kg/kg 0.144 0.187 0.017 0.08 
Carc. Adj. G:F, kg/kd 0.143 0.202 0.021 0.009 
Performance, d 0 to end     
ADG, kg/d 1.60 1.69 0.045 0.19 
Adj. ADG, kg/d 1.60 1.71 0.044 0.06 
DMI, kg/d 9.62 9.54 0.197 0.72 
G:F, kg/kg 0.167 0.177 0.005 0.15 




Table 5.4. Effect of Zilpaterol hydrochloride supplementation (30 d plus 3 d withdrawal) 
on carcass characteristics of steers. 
 
Item Control ZH S.E.M. Probability 
HCW, kg  359.50 373.60 3.027 0.005 
Dressing % 63.57 64.46 0.324 0.056 
LM area, cm 89.68 93.95 1.812 0.02 
12th-rib fat, cm 1.24 1.25 0.103 0.96 
KPH, % 1.90 1.91 0.230 0.87 
Marbling 37.15 37.45 0.956 0.83 
Preliminary YG 3.19 3.15 0.077 0.69 
Adj. preliminary YG 3.22 3.23 0.101 0.96 
Calculated YG 2.66 2.58 0.234 0.57 
USDA YG 2.24 2.14 0.094 0.41 
Skeletal maturity 70.04 72.42 4.818 0.31 
Lean maturity 62.04 63.38 9.722 0.64 
Overall maturity 67.38 69.04 5.824 0.38 







Figure 5.1.  
(a) Relative fold difference in cytochrome C-1 gene expression in control (green) and 
zilpaterol treatment (red) i.m. adipose tissue depots in steers at the end of the Finishing 
Phase.  The gene expression level for control i.m. adipose tissue was set as baseline and 
fold difference was calculated as described in Material and Methods.  Columns with 
different superscripts differ significantly (P < 0.002).   
(b) Relative fold difference in tumor necrosis factor receptor superfamily, ember 1B 
gene expression in control (green) and zilpaterol treatment (red) i.m. adipose t ssue 
depots in steers at the end of the Finishing Phase.  The gene expression level f r
zilpaterol treatment i.m. adipose tissue was set as baseline and fold difference was 
calculated as described in Material and Methods.  No significant difference was observed 
between control and zilpaterol treatment (P < 0.26).   
(c) Relative fold difference in heat shock 70kDa protein 4 gene expression in control 
(green) and zilpaterol treatment (red) s.c. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for control s.c. adipose tissue wa s t as 
baseline and fold difference was calculated as described in Material and Methods.  No 
significant difference was observed between control and zilpaterol treatment (P < 0.09).   
(d) Relative fold difference in SAPS domain family, member 1 gene expression in control 
(green) and zilpaterol treatment (red) s.c. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for control s.c. adipose tissue wa s t as 
baseline and fold difference was calculated as described in Material and Methods.  No 
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Figure 5.1.   
(e) Relative fold difference in angiotensin II receptor, type 1 in control (g een) and 
zilpaterol treatment (red) visceral adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for control visceral adipose tissue was set as 
baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (P < 0.002). 
(f) Relative fold difference in SH3 domain binding glutamic acid-rich protein like 3 gene 
expression in control (green) and zilpaterol treatment (red) visceral adipose tissue depots 
in steers at the end of the Finishing Phase.  The gene expression level for the control 
visceral adipose tissue was set as baseline and fold difference was calculated as described 
in Material and Methods.  No significant difference was observed between control and 
zilpaterol treatment (P < 0.21).   
(g) Relative fold difference in S-adenosylhomocysteine hydrolase gene expression in 
control (green) and zilpaterol treatment (red) LM depots in steers at the end of the 
Finishing Phase.  The gene expression level for control muscle depot was set as baseline 
and fold difference was calculated as described in Material and Methods.  No significant 
difference was observed between control and zilpaterol treatment (P < 0.75).  
(h) Relative fold difference in deoxyguanosine kinase gene expression in control (green) 
and zilpaterol treatment (red) LM depots in steers at the end of the Finishing P ase.  The 
gene expression level for the zilpaterol treatment muscle depot was set as baseline and 
fold difference was calculated as described in Material and Methods.  No significant 
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Figure 5.1.   
 
(i) Relative fold difference in adrenergic, beta-1- receptor expression in control (green) 
and zilpaterol treatment (red) i.m. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control i.m. adipose tissue wa  set as 
baseline and fold difference was calculated as described in Material and Methods.  No 
significant difference was observed between control and zilpaterol treatment (P < 0.27). 
   
(j) Relative fold difference in adrenergic, beta-1- receptor gene expression in control 
(green) and zilpaterol treatment (red) s.c. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control s.c. adipose tissue was set as 
baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (P < 0.01).   
 
(k) Relative fold difference in adrenergic, beta-1- receptor gene exprssion in control 
(green) and zilpaterol (red) visceral adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control visceral adipose tissue was set 
as baseline and fold difference was calculated as described in Material nd Methods.  No 
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Figure 5.1.   
 
(l) Relative fold difference in adrenergic, beta-2- receptor gene expression in control 
(green) and zilpaterol treatment (red) i.m. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control i.m. adipose tissue wa  set as 
baseline and fold difference was calculated as described in Material and Methods.  
Columns with different superscripts differ significantly (P < 0.006). 
   
(m) Relative fold difference in adrenergic, beta-2- receptor gene expression in control 
(green) and zilpaterol treatment (red) s.c. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control s.c. adipose tissue wa  set as 
baseline and fold difference was calculated as described in Material and Methods.  No 
significant difference was observed between control and zilpaterol treatment (P < 0.10).   
 
(n) Relative fold difference in adrenergic, beta-2- receptor gene exprssion in control 
(green) and zilpaterol treatment (red) visceral adipose tissue depots in steers at the end of 
the Finishing Phase.  The gene expression level for the control visceral adipose tissue was 
set as baseline and fold difference was calculated as described in Material and Methods.  
No significant difference was observed between control and zilpaterol treatment (P < 
0.55).  
 
(o) Relative fold difference in adrenergic, beta-2- receptor (green) and zilpaterol 
treatment (red) muscle depots in steers at the end of the Finishing Phase.  T e gene 
expression level for the control muscle depot was set as baseline and fold difference was 
calculated as described in Material and Methods.  No significant difference was observed 
between control and zilpaterol treatment (P < 0.72). 
   
(p) Relative fold difference in adrenergic, beta-3- receptor gene expression in control 
(green) and zilpaterol treatment (red) i.m. adipose tissue depots in steers at the end of the 
Finishing Phase.  The gene expression level for the control i.m. adipose tissue was s t as 
baseline and fold difference was calculated as described in Material and Methods.  No 
significant difference was observed between control and zilpaterol treatment (P < 0.41).   
 
(q) Relative fold difference in adrenergic, beta-3- receptor gene exprssion in control 
(green) and zilpaterol treatment (red) visceral adipose tissue depots in steers at the end of 
the Finishing phase.  The gene expression level for the control visceral adipose tissue was 
set as baseline and fold difference was calculated as described in Material and Methods.  
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Figure 5.1.   
 
(r) Relative fold difference in myosin heavy chain 1 (green) and zilpaterol tr atment (red) 
muscle depot in steers at the end of the Finishing Phase.  The gene expression level f r 
zilpaterol treatment muscle depot was set as baseline and fold difference was alculated 
as described in Material and Methods.  No significant difference was observed betw en 
control and zilpaterol treatment (P < 0.83). 
   
(s) Relative fold difference in myosin heavy chain 2 gene expression in control (green) 
and zilpaterol treatment (red) muscle depot in steers at the end of the Finishing Phase.  
The gene expression level for zilpaterol treatment muscle depotwas set as baseline and 
fold difference was calculated as described in Material and Methods.  No significant 
difference was observed between control and zilpaterol treatment (P < 0.60).  
 
(t) Relative fold difference in calpastatin gene expression in control (green) and zilpaterol 
treatment (red) muscle depot in steers at the end of the Finishing Phase.  Te gene 
expression level for the control muscle depot was set as baseline and fold difference was 
calculated as described in Material and Methods.  No significant difference was observed 
between control and zilpaterol treatment (P < 0.74).  
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ADG     average daily gain 
β-AA     β-adrenergic agonists 
β-AR     β-adrenergic receptor 
βARK1   β-adrenergic receptor kinase1 
BW     body weight 
CF    calf-fed diet 
C/EBP/α   CCAAT/enhancer binding protein alpha 
CRE    cAMP response element 
CREB    cAMP response element binding 
CLA     conjugated linoleic acid 
DE    differentially expressed 
DMI     dry matter intake  
DOF    days on feed 
ECM     extracellular matrix 
FABP4   fatty acid binding protein 4 
FAS     fatty acid synthase 
FDA     food and drug administration 
F:G     feed to gain 
FP    finishing phase 
GP    growing phase 
GRK    G-coupled receptor kinases 
HOL     Holstein 
HCW    hot carcass weight 
HSL     hormone-sensitive lipase 
i.m.    intramuscular 
INT    initial 
JB     Japanese Black 
KPH    kidney, pelvic and heart 
LM    Longissimus muscle 
LCFA     long chain fatty acid 
MAT    malonyl/acetyl-CoA transacylase 
ME    metabolizable energy  
MUFA    monounsaturated fatty acids 
PF    program-fed diet 
PPARγ    peroxisome proliferator-activated receptor-gamma 
PUFA     polyunsaturated fatty acids 
PKA     protein kinase A 
s.c.     subcutaneous 
SCD     stearoyl-CoA desaturase 
SF    silage-fed diet 
SNPs     single nucleotide polymorphisms 
TE     thioesterase  
VEGF     vascular endothelial growth factor 
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Appendices Table A2 
Clone ID, Gene Symbol, Gene Name, Entrez Gene ID, dEST ID, GenBank Accession number, M-value, GO/KEGG ID, and 




WP SF PF CF 
a1d11 ACSM1 Acyl-CoA synthetase medium-chain family member 1 [Bos taurus] 282576 46400009 ES343884 -0.55 -0.71 -0.37 -1.13 00650 Butanoate metabolism
a1e11 ELOVL5 ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) [Bos taurus] 617293 46400023 ES343898 -1.09 -1.25 -1.51 -1.37 01040 Biosynthesis of  unsaturated FAs
a1f09 CLU Clusterin [Bos taurus] 280750 46400043 ES343918 -0.87 -1.01 -0.81 -1.22 (GO:0008219) Cell Death
a2c10 DGAT2 Diacylglycerol O-acyltransferase homolog 2 (mouse) [Bos taurus] 404129 46400128 ES344003 -1.55 -1.69 -1.67 -2.76
00561                        
00830
Glycerolipid metabolism                                                             
Retinol metabolism
a2f05 GPAM Mitochondrial glycerol phosphate acyltransferase [Bos taurus] 497202 46400165 ES344040 1.31 -0.67 -0.91 -0.43
00561                        
00564
Glycerolipid metabolism                                 
Glycerophospholipid metabolism
a2f07 CD36 CD36 molecule (thrombospondin receptor) [Bos taurus] 281052 46400170 ES344045 -2.14 -1.00 -1.50 -1.89
04920                         
03320                         
04512                         
04640
Adipocytokine signaling pathway                            
PPAR signaling pathway                                           
ECM-receptor interaction
Hematopoietic cell lineage
f5e12 FABP4 Fatty acid binding protein 4, adipocyte [Bos taurus] 281759 46400286 ES344161 -1.63 -1.28 -1.96 -1.72 03320 PPAR signaling pathway
f5h15 PSAP Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy) [Bos taurus] 281433 46400357 ES344232 -0.97 -0.08 -0.20 -0.19 (GO:0006629) Lipid metabolism
f5k13 SCD Stearoyl-CoA desaturase (delta-9-desaturase) [Bos taurus] 280924 46400413 ES344288 -1.27 -1.89 -2.36 -2.68
03320                             
01040
PPAR signaling pathway                                                 
Biosynthesis of unsaturated FAs
f5l20 ADIPOQ Adiponectin, C1Q and collagen domain containing [Bos taurus] 282865 46400433 ES344308 -1.07 -1.25 -1.46 -1.80
03320                        
04920
PPAR signaling pathway                              
Adipocytokine signaling pathway
f6k07 PLD1 Predicted: Phospholipase D1, phosphatidylcholine-specific [Homo sapiens] 5337 46400615 ES344490 1.18 -0.62 -0.29 -0.49
00565                              
00564                             
04912
Ether lipid metabolism Glycerophospholipid 
metabolism GnRH signaling pathway 
f8c02 PTGS2  Predicted: Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase & cyclooxygenase) [Bos taurus] 282023 46400821 ES344696 1.08 -0.67 -0.34 -0.66 00590 Arachidonic acid metabolism
f8c05 TM7SF2 Transmembrane 7 superfamily member 2 [Bos taurus] 282384 46400823 ES344698 1.14 0.66 0.83 1.38 00100 Biosynthesis of steroids
f8g23 MSR1 Macrophage scavenger receptor 1 [Bos taurus] 281311 46400898 ES344773 -1.13 -1.61 -1.57 -1.65
(GO:0006817)  
(GO:0006898)
Phosphate transport                                
Receptor-mediated endocytosis
g2j05 CXCL16 Chemokine (C-X-C motif) ligand 16 [Bos taurus] 511671 46401209 ES345084 -1.71 -1.32 -1.92 -1.63 04060 Cytokine-cytokine receptor interaction
g3e21 HADH Hydroxyacyl-Coenzyme A dehydrogenase [Bos taurus] 613570 50172310 EX656787 1.47 -0.51 -0.13 -0.12 (GO:0006631) Fatty acid metabolism
g4h03 APOE Apolipoprotein E [Bos taurus] 281004 46401312 ES345187 -0.55 -0.56 -0.81 -0.93 01510 Neurodegenerative Diseases
g4l23 ACSS2 Predicted: Acyl-CoA synthetase short-chain family member 2 [Bos taurus] 506459 46401399 ES345274 -0.96 -1.46 -1.37 -1.25 (GO:0003824)  Catalytic activity
a2d07 CYCS Predicted: Cytochrome c, somatic [ Bos taurus ] 510767 46400140 ES344015 1.30 -0.04 -0.09 -0.05
04115                         
04210
p53 signaling pathway                              
Apoptosis
f5o23 GCLC Glutamate-cysteine ligase, catalytic subunit [Bos taurus]    (Anti-apoptosis) 512468 46400499 ES344374 1.28 -0.59 -0.22 -0.52 (GO:0006916) Aniti-apoptosis
f6h07 RTN3 Reticulon 3 [Bos taurus] 359721 46400586 ES344461 -1.13 0.17 -0.48 -0.78 (GO:0006915) Apoptosis
g1m22 DNASE1 Deoxyribonuclease I [Bos taurus] 282217 46401119 ES344994 -1.10 0.20 -0.22 -0.25 (GO:0006915) Apoptosis
g4h07 PEA15 Phosphoprotein enriched in astrocytes 15 [Bos taurus] 510586 46401315 ES345190 0.35 0.76 0.94 1.00 (GO:0042981) Regulation of apoptosis
a2d02 CKB Creatine kinase, brain [Bos taurus] 516210 46400130 ES344005 0.46 0.83 1.32 2.24 00330 Arginine and proline metabolism
f5d07 BSG Basigin [Bos taurus] 508716 46400258 ES344133 -1.04 -0.51 -0.80 -0.21 (GO:0005524) ATP binding
f5f18 YY1 YY1 transcription factor [Bos taurus] 534353 46400322 ES344197 -0.93 0.30 0.30 -0.29
(GO:0003676) 
(GO:0008270)
Nucleic acid binding                                                          
Zn binding
f5h18 ZMYM4 Zinc finger, MYM-type 4 [Bos taurus] 529962 46400361 ES344236 -1.17 0.33 0.08 -0.10
(GO:0008270)         
(GO:0005179)
Zn binding                                                     
Hormone activity




Protein binding                                                         
Ca binding                                                   
Phospholipid binding
f5j12 LRRC55 Predicted: Leucine rich repeat containing 55 [ Pan troglodytes ] 466584 46400401 ES344276 1.46 -0.58 -0.31 -0.45
f6k04 PDK4 Pyruvate dehydrogenase kinase, isozyme 4 [Bos taurus] 507367 46400613 ES344488 -0.03 0.67 1.47 0.61 (GO:0005524) ATP binding
f5k15 CCDC75 Coiled-coil domain containing 75 [ Bos taurus ] 512655 46400414 ES344289 1.05 -0.56 -0.32 -0.66 (GO:0003676) binding nucleic acids
f6f23 ZCCHC7 Zinc finger, CCHC domain containing 7 [Bos taurus] 511821 46400576 ES344451 1.09 -0.60 -0.22 -0.38 (GO:0003676) binding nucleic acids
f6p17  ATP11B ATPase, class VI, type 11B [ Homo sapiens ] 
23200
46400673 ES344548 1.131 -0.63 -0.32 -0.45
(GO:0005524) 
(GO:0004012) ATP binding                                              
Phospholipid-translocating ATPase activity
f8b05 ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 [Bos taurus] 536203 46400813 ES344688 1.30 -0.66 -0.32 -0.56 02010 ABC transporters - General
f8c15 SPARC Secreted protein, acidic, cysteine-rich (osteonectin) [Bos taurus] 282077 46400831 ES344706 -0.67 -1.03 -1.49 -1.47
(GO:0005509)  
(GO:0005507)
Ca binding                                                                   
Cu binding
f8f21 DACH1 Similar to  dachshund homolog 1 (Drosophila) [Bos taurus] 537184 46400882 ES344757 1.10 -0.65 -0.32 -0.48 (GO:0000166) binding nucleotides
f8g05 MGC152084 Predicted: Hypothetical protein LOC522276 [Bos taurus] 522276 46400888 ES344763 -1.20 0.13 -0.26 -0.70 (GO:0005509) Ca binding                              













WP SF PF CF 
f8h20 ILF2 Interleukin enhancer binding factor 2, 45kDa [Bos taurus] 539760 46400911 ES344786 1.02 -0.43 -0.22 -0.41
(GO:0005524) 
(GO:0003723)
ATP binding                                                              
RNA binding
f8i24 EHD2 EH-domain containing 2 [Bos taurus] 538348 46400926 ES344801 -0.71 -1.18 -0.97 -0.62
(GO:0005509) 
(GO:0005525)
Ca binding                                                                
GTP binding                             
f8o12 MRLC2 Fast skeletal myosin light chain 2 [Bos taurus] 531505 46400996 ES344871 1.05 2.13 1.75 1.73
04510                        
04530                        
04670                        
04810
Focal adhesion                                                 
Tight junction                                                             
Leukocyte transendothelial migration              
Regulation of actin cytoskeleton
f8p11 CHRAC1 Chromatin accessibility complex 1 [Bos taurus] 510942 46401008 ES344883 1.51 1.59 1.75 1.19 (GO:0043565) Sequence Specific DNA binding
g2c09 S100G S100 calcium binding protein G [Bos taurus] 281658 46401165 ES345040 -0.69 -0.91 -0.12 -0.27
(GO:0005509) 
(GO:0005499)
Ca binding                                                              
Vit.D binding
g3c21 MYL6 Myosin, light chain 6, alkali, smooth muscle and non-muscle [Bos taurus] 281341 50172305 EX656782 0.99 1.42 1.11 1.04 (GO:0005509) Ca binding                              
g3e11 SPARCL1 SPARC-like 1 (mast9, hevin) [Bos taurus] 507537 50172306 EX656783 1.54 0.86 1.66 1.16 (GO:0005509) Ca binding                              
g3i11 TPT1 Tumor protein, translationally-controlled 1 [Bos taurus] 326599 50172315 EX656792 -0.09 0.98 0.84 1.38 (GO:0005509) Ca binding                              
g4d13 DCN Decorin [Bos taurus] 280760 46401261 ES345136 -0.23 -1.32 -0.86 -0.91 04350 TGF-beta signaling pathway
g4k02 GNL3 Guanine nucleotide binding protein-like 3 (nucleolar) [Bos taurus] 506152 46401362 ES345237 1.15 -0.61 -0.23 -0.07 (GO:0005525) GTP binding
g4l06 LCP1 Lymphocyte cytosolic protein 1 (L-plastin) [Bos taurus] 540990 46401383 ES345258 1.08 -0.38 0.09 -0.08
(GO:0005509) 
(GO:0003779)
Ca binding                                                                           
Actin binding
g4m13 SH3PXD2A  Homo sapiens SH3 and PX domains 2A, mRNA 9644 46401408 ES345283 0.30 0.42 0.66 0.91 (GO:0005488) Binding
g4m20 FHL1 Four and a half LIM domains 1 [Bos taurus] 509056 46401413 ES345288 0.63 1.71 1.56 2.55
(GO:0008270) 
(GO:0046872)
Zn binding                                                                        
Metal ion binding
g4o07 TLN1 Talin 1 [ Bos taurus ] 783470 46401435 ES345310 1.07 -0.25 0.09 -0.13 (GO:0005488) Binding
a2g06 GAPDH Glyceraldehyde-3-phosphate dehydrogenase [Bos taurus] 786101 46400184 ES344059 2.49 2.13 2.61 3.62   
f6a03 PCK2 Phosphoenolpyruvate carboxykinase 2 (mitochondrial) [Bos taurus] 282856 46400519 ES344394 -0.95 -0.28 0.00 -0.17
 04920 
00020 








f7b08 PKM2 Predicted: similar to Pyruvate kinase, muscle [Bos taurus] 512571 46400685 ES344560 0.99 1.79 2.02 2.70 (GO:0006096) Glycolysis
f8a13 ALG11 Asparagine-linked glycosylation 11 homolog (S. cerevisiae, alpha-1,2-mannosyltransferase) [Bos taurus] 540845 46400809 ES344684 1.25 -0.34 -0.27 -0.29
01030                               
00510
N-Glycan biosynthesis                                                    
Glycan structures - biosynthesis 
f8d01 LDHB Lactate dehydrogenase B [Bos taurus] 281275 46400838 ES344713 0.28 -0.12 -0.38 -1.10
00272                            
00010                            






g4i20 PFKL Phosphofructokinase, liver [Bos taurus] 508683 46401338 ES345213 0.23 0.20 0.99 0.36 (GO:0006096) Glycolysis
g4p13 GPI Glucose phosphate isomerase [Bos taurus] 280808 46401454 ES345329 0.25 0.57 0.74 1.08
00010                                     




Starch and sucrose metabolism 
f5b15 MAPRE1 Microtubule-associated protein, RP/EB family, member 1 [Bos taurus] 507845 46400229 ES344104 0.93 -0.18 -0.06 -0.20 (GO:0007049) Cell-division cycle
f5h11 NBN Nibrin [Bos taurus] 522943 46400351 ES344226 1.07 -0.53 -0.18 -0.11 (GO:0031575) G1/S transition  checkpoint
f7e10 TIPIN TIMELESS interacting protein [Bos taurus] 506176 46400705 ES344580 1.16 -0.68 -0.34 -0.50 (GO:0007049) Cell-division cycle
g1c17 IGFBP5 Predicted: Insulin-like growth factor binding protein 5 [Homo sapiens] 3488 46401038 ES344913 -1.38 0.09 -0.40 -0.61 (GO:0001558) Regulation of cell growth
g1p15 SEPT4 Septin 4 [Bos taurus] 538801 46401139 ES345014 1.11 0.02 -0.48 -0.64 (GO:0007049) Cell-division cycle
g2e02 SBDS Shwachman-Bodian-Diamond syndrome [Bos taurus] 513237 46401177 ES345052 -1.34 -0.65 -1.06 -0.76
(GO:0042254)    
(GO:0008283)
Ribosome biogenesis/assembly                                   
Cell proliferation
a1g04 FN1 Fibronectin 1 [Bos taurus] 280794 46400056 ES343931 -0.52 -0.85 -1.36 -0.70
01430




Regulation of actin cytoskeleton 
a1h01 ACTB Actin, beta [Bos taurus] 280979 46400070 ES343945 1.93 2.02 1.75 2.19
01430   
 04510 
 04670 








Regulation of actin cytoskeleton 
f5g12 COL6A2 Collagen, type VI, alpha 2 [Bos taurus] 282194 46400332 ES344207 -0.46 -0.72 -0.68 -1.02 (GO:0007155) Cell adhesion
f5m18 COL3A1 Collagen, type III, alpha 1 [Bos taurus] 510833 46400452 ES344327 -0.72 -1.21 -0.75 -0.81 (GO:0005201) ECM glycoprotein
 Term/Pathway
Cell Cytoskeletal/Adhesion/Extracellular Matrix Related
Cell Growth/Differentiation










WP SF PF CF 
f6l17 SUSD5 Sushi domain containing 5 [Homo sapiens] 26032 46400633 ES344508 0.63 -0.72 -0.92 -1.42 (GO:0007155) Cell adhesion
f7d14 DPT Dermatopontin [Bos taurus] 504963 46400699 ES344574 -1.25 0.37 -0.37 -1.03 (GO:0007155) Cell adhesion
f7e19 TMSB4X Thymosin beta 4, X-linked [Bos taurus] 282386 46400710 ES344585 -0.92 -0.98 -0.67 -1.20 04810 Regulation of actin cytoskeleton
f8o03 SPP1 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) [Bos taurus] 281499 46400649 ES344524 1.31 -0.61 -0.26 -0.36
01430  






Toll-like receptor signaling pathway 
a2h09 NMT2 N-myristoyltransferase 2 [Bos taurus] 282049 46400202 ES344077 -1.60 -1.70 -2.00 -2.25 (GO:0042158) Lipoprotein biosynthesis
f8g21 LOC789894 LOC789894 similar to PAP-associated domain-containing protein 5  (TRF4-2) [Bos taurus] 789894 46400896 ES344771 1.25 -0.33 -0.07 0.14 (GO:0016779) Nucleotidyltransferase activity
g4k06 LYZ Lysozyme (renal amyloidosis) [Bos taurus] 781349 46401366 ES345241 1.08 -0.47 -0.34 -0.55  (GO:0016798) Hydrolase activity on glycosyl bonds
f6k24 DPYD Dihydropyrimidine dehydrogenase [Bos taurus] 
281124
46400622 ES344497 1.33 -0.62 -0.30 -0.68
00770              
00240             
00410     
Pantothenate and CoA biosynthesis            
Pyrimidine metabolism                                           
beta-Alanine metabolism
f8f24 NP Nucleoside phosphorylase [Bos taurus] 493724 46400885 ES344760 0.98 -0.56 -0.28 -0.63
00230   
 00760




f8j18 HPRT1 Hypoxanthine phosphoribosyltransferase 1 (Lesch-Nyhan syndrome) [Bos taurus] 281229 46400938 ES344813 -0.64 -0.46 -0.88 -1.30 00230 Purine metabolism
a2a06 UQCRC1 UQCRC1 protein [ Bos taurus ] 282393 46400092 ES343967 0.26 0.93 0.86 0.87 00190 Oxidative Phosphorylation
g4m07 NDUFS5 NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) [ Bos taurus ] 338057 46401405 ES345280 0.16 0.44 0.73 1.19 00190 Oxidative Phosphorylation
g4p08 ATP5O ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit  [ Bos taurus ] 281640 46401450 ES345325 1.15 0.06 -0.28 0.10 00190 Oxidative Phosphorylation
f6b09 CRYZ Crystallin, zeta (quinone reductase) [Bos taurus] 281093 46400523 ES344398 1.01 -0.66 -0.49 -0.45 (GO:0016491) Oxidoreductase Activity
f6k09 MGST1 Microsomal glutathione S-transferase 1 [Bos taurus] 493719 46400617 ES344492 -1.89 -1.43 -1.99 -2.00 00480 Glutathione metabolism





g4g07 PAOX Polyamine oxidase (exo-N4-amino) [Bos taurus] 282639 46401300 ES345175 0.98 -0.25 -0.08 0.51 (GO:0016491) Oxidoreductase Activity
g4h09 PCYOX1 Prenylcysteine oxidase 1 [ Homo sapiens ] 51449 46401317 ES345192 -0.51 0.17 0.82 0.93 (GO:0016491) Oxidoreductase Activity
g4l15 CYP2D6 Cytochrome P450, family 2, subfamily D, polypeptide 6 [Bos taurus] 282211 46401392 ES345267 0.07 0.34 0.80 0.91 (GO:0016491) Oxidoreductase Activity





f5i05 SCPEP1 Serine carboxypeptidase 1 [Bos taurus] 505054 46400371 ES344246 0.75 0.39 0.44 0.90 (GO:0006508) Proteolysis
f5n06 CFB Complement factor B [Bos taurus] 514076 46400462 ES344337 -1.06 -1.13 -1.66 -1.33 04610 Complement/coagulation cascades










Alanine and aspartate metabolism
Alkaloid biosynthesis I







f8a09 FKBP3 FK506 binding protein 3, 25kDa [Bos taurus] 515069 46400807 46400807 1.08 -0.24 0.19 0.17 (GO:0006457) Protein folding
f8e02 DPP8 Dipeptidyl-peptidase 8 [Bos taurus] 536604 46400855 ES344730 -0.35 -0.58 -1.07 -1.23 (GO:0006508) Proteolysis
f8k22 LAP3 Leucine aminopeptidase 3 [Bos taurus] 781648 46400952 ES344827 1.05 -0.57 -0.26 -0.49 00330 Arginine and proline metabolism
g2e20 PLAU Plasminogen activator, urokinase [Bos taurus] 281408 46401183 ES345058 -1.15 0.02 -0.24 -0.52 04610 Complement /coagulation cascades
g2g22 CSTB Cystatin B (stefin B) [Bos taurus] 512805 46401193 46401193 -0.93 0.19 -0.13 -0.06 (GO:0004869) Thiol protease inhibitor
g4d21 PCSK7 Predicted: similar to Proprotein convertase subtilisin/kexin type 7 [Bos taurus] 515398 46401265 ES345140 0.80 0.92 0.78 1.48 (GO:0006508) Proteolysis
g4j14 OAT Ornithine aminotransferase (gyrate atrophy) [Bos taurus] 505323 46401352 ES345227 -1.62 -1.86 -2.23 -1.44 (GO:0004587) Ornithine-oxo-acid transaminase 









Protein Synthesis:Turn Over/Proteolysis/Amino Acid Metabolism









WP SF PF CF 




Antigen processing and presentation
f8k01 LOC616903 LOC616903 similar to cutA divalent cation tolerance homolog [ Bos taurus ] 616903 46400939 ES344814 1.35 -0.58 -0.16 -0.04 (GO:0010038) Response to metal






Regulation of actin cytoskeleton




Wnt signaling pathway 
f5e16 STARD13 StAR-related lipid transfer (START) domain containing 13 [Bos taurus] 538697 46400290 ES344165 0.77 0.48 0.59 1.16 ( GO:0007165) Signal cascade
f6b10 GHRH Growth hormone releasing hormone [Bos taurus] 281191 46400524 ES344399 1.21 -0.56 -0.44 -0.28 04080 Neuroactive ligand-recept interaction
f7i11 TBC1D2B Predicted: TBC1 domain family, member 2B [Bos taurus] 535927 46400737 ES344612 0.98 -0.37 -0.23 -0.45 (GO:0032313)  Regulates RAB GTPase  







f8k18 NCSTN Predicted: Nicastrin [Pan troglodytes] 457435 46400950 ES344825 -0.41 -0.54 -1.31 -1.06 04330 Notch Pathway
g1e23 RAP1A RAP1A, member of RAS oncogene family [Bos taurus] 282031 46401057 ES344932 1.27 -0.23 -0.22 -0.29
 04510   
 04670   
 04720 




MAPK signaling pathway 
g1g17 CDH13 Cadherin 13, H-cadherin (heart) [Bos taurus] 512302 46401067 ES344942 -0.73 -0.25 -0.98 -0.64
(GO:0016601)    
(GO:0007266) 
(GO:0055096)                    
(GO:0050850)
Rac protein signaling                                                                             
Rho protein signaling                                             
Lipoprotein med.signaling                                 
+ regulation  of Ca mediated signaling
g1k22 CHD8 Chromodomain helicase DNA binding protein 8 [Bos taurus] 507111 46401102 ES344977 -1.30 0.21 -0.08 -0.04 04310 Wnt signaling pathway 
g1p19 TAOK1 Similar to TAO kinase 1 [ Pan troglodytes ] 454548 46401142 ES345017 -1.24 0.163 -0.01 -0.2 04010 MAPK signaling pathway
g2c06 PTP4A2 Protein tyrosine phosphatase type IVA, member 2 [Bos taurus] 614435 46401163 ES345038 -1.28 -1.13 -1.83 -1.93 (GO:0004725) Protein-tyrosine-phosphatase activity
g3e13 SRPR Signal recognition particle receptor ('docking protein') [Bos taurus] 281504 50172307 50172307 0.14 0.56 1.43 0.35 (GO:0005047) Signal recognition particle receptor
g4c09 STAT1 Signal transducer and activator of transcription 1, 91kDa [Bos taurus] 510814 46401248 ES345123 1.47 0.25 0.53 0.59 04630 Jak-STAT signaling pathway
g4p15 ADRBK2 Adrenergic, beta, receptor kinase 2 [Bos taurus] 282136 46401456 ES345331 1.22 -0.71 -0.23 -0.39 04740 Olfactory transduction
a2d06 ZNF547 Zinc finger protein 547 [Bos taurus] 512684 46400137 ES344012 0.33 0.27 0.77 1.08 (GO:0006355) Regulation of transcription-DNA dependent
f5c16 LOC507271 LOC507271 Similar to ribosomal protein L4 [Bos taurus] 507271 N/A AV592480 1.17 -0.50 -0.21 -0.48 (GO:0006412) Translation
f5d16 EIF1 Eukaryotic translation initiation factor 1 [Bos taurus] 509764 46400267 ES344142 0.91 0.18 0.26 0.34 (GO:0006413) Translational initiation
f5f05 PCNA Similar to proliferating cell nuclear antigen [Bos taurus] 515499 46400301 ES344176 -0.12 0.72 0.59 0.97
  03410 
  04110 
  03030
  03430 





Nucleotide excision repair 
f5f21 FHL2 Four and a half LIM domains 2 [Bos taurus] 510008 46400324 ES344199 -0.38 0.51 1.13 0.37 (GO:0006357) 
Regulation of transcription from RNA-
Polymerase II 
f7f23 ZNF618 Predicted: Zinc finger protein 618 [ Homo sapiens ] 114991 46400718 ES344593 -1.08 -1.14 -1.19 -1.74 (GO:0006355) Regulation of transcription-DNA dependent





f7p02 EIF3B Predicted: Eukaryotic translation initiation factor 3, subunit B [Bos taurus] 789999 46400794 ES344669 -1.18 -0.03 -0.41 -0.55 (GO:0006413) Translational initiation
g1c20 RBMS1 RNA binding motif, single stranded interacting protein 1 [Bos taurus] 526135 46401040 ES344915 1.03 0.90 0.87 0.80 (GO:0006260) DNA replication
g1i17 PRNP
Prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia)   [Bos 
taurus] 281427
46401085 ES344960 1.04 -0.60 -0.25 -0.49 (GO:0006355) 
Regulation of transcription, DNA-dependent
g1k09 NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) [Bos taurus] 616115 46401099 46401099 -0.82 0.25 -0.28 -1.01
   04920
   04660 
  04210 
   04662 
  04010 
  04620 
Adipocytokine signaling pathway
T cell receptor signaling pathway
Apoptosis
B cell receptor signaling pathway
MAPK signaling pathway                                                            
Toll-like receptor signaling pathway 
g2d17 ZNF280C Zinc finger protein 280C [Homo sapiens] 55609 46401174 ES345049 -1.38 0.16 -0.17 -0.54 (GO:0006355) Regulation of transcription-DNA dependent
g4a06 LOC537712 LOC537712 similar to early B-cell factor [Bos taurus] 537712 46401224 ES345099 1.08 -0.49 -0.25 -0.40
(GO:0006355) 













WP SF PF CF 
g4g08 PRPF38A PRP38 pre-mRNA processing factor 38 (yeast) domain containing A [Bos taurus] 507240 46401301 ES345176 0.17 0.51 0.73 1.18
(GO:0006397) 
(GO:0008380) 
mRNA processing                                                      
RNA splicing
g4j03 HNRNPF Heterogeneous nuclear ribonucleoprotein F [Bos taurus] 506917 46401343 ES345218 -1.29 -0.80 -1.42 -1.23
(GO:0006397) 
(GO:0008380) 
mRNA processing                                                      
RNA splicing
g4l05 PFN1 Predicted: Profilin 1 [Bos tauru ] 513895 46401382 ES345257 1.03 0.21 -0.03 0.67 04810 Regulation of actin cytoskeleton
g4m10 LOC790411 LOC790411 endonuclease reverse transcriptase [Bos taurus] 790411 46402948 ES346823 1.46 -0.47 -0.13 -0.63 (GO:0006278) RNA -dependent DNA replication
a1d10 SLC25A4 Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 [Bos taurus] 282478 46400007 ES343882 -0.08 0.74 0.42 1.00 04020 Calcium signaling pathway
f5d18 CYB5 CYB5 protein [Bos taurus] 281110 46400269 ES344144 -1.11 -0.93 -1.33 -1.38 (GO:0006810) Transport
f5d23 AQP4 Aquaporin 4 [Bos taurus] 281008 46400277 ES344152 0.91 -0.37 0.01 -0.22 (GO:0006810) Transport
f7h10 SLC15A4 Solute carrier family 15, member 4 [Bos taurus] 510499 46400732 ES344607 1.21 -0.48 -0.24 -0.53  (GO:0006857) Oligopeptide transport
g1l22 NUP107 Nucleoporin 107kDa [Bos taurus] 504823 46401111 ES344986 -0.97 -0.18 0.12 0.23 (GO:0006810) Transport
g4l13 BET1L Blocked early in transport 1 homolog (S. cerevisiae)-like [Bos taurus] 509758 46401390 ES345265 1.17 -0.51 -0.22 -0.30 04130 SNARE interaction in vesicle transport
WP SF PF CF 
a1e02 THRSP Thyroid hormone responsive (SPOT14 homolog, rat) [Bos taurus] 515940 46400011 ES343886 -1.23 -0.97 -0.92 -1.34   
a1f06 NOD1 Nucleotide-binding oligomerization domain containing 1 [Bos taurus] 520275 46400037 ES343912 1.10 -0.34 -0.57 -0.04   
a1f11 PEX11G Peroxisomal biogenesis factor 11 gamma [Bos taurus] 506518 46400046 ES343921 0.01 0.25 0.99 0.72   
a1g02 LOC783504 Predicted: LOC783504 similar to ribosomal protein S23 [ Bos taurus ] 783504 46400051 ES343926 1.29 -0.64 -0.34 -0.53
a2c05 PTP4A2 Predicted: Protein tyrosine phosphatase type IVA, member 2 [Canis lupus familiaris] 609835 46400124 ES343999 0.73 0.78 0.81 1.06   
a2h06 BAP1 BRCA1 associated protein-1 [Bos taurus] 100124510 46400199 ES344074 0.88 0.76 1.07 1.49   
f5b22 C28H10ORF116 Chromosome 10 open reading frame 116 ortholog [Bos taurus] 613941 46400234 ES344109 -0.94 0.25 0.13 0.04   
f5c10 LOC619156 Predicted: LOC619156 similar to ribosomal protein L17 [Bos taurus] 619156 46400242 ES344117 1.00 -0.42 -0.07 -0.16   
f5d14 SLC24A6 Predicted: Solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 [ Bos taurus ] 508887 46400264 ES344139 1.14 -0.49 -0.29 -0.26   
f5d15 LOC533444 LOC533444 similar to WD repeat protein Gemin5 [Bos taurus] 533444 46400266 ES344141 0.96 0.49 0.58 0.88   
f5e15 TMEM66 Transmembrane protein 66 [Bos taurus] 515461 N/A EW681864 0.77 0.69 0.90 0.93   
f5g03 MGC139109 MGC139109 hypothetical LOC533333 [Bos taurus] 533333 N/A EH180189 -0.91 -0.15 -0.32 -0.17   
f5g22 LOC100054421 LOC100054421 similar to procollagen alpha 2(V) [ Equus caballus ] 100054421 46400341 ES344216 -1.04 -0.81 -0.86 -0.58   
f5h19 ZNFN1A1 Predicted: Zinc finger protein, subfamily 1A, 1 (Ikaros) [Macaca mulatta] 693936 46400362 ES344237 -1.16 0.34 0.10 0.04   
f5i23 CCNL2 Cyclin L2 [Bos taurus] 538796 46400383 ES344258 -1.72 -1.27 -1.91 -1.81   
f5j06 LOC782311 LOC782311 similar to Tyrosylprotein sulfotransferase 1 [Bos taurus] 782311 46400393 ES344268 0.81 0.61 0.52 0.99   
f5o05 LOC789925 Predicted: LOC789925 similar to Mid-1-related chloride channel 1 [Bos taurus] 789925 N/A EE961626 -1.20 -1.12 -1.52 -1.40
f5o07 LOC783366 LOC783366 similar to Ankyrin repeat domain-containing protein 26 [Bos taurus] 783366 46400488 ES344363 1.07 -0.61 -0.41 -0.58   
f5p16 GRN Granulin [Bos taurus] 767942 46400512 ES344387 -0.18 0.27 -0.43 -0.95   
f6d04 LOC100152073 Predicted: LOC100152073 similar to Stress 70 protein chaperone, microsome-associated, 60kD [Sus scrofa] 100152073 46400543 ES344418 1.11 -0.58 -0.24 -0.34
f6d07 LOC509875 Predicted: Hypothetical protein LOC509875 [Bos taurus] 509875 46400545 ES344420 -0.94 -0.08 -0.48 -0.69   
f6e07 LOC505415 Hypothetical protein LOC505415 [Bos taurus] 505415 46400558 46400558 -0.95 0.17 -0.16 -0.42   
f6f04 DHX16 Predicted: DEAH (Asp-Glu-Ala-His) box polypeptide 16 [Bos taurus] 506405 46400570 ES344445 -1.05 -0.05 -0.59 -1.07   
f6i07 LOC506707 Predicted: LOC506707 similar to C4BP alpha chain [Bos taurus] 506707 46400598 ES344473 1.65 0.07 -0.50 -0.23   
f6l15 SCAMP2 Secretory carrier membrane protein 2 [Bos taurus] 534312 46400631 46400631 0.94 -0.14 0.01 0.16   
f6m23 WDR68 WD repeat domain 68 [Bos taurus] 516678 46400643 ES344518 -0.67 -0.82 -0.94 -0.81   
f6p11 CPM Carboxypeptidase M [Bos taurus] 513281 46400671 ES344546 2.04 -0.33 -0.07 -0.61   
f7a12 C16H1ORF21 Chromosome 1 open reading frame 21 ortholog [Bos taurus] 781721 46400680 ES344555 0.00 0.50 0.78 0.99   
f7a14 MRAS Muscle RAS oncogene homolog [Bos taurus] 540803 46400681 ES344556 -1.31 0.32 -0.35 -0.94   
f7b07 LOC788567  Hypothetical protein LOC788567 [Bos taurus] 788567 46400684 ES344559 0.10 0.36 0.50 1.09   
f7c11 LOC509995
LOC509995 similar to Leucine-rich PPR motif-containing protein, mitochondrial precursor (130 kDa leucine-rich protein) 
(LRP 130) (GP130) [ Bos taurus ] 
509995 46400691 ES344566 1.36 -0.22 0.00 -0.72
f7e16 LOC533350 Predicted: LOC533350 similar to KIAA1451 protein [Bos taurus] 533350 46400709 ES344584 -1.19 -1.16 -0.86 -1.17   
f7g21 MANBAL Mannosidase, beta A, lysosomal-like [Bos taurus] 787482 46400727 ES344602 1.31 -0.42 -0.02 -0.18   
f7k10 ITM2B Predicted: Integral membrane protein 2B [Canis lupus familiaris] 476916 46400755 ES344630 -0.94 0.01 -0.37 -0.47   
f7m07 ANLN Anillin, actin binding protein [Bos taurus] 518274 46400764 ES344639 1.20 -0.30 -0.42 0.05   
f7o22 GOLGA7 Golgi autoantigen, golgin subfamily a, 7 [Bos taurus] 616809 46400793 ES344668 -0.84 -0.99 -1.06 -0.94   
f7p13 LOC100059158
Predicted: LOC100059158 similar to Chain A, Crystal Structure Of Human Translationally Controlled Tumor Associated 
Protein [Equus caballus]
100059158 46400800 ES344675 0.13 0.98 0.70 1.25
f8a08 LOC100137838 LOC100137838 similar to tripartite motif protein TRIM4 [Bos taurus] 100137838 46400806 ES344681 1.49 -0.38 -0.16 -0.70

















WP SF PF CF 
f8c13 SNF8 SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) [Bos taurus] 505628 46400829 ES344704 -1.08 0.26 -0.02 -0.16   
f8d09 RASEF Predicted: RAS and EF-hand domain containing [Bos taurus] 513223 46400842 ES344717 1.02 -0.47 -0.13 -0.10   
f8g22 LOC613996 LOC613996 Similar to FLJ10769 protein [Bos taurus] 613996 46400897 ES344772 1.37 -0.37 -0.10 0.04   
f8l21 MAGED2 Melanoma antigen family D, 2 [Bos taurus] 514372 46400963 ES344838 1.06 -0.36 -0.10 -0.28   
f8m14 LOC782097 Hypothetical protein LOC782097 [Bos taurus] 782097 46400972 ES344847 1.17 -0.58 -0.27 -0.43   
f8n02 DMRT2 Doublesex and mab-3 related transcription factor 2 [Bos taurus] 514435 46400977 ES344852 1.25 0.50 0.62 -0.18   
f8o18 BLOC1S2 Biogenesis of lysosome-related organelles complex-1, subunit 2 [Bos taurus] 519172 46401000 ES344875 -0.61 -0.67 -0.86 -0.96   
g1a20 TGFBRAP1 Transforming growth factor, beta receptor associated protein 1 [Bos taurus] 514660 46401020 ES344895 -0.77 -1.06 -0.91 -1.25   
g1b19 EHBP1 Predicted: EH domain binding protein 1 [Bos taurus] 533149 46401030 46401030 1.00 -0.04 0.22 -0.44   
g1c02 PCYOX1 Prenylcysteine oxidase 1 [Bos taurus] 100125835 46401033 ES344908 -1.21 0.32 -0.38 -0.87   
g1f04 LOC523451   LOC523451 similar to tetratricopeptide repeat domain 9 [Bos taurus] 523451 46401059 ES344934 -0.06 0.76 0.81 1.19    
g1f13 CIDEA Cell death-inducing DFFA-like effector a [Bos taurus] 527051 46401062 ES344937 -0.62 -0.80 -1.05 -0.98   
g1h03 LIPA Lipase A, lysosomal acid, cholesterol esterase [Bos taurus] 100125267 46401072 ES344947 -1.14 -0.85 -1.09 -1.01   
g1h23 UBAC2 UBA domain containing 2 [Bos taurus] 100125312 46401079 ES344954 -1.30 -1.15 -1.36 -1.42    
g1k14 LOC504909 LOC504909 Similar to ATP-binding cassette sub-family A member 10 [Bos taurus] 504909 46401100 ES344975 1.29 -0.59 -0.23 -0.24    
g1l14 LSM14A LSM14A, SCD6 homolog A (S. cerevisiae) [Bos taurus] 538838 46401107 ES344982 -0.72 -1.32 -1.72 -1.35   
g1l24 NDFIP1 Predicted: Nedd4 family interacting protein 1 [Canis lupus familiaris] 478044 46401112 ES344987 -1.32 -0.49 -0.64 -1.47
g1n05 TRAF3IP1 TNF receptor-associated factor 3 interacting protein 1 [Bos taurus] 504984 46401121 ES344996 -1.40 -0.07 -0.76 -1.94    
g1n21 LOC521099  Predicted: Hypothetical  proetin LOC521099 [Bos taurus] 521099 46401127 ES345002 -1.32 0.14 -0.39 -0.48   
g1o09 POLR1D Polymerase (RNA) I polypeptide D [Bos taurus] 616972 46401130 ES345005 -0.65 -0.75 -1.20 -0.70    
g1o20 MGC148679 Hypothetical LOC505853 [Bos taurus] 505853 46401134 ES345009 -1.60 0.13 -0.29 -0.52   
g2a08 FBXO36 F-box protein 36 [Bos taurus] 617339 46401148 ES345023 1.45 -0.18 0.16 0.40   
g2c21 STRN3 Striatin, calmodulin binding protein 3 [Bos taurus] 516375 N/A DV895764 -1.41 -0.78 -1.08 -1.57   
g2c22 LOC532244  LOC532244 similar to microtubule associated monoxygenase, calponin and LIM domain containing 3[Bos taurus] 532244 46401168 ES345043 -1.93 -0.33 -1.22 -2.58   
g2e17 LOC100158124 LOC100158124 similar to MID1 interacting G12-like protein [Sus scrofa] 100158124 46401181 ES345056 -1.06 -0.23 -0.59 -0.88
g2e23 VEZT Vezatin, adherens junctions transmembrane protein [Bos taurus] 535351 46401185 ES345060 1.03 -0.52 -0.31 -0.27   
g2k24 MGC127989  Hypothetical protein MGC127989 [Bos taurus] 767921 46401215 ES345090 -1.10 0.22 0.29 0.08   
g3c15 VSTM1 V-set and transmembrane domain containing 1 [Bos taurus] 618514 50172304 EX656781 1.19 -0.65 -0.34 -0.32   
g3i05 LOC528398 LOC528398 similar to Abelson helper integration site 1 [ Bos taurus ] 528398 N/A N/A 0.474 0.993 0.579 1.535
g4b07 NLRX1 NLR family member X1 [Bos taurus] 539974 46401235 ES345110 1.30 -0.59 -0.08 0.13    
g4c24 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 [Bos taurus] 504278 46401255 ES345130 1.38 -0.29 -0.13 0.22   
g4e15 CDC42BPA CDC42-binding protein kinase alpha [Pan troglodytes] 738981 46401276 ES345151 0.79 0.33 0.96 0.75   
g4f14 LOC787439  Hypothetical protein LOC787439 [Bos taurus] 787439 46401290 ES345165 0.98 -0.22 0.06 -0.04   
g4i06 SETD3 Predicted: SET domain containing 3 [Bos taurus] 512324 46401328 ES345203 -0.92 -0.44 -0.73 -0.62   
g4j12 ROR2 Predicted: Receptor tyrosine kinase-like orphan receptor 2 [Bos taurus] 785924 46401350 ES345225 1.41 0.05 -0.33 -0.46   
g4l21 THUMPD3 Predicted: THUMP domain containing 3 [Pan troglodytes] 460147 46401397 ES345272 0.98 -0.49 -0.17 -0.31
g4m11 FAM32A Family with sequence similarity 32, member A [Bos taurus] 508634 46401407 ES345282 1.19 -0.26 0.22 -0.19   
g4n13 SETMAR SET domain and mariner transposase fusion gene [Bos taurus] 534913 46401423 ES345298 1.11 -0.38 -0.16 -0.30   
g4o12 SASH3 Predicted: SAM and SH3 domain containing 3 [Bos taurus] 534137 46401439 46401439 1.50 -0.05 -0.16 0.68   
g4o16 TXNIP Thioredoxin interacting protein [Bos taurus] 506790 46401442 ES345317 -0.97 -0.13 0.03 -0.16   
g4p10 RSRC1 Arginine/serine-rich coiled-coil 1 [Bos taurus] 509437 46401451 ES345326 -1.15 -0.81 -1.12 -0.99   















f5c15 .. Pan troglodytes RBP4 gene for retinol binding protein4   AB124586 46400247 ES344122 1.00 -0.56 -0.36 -0.65
f5n09 .. Sus scrofa toll-like receptor 4 (TLR4) gene, complete cds  AY753179 46400467 ES344342 0.33 0.48 0.85 0.95   
g2a15 .. Bos taurus X-inactivation center region, Jpx and Xist genes  AJ421481 46401151 ES345026 1.16 -0.18 0.38 0.38   
g2h22 .. Csf1R gene, smf gene, tigd14 gene, slc26a2 gene [Equus caballus]  AJ698944 46401198 ES345073 -0.20 0.97 1.06 1.27   
f5a18 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f5a18ca 3-, mRNA sequence ES344086.1 46400211 ES344086 0.29 -0.83 -0.50 -1.66
f5j14 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f5j14ca 5', mRNA sequence. ES344278.1 46400403 ES344278 1.20 -0.72 -0.43 -0.68
f5l22 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f5l22ca 3-, mRNA sequence ES344310.1 46400435 ES344310 1.08 -0.48 -0.16 -0.49
f5p07 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f5p07ca 3-, mRNA sequence ES344381.1 46400506 ES344381 1.11 -0.69 -0.42 -0.72
f5p21 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f5p21ca 5-, mRNA sequence ES344392.1 46400517 ES344392 -1.32 -1.31 -1.43 -1.95
f6e15 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f6e15ca 3-, mRNA sequence ES344439.1 46400564 ES344439 1.12 -0.56 -0.21 -0.34
f6l01 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f6l01ca 3-, mRNA sequence ES344498.1 46400623 ES344498 1.11 -0.60 -0.40 -0.41
f6o01 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f6o01ca 3-, mRNA sequence ES344529.1 46400654 ES344529 1.01 -0.21 0.01 0.17
f6o18 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f6o18ca 3-, mRNA sequence ES344538.1 46400663 ES344538 1.45 -0.43 -0.51 -0.74
f7g24 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f7g24ca 3-, mRNA sequence ES344605.1 46400730 ES344605 -1.18 -1.11 -1.30 -1.07
f7m19 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f7m19ca 3-, mRNA sequence ES344643.1 46400768 ES344643 0.99 -0.47 -0.43 -0.56
f8f01 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8f01ca 3-, mRNA sequence ES344747.1 46400872 ES344747 -1.11 -0.76 -1.30 -0.89
f8j04 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8j04ca 3-, mRNA sequence ES344804.1 .. 46400929 1.11 -0.66 -0.46 -0.59
f8j07 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8j07ca 3-, mRNA sequence ES344807.1 46400932 ES344807 0.96 -0.13 0.53 -0.10
f8k08 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8k08ca 3-, mRNA sequence ES344819.1 46400944 ES344819 1.22 -0.58 -0.24 -0.25
f8l04 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8l04ca 3-, mRNA sequence ES344829.1 46401104 ES344979 0.92 -0.45 -0.17 -0.28
f8m02 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f8m02ca 3-, mRNA sequence ES344842.1 46400967 ES344842 0.99 -0.47 -0.29 -0.60
g1b14 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone g1b14ca 3-, mRNA sequence ES344901.1 46401026 ES344901 0.03 0.83 1.03 0.80
g1h04 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone g1h04ca 3-, mRNA sequence ES344948.1 46401073 ES344948 -0.74 -0.28 -1.23 -1.25
g1l10 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone g1l10ca 3-, mRNA sequence ES344979.1 46401104 46401104 -1.36 0.40 -0.31 -0.91
g1m12 .. 4095050 BARC 10BOV Bos taurus cDNA clone 10BOV34_B01 3-, mRNA sequence CK955313.1 .. AM30074 0.97 0.48 0.26 0.59
g3e17 .. cattle adipose tissue cDNA library Bos taurus cDNA clone g3e17ca 5-, mRNA sequence EX656785.1 50172308 EX656785 1.41 -0.64 -0.14 -0.37
g3k13 .. cattle adipose tissue cDNA library Bos taurus cDNA clone g3k13ca 5-, mRNA sequence EX656796.1 50172319 EX656796 0.76 0.94 0.71 1.34
g4d08 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone g4d08ca 3-, mRNA sequence ES345133.1 46401258 ES345133 1.26 -0.58 -0.23 -0.45   
f6b03 .. cattle subcutaneous adipose tissue cDNA library Bos taurus cDNA clone f6b03ca 3-, mRNA sequence ES344397.1 46400522 ES344397 0.30 0.48 1.12 0.84
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